0001493152-23-017264.txt : 20230515 0001493152-23-017264.hdr.sgml : 20230515 20230515160109 ACCESSION NUMBER: 0001493152-23-017264 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 64 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230515 DATE AS OF CHANGE: 20230515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CEA Industries Inc. CENTRAL INDEX KEY: 0001482541 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE SERVICES [0700] IRS NUMBER: 273911608 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41266 FILM NUMBER: 23921738 BUSINESS ADDRESS: STREET 1: 1780 55TH STREET, SUITE C CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 303-993-5271 MAIL ADDRESS: STREET 1: 1780 55TH STREET, SUITE C CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: Surna Inc. DATE OF NAME CHANGE: 20100128 10-Q 1 form10-q.htm
0001482541 false --12-31 Q1 Yes Yes 0001482541 2023-01-01 2023-03-31 0001482541 CEAD:CommonStock0.00001ParValueMember 2023-01-01 2023-03-31 0001482541 CEAD:WarrantsToPurchaseCommonStockMember 2023-01-01 2023-03-31 0001482541 2023-05-15 0001482541 2023-03-31 0001482541 2022-12-31 0001482541 2022-01-01 2022-03-31 0001482541 us-gaap:CommonStockMember 2022-12-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001482541 us-gaap:RetainedEarningsMember 2022-12-31 0001482541 us-gaap:CommonStockMember 2021-12-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001482541 us-gaap:RetainedEarningsMember 2021-12-31 0001482541 2021-12-31 0001482541 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001482541 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001482541 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001482541 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001482541 us-gaap:CommonStockMember 2023-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001482541 us-gaap:RetainedEarningsMember 2023-03-31 0001482541 us-gaap:CommonStockMember 2022-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001482541 us-gaap:RetainedEarningsMember 2022-03-31 0001482541 2022-03-31 0001482541 us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-03-31 0001482541 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-03-31 0001482541 CEAD:DirectorAndStaffMember 2023-01-01 2023-03-31 0001482541 CEAD:DirectorAndStaffMember 2022-01-01 2022-03-31 0001482541 2022-01-01 2022-06-30 0001482541 CEAD:MiscellaneousMember 2023-01-01 2023-03-31 0001482541 CEAD:TwoThousandAndTwentyThreeMember CEAD:BookedSalesOrdersFromThreeCustomersMember 2023-03-31 0001482541 CEAD:OneCustomerMember 2023-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerOneMember 2023-01-01 2023-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerTwoMember 2023-01-01 2023-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerThreeMember 2023-01-01 2023-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerOneMember 2022-01-01 2022-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerOneMember 2023-01-01 2023-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerTwoMember 2023-01-01 2023-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerThreeMember 2023-01-01 2023-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerOneMember 2022-01-01 2022-12-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerTwoMember 2022-01-01 2022-12-31 0001482541 CEAD:EquipmentAndSystemsSalesMember 2023-01-01 2023-03-31 0001482541 CEAD:EquipmentAndSystemsSalesMember 2022-01-01 2022-03-31 0001482541 CEAD:EngineeringAndOtherServicesMember 2023-01-01 2023-03-31 0001482541 CEAD:EngineeringAndOtherServicesMember 2022-01-01 2022-03-31 0001482541 us-gaap:ShippingAndHandlingMember 2023-01-01 2023-03-31 0001482541 us-gaap:ShippingAndHandlingMember 2022-01-01 2022-03-31 0001482541 CEAD:MiscellaneousMember 2022-01-01 2022-03-31 0001482541 CEAD:TwoThousandAndTwentyThreeMember 2023-03-31 0001482541 CEAD:TwoThousandAndTwentyFourMember 2023-03-31 0001482541 us-gaap:CostOfSalesMember 2023-01-01 2023-03-31 0001482541 us-gaap:CostOfSalesMember 2022-01-01 2022-03-31 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2023-01-01 2023-03-31 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2022-01-01 2022-03-31 0001482541 CEAD:ProductDevelopmentCostsMember 2023-01-01 2023-03-31 0001482541 CEAD:ProductDevelopmentCostsMember 2022-01-01 2022-03-31 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-03-31 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-03-31 0001482541 CEAD:NewFacilityLeaseMember 2021-07-28 0001482541 CEAD:NewFacilityLeaseMember 2021-07-24 2021-07-28 0001482541 2021-07-28 0001482541 2022-01-01 2022-12-31 0001482541 us-gaap:FurnitureAndFixturesMember 2023-03-31 0001482541 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001482541 us-gaap:VehiclesMember 2023-03-31 0001482541 us-gaap:VehiclesMember 2022-12-31 0001482541 us-gaap:PropertyPlantAndEquipmentMember us-gaap:CostOfSalesMember 2023-01-01 2023-03-31 0001482541 us-gaap:PropertyPlantAndEquipmentMember CEAD:InventoryMember 2023-01-01 2023-03-31 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-01-03 0001482541 CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-01-03 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:JanuarySeventeernTwoThousandTwentyTwoMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember CEAD:JanuarySeventeernTwoThousandTwentyThreeMember 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember CEAD:JanuarySeventeernTwoThousandTwentyTwoMember 2022-01-12 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember CEAD:JanuarySeventeernTwoThousandTwentyThreeMember 2022-01-12 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2023-01-03 0001482541 CEAD:DirectorsMember CEAD:TwoThousandTwentyOneEquityPlanMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-02 2023-01-03 0001482541 srt:DirectorMember 2022-01-12 2022-01-17 0001482541 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-12 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember 2022-01-12 2022-01-17 0001482541 CEAD:AuditCommitteeChairmanMember 2022-01-12 2022-01-17 0001482541 CEAD:CommitteeChairmanMember 2022-01-12 2022-01-17 0001482541 srt:DirectorMember 2023-01-01 2023-03-31 0001482541 2022-01-12 2022-01-17 0001482541 2021-12-30 0001482541 srt:BoardOfDirectorsChairmanMember 2023-03-31 0001482541 2022-02-14 2022-02-15 0001482541 us-gaap:CommonStockMember 2022-02-14 2022-02-15 0001482541 us-gaap:WarrantMember 2022-02-14 2022-02-15 0001482541 us-gaap:WarrantMember 2022-02-15 0001482541 us-gaap:WarrantMember CEAD:UnderwritersMember 2022-02-14 2022-02-15 0001482541 us-gaap:WarrantMember CEAD:UnderwritersMember 2022-02-15 0001482541 2022-06-20 2022-06-21 0001482541 2022-06-21 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-01-01 2023-03-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember us-gaap:RestrictedStockMember 2023-01-01 2023-03-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:NonQualifiedStockOptionMember 2023-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2021-03-22 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2023-01-01 2023-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityIncentivePlanMember CEAD:FiveEmployeesMember 2023-01-01 2023-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2023-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember us-gaap:RestrictedStockMember 2023-01-01 2023-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:NonQualifiedStockOptionMember 2023-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:IncentiveStockOptionMember 2023-03-31 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2023-01-01 2023-03-31 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2022-01-01 2022-03-31 0001482541 srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-01-01 2023-03-31 0001482541 srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2022-01-01 2022-03-31 0001482541 CEAD:DirectorsMember CEAD:TwoThousandTwentyOneEquityPlanMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-16 2023-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:EmployeesDirectorsandConsultantsMember 2023-01-01 2023-03-31 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:EmployeesDirectorsandConsultantsMember 2022-01-01 2022-03-31 0001482541 CEAD:TwoThousandSeventeenAndTwoThousandTwentyOneEquityPlanMember CEAD:DirectorsMember 2023-01-01 2023-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-12-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-03-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-12-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-03-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-12-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2023-01-01 2023-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-03-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2023-03-31 0001482541 CEAD:WarrantsRangeMember 2023-03-31 0001482541 CEAD:WarrantsRangeMember 2023-01-01 2023-03-31 0001482541 CEAD:WarrantsRangeOneMember 2023-03-31 0001482541 CEAD:WarrantsRangeOneMember 2023-01-01 2023-03-31 0001482541 CEAD:WarrantsRangeTwoMember 2023-03-31 0001482541 CEAD:WarrantsRangeTwoMember 2023-01-01 2023-03-31 0001482541 CEAD:WarrantsRangeThreeMember 2023-03-31 0001482541 CEAD:WarrantsRangeThreeMember 2023-01-01 2023-03-31 0001482541 CEAD:OwnershipMember 2023-03-31 0001482541 CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember srt:ChiefExecutiveOfficerMember 2022-10-12 2022-10-13 0001482541 CEAD:LoneStarBioscienceIncMember srt:ChiefExecutiveOfficerMember CEAD:ConsultingAgreementMember 2022-01-01 2022-12-31 0001482541 CEAD:ConsultingAgreementMember 2022-12-19 2022-12-20 0001482541 CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember srt:ChiefExecutiveOfficerMember 2023-01-01 2023-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft CEAD:integer CEAD:Segment

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2023

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 001-41266

 

CEA INDUSTRIES INC.

(Exact name of registrant as specified in its charter)

 

Nevada   27-3911608

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

385 South Pierce Avenue, Suite C

Louisville, Colorado 80027

  80027
(Address of principal executive offices)   (Zip code)

 

(303) 993-5271

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.00001 par value   CEAD   Nasdaq Capital Markets
Warrants to purchase common stock   CEADW   Nasdaq Capital Markets

 

Securities registered pursuant to Section 12(g) of the Act:

 

None

 

Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days. YES ☒ NO ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). YES ☒ NO ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer Accelerated Filer
Non-accelerated Filer Smaller Reporting Company
    Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO

 

As of May 15, 2023, the number of outstanding shares of common stock of the registrant was 8,076,372.

 

 

 

 
 

 

CEA Industries Inc.

Quarterly Report on Form 10-Q

For the Quarterly Period Ended March 31, 2023

 

Table of Contents

 

  Page
Cautionary Statement ii
   
PART I — FINANCIAL INFORMATION  
   
Item 1. Financial Statements (Unaudited)  
   
Condensed Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022 2
   
Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2023 and March 31, 2022 3
   
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Deficit) for the Three Months Ended March 31, 2023 and March 31, 2022 4
   
Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2023 and March 31, 2022 5
   
Notes to the Condensed Consolidated Financial Statements 6
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 26
   
Item 3. Quantitative and Qualitative Disclosures About Market Risk 33
   
Item 4. Controls and Procedures 34
   
PART II — OTHER INFORMATION  
   
Item 1. Legal Proceedings 34
   
Item 1A. Risk Factors 34
   
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 34
   
Item 3. Defaults Upon Senior Securities 35
   
Item 4. Mine Safety Disclosures 35
   
Item 5. Other Information 35
   
Item 6. Exhibits 35
   
SIGNATURES 36
   
EXHIBIT INDEX 37

 

i
 

 

In this Quarterly Report on Form 10-Q, unless otherwise indicated, the “Company”, “we”, “us” or “our” refer to CEA Industries Inc. and, where appropriate, its wholly owned subsidiary.

 

CAUTIONARY STATEMENT

 

This Quarterly Report on Form 10-Q, including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 2, contains forward-looking statements that involve substantial risks and uncertainties. These forward-looking statements are not historical fact but are based on current management expectations that involve substantial risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed in, or implied by, these forward-looking statements. Forward-looking statements relate to future events or our future financial performance. We generally identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of these terms or other similar words. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements including, but not limited to, any projections of revenue, gross profit, earnings or loss, tax provisions, cash flows or other financial items; any statements of the plans, strategies or objectives of management for future operations; any statements regarding current or future macroeconomic or industry-specific trends or events and the impact of those trends and events on us or our financial performance; any statements regarding pending investigations, legal claims or tax disputes; any statements of expectation or belief; and any statements of assumptions underlying any of the foregoing.

 

These forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that could cause our actual results of operations, financial condition, liquidity, performance, prospects, opportunities, achievements or industry results, as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or suggested by, these forward-looking statements. These forward-looking statements are based on assumptions regarding our present and future business strategies and the environment in which we operate. Important factors that could cause those differences include, but are not limited to:

 

  our business prospects and the prospects of our existing and prospective customers;
     
  the impact on our business and that of our customers of the lasting effects of the COVID-19 government response.;
     
 

our overall financial condition, including the impact of higher interest rates and inflation, business disruption due to the COVID-19 pandemic, the Ukraine war, and the supply chains on which we depend;

 

 

the impact on our business from our restructuring and cost containment actions taken in the first quarter of 2023;

 

  the inherent uncertainty of product development and product selection to meet client requirements;
     
  regulatory, legislative and judicial developments, especially those related to changes in, and the enforcement of, cannabis laws;
     
  increasing competitive pressures in the CEA (Controlled Environment Agriculture) industry and our engineering service and product supply position within the industry;
     
  the ability to effectively operate our business, including servicing our existing customers and obtaining new business;
     
  our relationships with our customers and suppliers;

 

ii
 

 

  the continuation of normal payment terms and conditions with our customers and suppliers, including our ability to obtain advance payments from our customers;
     
  general economic conditions, our customers’ operations and access to capital, and market and business disruptions including severe weather conditions, natural disasters, health hazards, terrorist activities, financial crises, political crises or other major events, or the prospect of these events, adversely affecting demand for the products and services offered by us in the markets in which we operate;
     
  the supply of products from our suppliers and our ability to complete contracts, some of which depend on other actors for a comprehensive project completion;
     
  changes in our business strategy or development plans, including our expected level of capital expenses and working capital;
     
  our ability to attract and retain qualified personnel;
     
  our ability to raise equity and debt capital, as needed from time to time, to fund our operations and growth strategy, including possible acquisitions;

 

  our ability to identify, complete and integrate potential strategic acquisitions;
     
  future revenue being lower than expected;
     
  our ability to convert our backlog into revenue in a timely manner, or at all; and
     
  our intention not to pay dividends.

 

These factors should not be construed as exhaustive and should be read with the other cautionary statements in this report.

 

Although we believe that we use reasonable assumptions for these forward-looking statements, any of those assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this Quarterly Report on Form 10-Q should not be regarded as a representation by us that our plans and objectives will be achieved. These risks and uncertainties include those described or identified in “Item 1A – Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022, as updated from time to time in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”). You should not place undue reliance on these forward-looking statements, which apply only as of the date of this Quarterly Report on Form 10-Q. Except as required by the federal securities laws, we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, to reflect events or circumstances occurring after the date of this Quarterly Report on Form 10-Q. The forward-looking statements and projections contained in this Quarterly Report on Form 10-Q are intended to be within the meaning of “forward-looking statements” in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”).

 

iii
 

 

PART I — FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

CEA Industries Inc.

Condensed Consolidated Balance Sheets

(in US Dollars except share numbers)

 

   2023   2022 
   March 31,   December 31, 
   2023   2022 
   (Unaudited)     
ASSETS          
Current Assets          
Cash and cash equivalents  $15,948,077   $18,637,114 
Accounts receivable, net   61,774    2,649 
Inventory, net   441,133    348,411 
Prepaid expenses and other   471,137    1,489,921 
Total Current Assets   16,922,121    20,478,095 
Noncurrent Assets          
Property and equipment, net   60,713    68,513 
Intangible assets, net   1,830    1,830 
Deposits   14,747    14,747 
Operating lease right-of-use asset   436,549    462,874 
Total Noncurrent Assets   513,839    547,964 
           
TOTAL ASSETS  $17,435,960   $21,026,059 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
           
LIABILITIES          
Current Liabilities          
Accounts payable and accrued liabilities  $1,164,134   $1,207,258 
Deferred revenue   1,102,601    4,338,570 
Accrued equity compensation   -    89,970 
Current portion of operating lease liability   120,245    118,235 
Total Current Liabilities   2,386,980    5,754,033 
           
Noncurrent Liabilities          
Operating lease liability, net of current portion   348,179    376,851 
Total Noncurrent Liabilities   348,179    376,851 
           
TOTAL LIABILITIES   2,735,159    6,130,884 
           
Commitments and Contingencies (Note 6)   -    - 
           
SHAREHOLDERS’ EQUITY          
Preferred stock, $0.00001 par value; 25,000,000 shares authorized; 0 shares issued and outstanding   -    - 
Common stock, $0.00001 par value; 200,000,000 authorized; 8,076,372 and 7,953,974 shares issued and outstanding, respectively   81    80 
Additional paid in capital   49,410,899    49,173,836 
Accumulated deficit   (34,710,179)   (34,278,741)
Total Shareholders’ Equity   14,700,801    14,895,175 
           
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY  $17,435,960   $21,026,059 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

2
 

 

CEA Industries Inc.

Condensed Consolidated Statements of Operations

(in US Dollars except share numbers)

(Unaudited)

 

   2023   2022 
  

For the Three Months Ended

March 31,

 
   2023   2022 
Revenue, net  $4,682,573   $1,744,427 
           
Cost of revenue   3,829,297    1,653,919 
           
Gross profit   853,276    90,508 
           
Operating expenses:          
Advertising and marketing expenses   202,323    251,015 
Product development costs   76,413    138,918 
Selling, general and administrative expenses   1,020,702    1,311,777 
Total operating expenses   1,299,438    1,701,710 
           
Operating loss   (446,162)   (1,611,202)
           
Other income (expense):          
Other income (expense), net   5,704    185,000 
Interest income (expense), net   9,020    3,260 
Total other income (expense)   14,724    188,260 
           
Loss before provision for income taxes   (431,438)   (1,422,942)
           
Income taxes   -    - 
           
Net loss  $(431,438)  $(1,422,942)
           
Convertible preferred series B stock dividends   -    (35,984)
Deemed dividend on convertible preferred series B stock on down round   -    (439,999)
           
Net loss available to common shareholders  $(431,438)  $(1,898,925)
           
Loss per common share – basic and diluted  $(0.05)  $(0.41)
           
Weighted average number of common shares outstanding, basic and diluted   8,071,731    4,622,427 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3
 

 

CEA Industries Inc.

Condensed Consolidated Statements of Changes in Shareholders’ Equity (Deficit)

For the Three Months Ended March 31, 2023 and March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

  

Number of

Shares

   Amount  

Paid in

Capital

  

Accumulated

Deficit

  

Shareholders  ’

Equity

 
   Common Stock  

Additional

       
  

Number of

Shares

   Amount  

Paid in

Capital

  

Accumulated

Deficit

  

Shareholders  ’

Equity

 
Balance December 31, 2022   7,953,974   $80   $49,173,836   $(34,278,741)  $       14,895,175 
Fair value of vested stock options granted to employees   -    -    135,748    -    135,748 
Common shares issued in settlement of restricted stock units issued to directors   123,398    1    (1)   -    - 
Fair value of restricted stock units issued to directors   -         101,316         101,316 
Net loss   -    -    -    (431,438)   (431,438)
Balance March 31, 2023   8,077,372   $ 81   $49,410,899   $(34,710,179)  $14,700,801 

 

  

Number of

Shares

   Amount  

Paid in

Capital

  

Accumulated

Deficit

  

Equity

(Deficit)

 
   Common Stock  

Additional

     

Shareholders’

 
  

Number of

Shares

   Amount  

Paid in

Capital

  

Accumulated

Deficit

  

Equity

(Deficit)

 
Balance December 31, 2021    1,600,835   $16   $25,211,017   $(28,781,566)  $(3,570,533)
Fair value of vested stock options granted to employees   -    -    32,938    -    32,938 
Fair value of vested stock options granted to directors   -    -    29,656    -    29,656 
Common shares issued in settlement of restricted stock units issued to directors   3,367    -    24,994    -    24,994 
Fair value of restricted stock units issued to directors   -    -    4,928    -    4,928 
Issuance of common shares to round up partial shares following reverse split   6,798    -    -         - 
Common shares and warrants issued for cash   5,811,138    58    21,711,073    -    21,711,131 
Common shares issued and warrants on conversion of series B preferred stock   362,306    4    1,979,996    -    1,980,000 
Dividends on series B preferred stock   -    -    (35,984)   -    (35,984)
Net loss   -    -    -    (1,422,942)   (1,422,942)
Balance March 31, 2022   7,784,444   $78   $48,958,618   $(30,204,508)  $18,754,188 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4
 

 

CEA Industries Inc.

Condensed Consolidated Statements of Cash Flows

(in US Dollars except share numbers)

(Unaudited)

 

   2023   2022 
  

For the Three Months Ended

March 31,

 
   2023   2022 
Cash Flows From Operating Activities:          
Net loss  $(431,438)  $(1,422,942)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:          
Depreciation and intangible asset amortization expense   7,500    8,556 
Share-based compensation   147,094    92,517 
Provision for doubtful accounts   (1,705)   (22,168)
Provision for excess and obsolete inventory   33,638    3,676 
Loss on disposal of assets   100    5,499 
Amortization of operating lease ROU asset   26,325    25,433 
           
Changes in operating assets and liabilities:          
Accounts receivable   (57,420)   10,610 
Inventory   (126,360)   (631,269)
Prepaid expenses and other   1,018,785    (551,261)
Accounts payable and accrued liabilities   (43,124)   43,438 
Deferred revenue   (3,235,970)   2,645,579 
Operating lease liability, net   (26,662)   (14,811)
Net cash provided by (used in) operating activities   (2,689,237)   192,857 
           
Cash Flows From Investing Activities          
Purchases of property and equipment   -    (13,948)
Proceeds from the sale of property and equipment   200    - 
Net cash provided by (used in) investing activities   200    (13,948)
           
Cash Flows From Financing Activities          
Payment of dividends on series B preferred stock   -    (35,984)
Redemption of series B preferred stock   -    (1,980,000)
Net cash proceeds on sale of common stock and warrants, net of expenses   -    21,711,131 
Net cash provided by financing activities   -    19,695,147 
           
Net change in cash and cash equivalents   (2,689,037)   19,874,056 
Cash and cash equivalents, beginning of period   18,637,114    2,159,608 
Cash and cash equivalents, end of period  $15,948,077   $22,033,664 
           
Supplemental cash flow information:          
Interest paid  $-   $- 
Income taxes paid  $-   $- 
           
Non-cash investing and financing activities:          
Conversion of series B preferred stock   -   $1,980,000 
Deemed dividend on series B preferred stock arising on down round   -   $439,999 
Options issued for accrued equity compensation liability  $89,970   $- 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

5
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Note 1 – Nature of Operations and Significant Accounting Policies

 

Description of Business

 

CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the fastest-growing sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, and tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) air sanitation products, (v) LED lighting, (vi) benching and racking solutions for indoor cultivation, (vii) proprietary and third party controls systems and technologies used for environmental, lighting, and climate control, and (viii) preventive maintenance services, through our partnership with a certified service contractor network, for CEA facilities. Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services, and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.

 

Impact of the COVID-19 Pandemic on Our Business

 

The impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, and working capital.

 

The resulting effects and uncertainties from the COVID-19 pandemic, including the depth and duration of the disruptions to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, cannot be predicted. We expect that the economic disruptions will continue to have an effect on our business over the longer term. Despite this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2022, and continuing into the current fiscal quarter, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.

 

6
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Impact of Ukrainian Conflict

 

Currently, we believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it has a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflationary results of the conflict and government spending for and funding of our country’s response. As our operations are related only to the North American controlled environment agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to this conflict. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.

 

Inflation

 

Recently, our operations have started to be influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build facilities in which we operate. We are likely to continue to face inflationary increases on the cost of products and our operations, which may adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment and other products that we have contracted to provide to our customers, and generally higher prices across all sectors of the economy. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.

 

Financial Statement Presentation

 

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.

 

Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2023. The balance sheet information as of December 31, 2022 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2022.

 

7
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.

 

Use of Estimates

 

Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets and goodwill, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.

 

Cash, Cash Equivalents, and Restricted Cash

 

All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount of $250,000. As of March 31, 2023, the balance in the Company’s accounts was approximately $15,948,000, consequently approximately $15,698,000 of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.

 

Income (Loss) Per Common Share

 

Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.

 

8
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

As of March 31, 2023, and March 31, 2022, there were respectively, 8,010,957 and 8,021,057, potentially dilutive equity instruments outstanding in respect of options outstanding to purchase Company common stock, warrants, and restricted stock units that were convertible into shares of the Company’s common stock. Of these potentially dilutive equity instruments outstanding, 7,623,772 as of March 31, 2023 and 7,794,154 as of March 31, 2022 related to warrants issued in connection with the sale of our shares of series B Preferred stock and common stock in prior periods. The remaining 387,185 potentially dilutive equity instruments outstanding as of March 31, 2023 and 226,903 as of March 31, 2022 related to options and restricted stock units issued to our directors and staff.

 

Goodwill

 

The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its carrying amount, including goodwill. The Company’s fair value is calculated using a market valuation technique whereby an appropriate control premium is applied to the Company’s market capitalization as calculated by applying its publicly quoted share price to the number of its common shares issued and outstanding. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.

 

As of June 30, 2022, the Company experienced a triggering event due to a drop in its stock price and performed a quantitative analysis for potential impairment of its goodwill. Based on this analysis, the Company determined that its carrying value exceeded its fair value. As a result, the Company recorded a non-cash goodwill impairment charge of $631,064 at June 30, 2022. No income tax benefit related to this goodwill impairment charge was recorded at June 30, 2022.

 

Temporary Equity

 

Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the Company. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.

 

Revenue Recognition

 

9
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

The following table sets forth the Company’s revenue by source:

 

   2023   2022 
  

For the Three Months Ended

March 31,

 
   2023   2022 
Equipment and systems sales  $4,396,827   $1,642,572 
Engineering and other services   124,410    86,049 
Shipping and handling   12,560    15,806 
Miscellaneous   148,776    - 
Total revenue  $4,682,573   $1,744,427 

 

Miscellaneous revenue of $148,776 represents non-refundable deposits, forfeited by former customers on previously cancelled contracts.

 

Revenue Recognition Accounting Policy Summary

 

The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.

 

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on the standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.

 

Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.

 

10
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.

 

The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.

 

Disaggregation of Revenue

 

In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).

 

Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by sales, services, shipping and handling, and miscellaneous was required.

 

Other Judgments and Assumptions

 

The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.

 

Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.

 

11
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Contract Assets and Contract Liabilities

 

Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.

 

Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of March 31, 2023 and December 31, 2022, the Company had no contract assets.

 

Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited. As of March 31, 2023, and December 31, 2022, deferred revenue, which was classified as a current liability, was $1,102,601 and $4,338,570, respectively.

 

For the three months ended March 31, 2023, the Company recognized revenue of $3,852,906 related to the deferred revenue at January 1, 2023. For the three months ended March 31, 2022, the Company recognized revenue of $1,162,374 related to the deferred revenue at January 1, 2022.

 

Remaining Performance Obligations

 

Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.

 

Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, the uncertainty regarding the COVID-19 virus, and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.

 

12
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

As of March 31, 2023, the Company’s remaining performance obligations, or backlog, was approximately $1,869,000. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at March 31, 2023, includes booked sales orders of $379,000 from three customers that the Company does not expect to be realized until 2024, if at all. This 2024 projected revenue amount contains a booked sales order of $279,000 (15% of the total backlog) from one customer that we believe is at risk of cancellation based on conversations with this customer. Given the current supply chain and bottleneck issues that are still being worked through by the Company’s supply chain partners, the Company believes that some of its current contracts could be delayed.

 

The remaining performance obligations expected to be recognized through 2024 are as follows:

 

   2023   2024   Total 
Remaining performance obligations related to engineering only paid contracts  $172,000   $-   $172,000 
Remaining performance obligations related to partial equipment paid contracts   1,318,000    379,000    1,697,000 
Total remaining performance obligations  $1,490,000   $379,000   $1,869,000 

 

Product Warranty

 

The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.

 

The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of March 31, 2023, and December 31, 2022, the Company had an accrued warranty reserve amount of $188,738 and $180,457, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.

 

Accounting for Share-Based Compensation

 

The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.

 

The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the three months ended March 31, 2023, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility of 152.23%; expected term in years of 10 and risk-free interest rate of 3.48%.

 

13
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.

 

The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.

 

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2023 and March 31, 2022:

 

   2023   2022 
  

For the Three Months Ended

March 31,

 
   2023   2022 
Share-based compensation expense included in:          
Cost of revenue  $4,898   $791 
Advertising and marketing expenses   1,113    2,762 
Product development costs   3,570    - 
Selling, general and administrative expenses   137,513    88,964 
Total share-based compensation expense included in consolidated statement of operations  $147,094   $92,517 

 

Concentrations

 

Three customers accounted for 39%, 28%, and 17% of the Company’s revenue for the three months ended March 31, 2023. One customer accounted for 35% of the Company’s revenue for the three months ended March 31, 2022.

 

Three customers accounted for 68%, 20%, and 10% of the Company’s accounts receivable as of March 31, 2023. Two customers accounted for 57% and 43% of the Company’s accounts receivable as of December 31, 2022.

 

Recently Issued Accounting Pronouncements

 

In March 2023, the FASB issued ASU 2023-01 to require entities to classify and account for leases with related parties on the basis of legally enforceable terms and conditions of the arrangement. The amendments are effective in periods beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

14
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

In December 2022, the FASB issued ASU No. 2022-06, which defers the sunset date of Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”) from December 31, 2022 to December 31, 2024. ASU No. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In September 2022, the FASB issued Update 2022-04, “Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations”. The update was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in Update 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this update do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard on Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.

 

In March 2020, the FAS issued ASU No. 2020-04 “Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

 

15
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Note 2 – Leases

 

In February 2016 the FASB issued ASU 2016-02, Leases (Topic 842) (“ASC 842” or the “new lease standard”). The Company adopted ASC 842 as of January 1, 2019, using the effective date method.

 

The new standard provides a number of optional practical expedients in transition. The Company has elected to apply the “package of practical expedients” which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii) the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.

 

On July 28, 2021, the Company entered into an agreement to lease 11,491 square feet of office and manufacturing space (the “New Facility Lease”), in Louisville, CO. The New Facility Lease commenced on November 1, 2021 and continues through January 31, 2027. From November 2021 through January 2022, the monthly rent was abated. Beginning February 2022, the monthly rent is $10,055 and will increase by 3% annually every November through the end of the New Facility Lease term. Pursuant to the New Facility Lease, the Company made a security deposit of $14,747. The Company has the option to renew the New Facility Lease for an additional five years. Additionally, the Company pays the actual amounts for property taxes, insurance, and common area maintenance. The New Facility Lease agreement contains customary events of default, representations, warranties, and covenants.

 

Upon commencement of the New Facility Lease, the Company recognized on the balance sheet an operating lease right-of-use asset and lease liability in the amount of $582,838. The lease liability was initially measured as the present value of the unpaid lease payments at commencement and the ROU asset was initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The renewal option to extend the New Facility Lease is not included in the right-of-use asset or lease liability, as the option is not reasonably certain to be exercised. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will include the renewal period in its lease term.

 

The lease cost, cash flows and other information related to the New Facility Lease were as follows:

 

  

As of

March 31, 2023

 
Operating lease right-of-use asset  $436,549 
Operating lease liability, current  $120,245 
Operating lease liability, long-term  $348,179 
      
Remaining lease term   3.8 years 
Discount rate   3.63%

 

  

For the Three

Months Ended

March 31, 2023

 
Operating cash outflow from operating lease  $31,069 

 

16
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Future annual minimum lease payments on the New Facility Lease as of March 31, 2023 are as follows:

 

Years ended December 31,    
2023 (excluding the three months ended March 31, 2023)  $124,897 
2024   128,643 
2025   132,503 
2026   136,473 
Thereafter   11,654 
Total minimum lease payments   534,170 
Less imputed interest   (65,746)
Present value of minimum lease payments  $468,424 

 

Note 3 – Inventory

 

Inventory consisted of the following:

 

   2023   2022 
   March 31,   December 31, 
   2023   2022 
Finished goods  $410,208   $270,555 
Work in progress   154    155 
Raw materials   135,316    148,608 
Allowance for excess & obsolete inventory   (104,545)   (70,907)
Inventory, net  $441,133   $348,411 

 

Overhead expenses of $14,101 and $12,770 were included in the inventory balance as of March 31, 2023, and December 31, 2022, respectively.

 

Advance payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses included approximately $219,000 and $1,176,000 in advance payments for inventory for the periods ended March 31, 2023, and December 31, 2022, respectively.

 

17
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Note 4 – Property and Equipment

 

Property and equipment consisted of the following:

 

   2023   2022 
   March 31,   December 31, 
   2023   2022 
Furniture and equipment  $275,994   $278,389 
Vehicles   15,000    15,000 
Property and equipment, gross   290,994    293,389 
Accumulated depreciation   (230,281)   (224,876)
Property and equipment, net  $60,713   $68,513 

 

Depreciation expense was $7,500 for the three months ended March 31, 2023. For the three months ended March 31, 2023, $1,214 was allocated to cost of sales, $304 was allocated to inventory with the remainder recorded as selling, general, and administrative expense.

 

Note 5 – Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities consisted of the following:

 

   2023   2022 
   March 31,   December 31, 
   2023   2022 
Accounts payable  $714,586   $311,162 
Sales commissions payable   24,468    25,951 
Accrued payroll liabilities   167,697    465,094 
Product warranty accrual   188,738    180,457 
Other accrued expenses   68,645    224,594 
Total  $1,164,134   $1,207,258 

 

Note 6 – Commitments and Contingencies

 

Litigation

 

From time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company’s view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company’s operations or its financial position, liquidity or results of operations.

 

Leases

 

The Company has a lease agreement for its manufacturing and office space. Refer to Note 2 Leases above.

 

Other Commitments

 

In the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.

 

18
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Note 7 – Stockholders’ Equity (Deficit)

 

As of March 31, 2023, the Company had 200,000,000 shares of common stock and 25,000,000 shares of preferred stock authorized at a $0.00001 par value.

 

As of March 31, 2023, 8,076,372 shares of common stock were issued and outstanding and no shares of preferred stock were issued and outstanding.

 

Directors Remuneration

 

On January 3, 2022, the Company issued 3,125 non-qualified stock options under the 2021 Equity Incentive Plan to each of two existing directors. The options had an exercise price of $4.80, vested immediately and had a term ending at the earlier of five years after the date on which the optionee’s continuous service ends, or the tenth anniversary on which the option was granted.

 

On January 17, 2022, the Company issued an RSU grant of 3,367 shares of common stock under the 2021 Equity Incentive Plan to each of two new directors, 1,684 shares of common stock vested immediately on grant date and the remaining 1,683 shares of common stock vested on January 17, 2023. 1,684 shares of common stock were issued on January 17, 2022 to each of the two new directors in settlement of the RSUs that vested immediately and a further 1,683 shares of common stock were issued to each of the two new directors on January 17, 2023 in settlement of the remainder.

 

On January 3, 2023, the Company issued an RSU grant of 29,758 shares of common stock under the 2021 Equity Incentive Plan to each of its four independent directors. The RSUs were granted as an equity retention award pursuant to the Company’s compensation plan for independent directors effective January 17, 2022 and vested immediately on the grant date. A total of 119,032 shares of the Company’s common stock were issued in settlement of the RSUs.

 

Revised Compensation Plan

 

On January 17, 2022, the Board of Directors revised the previously adopted compensation plan. This plan superseded the plan adopted on August 20, 2021. The Plan was effective retroactively for the then current independent directors and for independent directors elected or appointed after the Effective Date.

 

The plan is divided into two phases: from the Effective Date of the Plan until February 9, 2022, the day prior to the listing of the Company securities on Nasdaq. (“Pre-uplist”) and from February 10, 2022, the uplist date forward (“Post-uplist”).

 

Pre-uplist phase: The Company paid its independent directors an annual cash fee of $15,000, payable quarterly in advance on the first business day of each quarter, as consideration for their participation in: (i) any regular or special meetings of the Board or any committee thereof attended in person, (ii) any telephonic meeting of the Board or any committee thereof in which the director is a member, (iii) any non-meeting consultations with the Company’s management, and (iv) any other services provided by them in their capacities as directors (other than services as the Chairman of the Board, the Chairman of the Company’s Audit Committee, and the Committee Chairman).

 

19
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

At the time of initial election or appointment, each independent director received an equity retention award in the form of restricted stock units (“RSUs”). The aggregate value of the RSUs at the time of grant was to be $25,000, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. Vesting of the RSUs was as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date.

 

In addition, on the first business day of January each year, each independent director will also receive an equity retention award in the form of RSUs. The aggregate value of the RSUs at the time of grant will be $25,000, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. These RSUs will be fully vested at date of grant.

 

The Company pays the Audit Committee Chairman an additional annual fee of $10,000, payable quarterly in advance, for services as the Audit Committee Chairman.

 

The Company pays the Chairmen of any other committees of the Board an additional annual fee of $5,000, payable quarterly in advance, for services as a Committee Chairman.

 

There is no additional compensation paid to members of any committee of the Board. Interested (i.e. Executive directors) serving on the Board do not receive compensation for their Board service.

 

Post-uplist phase: The Company will pay its independent directors an annual cash fee of $25,000, payable quarterly in advance on the first business day of each quarter. All other terms remain the same.

 

Each director is responsible for the payment of any and all income taxes arising with respect to the issuance of common stock and the vesting and settlement of RSUs.

 

The Company reimburses independent directors for out-of-pocket expenses incurred in attending Board and committee meetings and undertaking certain matters on the Company’s behalf.

 

All independent directors, Messrs. Shipley, Etten, Reisner, and Mariathasan are subject to the Plan.

 

Each independent director is responsible for the payment of any and all income taxes arising with respect to the issuance of any equity awarded under the plan, including the exercise of any non-qualified stock options.

 

Employee directors do not receive separate fees for their services as directors.

 

Reverse Stock Split

 

On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. The reverse stock split was implemented effective January 27, 2022. The par value for the Common Stock was not affected.

 

An additional 6,798 shares of common stock were issued to round up partial shares following the reverse split.

 

As a result of this reverse stock split, the number of the Company’s shares of common stock issued and outstanding at December 31, 2021 was reduced from 240,125,224 to 1,600,835. All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split for all periods presented.

 

20
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Change in Authorized Share Capital

 

In connection with the aforementioned reverse stock split, the Company’s Board of Directors approved the reduction of the authorized capital of the Company to 200,000,000 shares of common stock and 25,000,000 shares of preferred stock.

 

Equity Raise

 

On February 10, 2022, the Company signed a firm commitment underwriting agreement for the public offering of shares of common stock and warrants, which closed on February 15, 2022. The Company received net proceeds of approximately $22 million for the sale of 5,811,138 shares of common stock and 6,572,808 warrants, each warrant to purchase one share of common stock for five years, exercisable immediately, at an exercise price of $5.00. The Company also issued to the representative of the underwriters 290,557 warrants, each warrant to purchase one share of common stock at an exercise price of $5.1625, during the period commencing August 9, 2022, and expiring on February 10, 2027.

 

Warrant Exercise

 

On June 21, 2022, the Company issued 169,530 shares of its common stock in connection with the cashless exercise of 170,382 prefunded conversion warrants.

 

Note 8 – Equity Incentive Plans

 

2017 Equity Incentive Plan

 

Under the Company’s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the “2017 Equity Plan”), the Board of Directors (the “Board”) (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock unit awards (“RSUs”), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates 333,333 shares of the Company’s common stock (“Plan Shares”) for issuance of equity awards under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity Plan.

 

During the three months ended March 31, 2023, no shares or options were issued, or cancelled under the 2017 Plan.

 

As of March 31, 2023, of the 333,333 shares authorized under the 2017 Plan for equity awards, 163,692 shares have been issued, awards relating to 147,177 options remain outstanding, and 22,464 shares remain available for future equity awards.

 

21
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

2021 Equity Incentive Plan

 

On March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the “2021 Equity Plan”), which was approved by the stockholders on July 22, 2021. The 2021 Equity Plan permits the Board to grant awards of up to 666,667 shares of common stock. The 2021 Equity Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), non-qualified stock options, stock appreciation rights (“SARs”), restricted stock awards and restricted stock unit awards and other equity linked awards to our employees, consultants, and directors. If an equity award (i) expires or otherwise terminates without having been exercised in full or (ii) is settled in cash (i.e., the holder of the award receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant to this Plan.

 

During the three months ended March 31, 2023, the Company issued 122,398 shares of its common stock in settlement of restricted stock units issued to its independent directors under the 2021 Equity Incentive Plan, pursuant to the Director Compensation plan adopted on January 17, 2022.

 

During the three months ended March 31, 2023,138,491 non-qualified stock options were issued to five employees and three former employees in respect of the Company’s 2021 Equity Incentive Plan. The options vested immediately, have a term of 10 years and an exercise price of $0.8955. An expense of $89,970 in respect of this issuance had been accrued in 2022. An additional expense of $32,376 was recognized in 2023 upon management and board finalization and approval of the awards.

 

As of March 31, 2023, of the 666,667 shares authorized under the 2021 Equity Plan, 132,568 shares have been issued in settlement of restricted stock units, awards relating to 183,615 non-qualified stock options, and 40,816 incentive stock options remain outstanding, and 309,668 shares remain available for future equity awards.

 

There was $45,919 in unrecognized compensation expense for unvested non-qualified stock options, and incentive stock options at March 31, 2023 which will be recognized over approximately 2 years.

 

Non-Qualified and Incentive Stock Options

 

A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the three months ended March 31, 2023, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value

 
                 
Outstanding, December 31, 2022   192,073   $8.94    7.6   $            - 
Granted   138,489   $0.90    8.4   $- 
Exercised   -   $-    -   $- 
Forfeited   (500)  $6.10    8.9   $- 
Expired   -   $-    -   $- 
Outstanding, March 31, 2023   330,062   $5.57    7.6   $- 
Exercisable, March 31, 2023   304,972   $5.59    8.2   $- 

 

22
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the three months ended March 31, 2023, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic Value

  

Grant-Date

Fair Value

 
                
Nonvested, December 31, 2022   43,846   $5.65   $  -   $247,730 
Granted   138,489   $0.88   $-   $122,346 
Vested   (156,912)  $1.49   $-   $(234,296)
Forfeited   (333)  $6.67   $-   $(2,225)
Expired   -   $-   $-   $- 
Nonvested, March 31, 2023   25,090   $4.98   $-   $133,555 

 

For the three months ended March 31, 2023 and March 31, 2022, the Company recorded $45,778 and $32,939 as compensation expense related to vested options issued to employees and consultants, net of forfeitures, respectively.

 

A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the three months ended March 31, 2023, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value ($000)

 
                 
Outstanding, December 31, 2022   57,122   $9.44    6.0   $      - 
Granted   -    -    0.0   $- 
Exercised   -    -    -   $- 
Forfeited/Cancelled   -    -    -   $- 
Expired   -    -    -   $- 
Outstanding, March 31, 2023   57,122   $9.44    5.7   $- 
Exercisable, March 31, 2023   57,122   $9.44    5.7   $- 

 

There were no non-vested, non-qualified stock options issued to directors under the 2017 Equity Plan and the 2021 Equity Plan, for the three months ended March 31, 2023.

 

23
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

During the three months ended March 31, 2023 and March 31, 2022, the Company incurred $0 and $29,656 respectively, as compensation expense related to 0 and 6,250 fully vested options issued to directors, respectively.

 

Restricted Stock Units

 

Effective January 3, 2023, the Company issued a total of 119,032 restricted stock units (RSUs) under the 2021 Equity Plan to its four independent directors. These RSUs vested upon grant.

 

Effective January 17, 2023, the Company settled 3,366 RSUs that had been issued on January 17, 2022 to two new directors and that vested after 12 months by the issuance of shares of common stock

 

During the three months ended March 31, 2023 and March 31, 2022, the Company recorded $101,316 and $29,923, respectively, as compensation expense related to vested RSUs issued to directors.

 

  

Number of

Units

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

 
            
Outstanding, December 31, 2022   3,366   $7.42   $- 
Granted   119,032   $0.84   $- 
Vested and settled with share issuance   (122,398)  $1.02   $- 
Forfeited/canceled   -   $-   $- 
Outstanding, March 31, 2023   -   $-   $- 

 

Note 9 - Warrants

 

The following table summarizes information with respect to outstanding warrants to purchase common stock during the three months ended March 31, 2023:

 

           Weighted   Weighted     
           Average   Average   Aggregate 
   Warrants   Exercise   Remaining Life   Intrinsic 
   Outstanding   Exercisable   Price   In Months   Value 
                     
Outstanding at December 31, 2022   7,623,772    7,623,772   $5.14    49         - 
                          
Granted   -    -    -    -    - 
                          
Exercised   -    -    -    -    - 
                          
Expired   -    -    -    -    - 
                          
Outstanding at March 31, 2023   7,623,772    7,623,772   $5.14    46    - 

 

The following table summarizes information about warrants outstanding at March 31, 2023:

 

    Warrants   Weighted Average 
Exercise price   Outstanding   Exercisable   Months Outstanding 
              
 9.45    192,982    192,982    18 
                  
 10.40    34,737    34,737    19 
                  
 5.00    7,105,496    7,105,496    47 
                  
 5.16    290,557    290,557    47 
                  
      7,623,772    7,623,772    46 

 

24
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Note 10 – Income Taxes

 

As of March 31, 2023, the Company has U.S. federal and state net operating losses (“NOLs”) of approximately $26,380,000, of which $11,196,000 will expire, if not utilized, in the years 2034 through 2037, however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to 80%.

 

In addition, pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of the Company’s NOLs carryforwards may be limited in the event of cumulative changes in ownership of more than 50% within a three-year period. In addition, under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”), and corresponding provisions of state law, if a corporation undergoes an “ownership change,” which is generally defined as a greater than 50% change, by value, in its equity ownership over a three-year period, the corporation’s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. Our sale of securities, both in September 2021 and February 2022, will need to be considered for determination of any “ownership change” that we have undergone during a determination period. If an ownership change occurs and our ability to use our net operating loss carryforwards is materially limited, it would harm our future bottom-line operating results by effectively increasing our future tax obligations.

 

The Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the Company believes that recovery is not likely, the Company establishes a valuation allowance. Management’s judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against the net deferred tax assets. The Company recorded a full valuation allowance as of March 31, 2023 and December 31, 2022. Based on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions that are consistent with the Company’s plans. Should the actual amounts differ from the Company’s estimates, the carrying value of the Company’s deferred tax assets could be materially impacted.

 

Note 11 – Related Party Transactions

 

The Company entered into a manufacturer representative agreement with RSX Enterprises (“RSX”) in March 2021 to become a non-exclusive representative for the Company to assist in marketing and soliciting orders. James R. Shipley, a current director of the Company, has a significant ownership interest in RSX.

 

Under the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada and Mexico and may receive a commission for qualified customer leads. The agreement had an initial term through December 31, 2021 with automatic one-year renewal terms unless notice is given 90 days prior to each annual expiration. During the three months ended March 31, 2023 and March 31, 2022, the Company paid $18,273 and $7,555, respectively, in commissions under this agreement.

 

On October 13, 2022, the Company entered into an agreement with Lone Star Bioscience, Inc. (Lone Star) to provide engineering design services. Nicholas Etten, one of our independent directors, is the Chief Executive Officer of Lone Star. The agreement totaled $2,500 with $1,250 received as a deposit in 2022. Another agreement for engineering services was signed on December 20, 2022, in the amount of $10,900. We entered into positive change orders in March of $3,577 increasing the total of the second sales order to $14,477. During the three months ended March 31, 2023, the Company received $14,035 in cash payments for these contracts. Revenue of $16,977 was recorded in the three months ended March 31, 2023 in respect of these agreements.

 

Note 12 – Subsequent Events

 

In accordance with ASC 855, Subsequent Events, the Company has evaluated all subsequent events through the date of issuance of these financial statements issued and determined no material subsequent events occurred after March 31, 2023 for which disclosure was required.

 

25
 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report, which include additional information about our accounting policies, practices, and the transactions underlying our financial results, as well as with our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC. In addition to historical information, the following discussion and other parts of this Quarterly Report contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under “Cautionary Statements” appearing elsewhere herein and the risks and uncertainties described or identified in “Item 1A – Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022, as updated from time to time in the Company’s filings with the SEC, and Part II, Item 1A of this Quarterly Report entitled “Risk Factors.”

 

Non-GAAP Financial Measures

 

To supplement our financial results on U.S. generally accepted accounting principles (“GAAP”) basis, we use non-GAAP measures including net bookings, backlog, as well as adjusted net income (loss) which reflects adjustments for certain non-cash expenses such as stock-based compensation, certain debt-related items and depreciation expense. We believe these non-GAAP measures are helpful in understanding our past performance and are intended to aid in evaluating our potential future results. The presentation of these non-GAAP measures should be considered in addition to our GAAP results and are not intended to be considered in isolation or as a substitute for financial information prepared or presented in accordance with GAAP. We believe these non-GAAP financial measures reflect an additional way to view aspects of our operations that, when viewed with our GAAP results, provide a more complete understanding of factors and trends affecting our business. For purposes of this Quarterly Report, (i) “adjusted net income (loss)” and “adjusted operating income (loss)” mean GAAP net income (loss) and operating income (loss), respectively, after adjustment for non-cash equity compensation expense, debt-related items and depreciation expense, and (ii) “net bookings” means new sales contracts executed during the quarter for which we received an initial deposit, net of any adjustments including cancellations and change orders during the quarter.

 

Our backlog, remaining performance obligations and net bookings may not be indicative of future operating results, and our customers may attempt to renegotiate or terminate their contracts for a number of reasons, including delays in or inability to obtain project financing or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included in the backlog or remaining performance obligations will actually generate revenues or when the actual revenues will be generated.

 

Overview

 

CEA Industries, through our subsidiary, Surna Cultivation Technologies LLC, is a company focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture (“CEA”) industry. The CEA industry aims to optimize the use of horticultural resources such as water, energy, space, capital, and labor, to create an agriculture business that is more efficient and more productive than those that use traditional farming methods. Typically, the CEA industry is focused on indoor agriculture and vertical farming.

 

Headquartered in Colorado, we leverage our experience in the CEA industry to bring our customers a variety of value-added technology solutions that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. We do this by offering our customers a variety of principal service and product offerings that include: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) air sanitation products, (v) LED lighting, (vi) benching and racking solutions for indoor cultivation, (vii) proprietary and third party controls systems and technologies used for environmental, lighting and climate control, and (viii) preventative maintenance services, through our partnership with a certified service contractor network, for CEA facilities.

 

26
 

 

Our revenue stream is currently derived primarily from supplying our products, services and technologies to licensed commercial indoor facilities operating in the cannabis industry. Our customers include state and provincial-regulated CEA growers located primarily in the U.S., Canada. We recently have developed customers in the non-cannabis CEA market to expand our market reach. Customers use our services for building new CEA facilities and expanding or retrofitting existing CEA facilities.

 

CEA growers currently face a challenging business environment that includes high energy costs, water usage and conservation issues, continuously evolving waste removal regulations, inflationary pressures, and labor shortages. In addition to these issues, our cannabis growing customers face increasingly rigorous quality standards and declining cannabis prices in a growing industry whose standards are constantly evolving.

 

We support our clients by providing integrated mechanical, electrical, and plumbing (“MEP”) engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. Over our 16 years in business, we have served hundreds of commercial indoor CEA facilities.

 

We believe our customers partner with us because we have the reputation and experience to help them make cost-conscious and effective decisions on the design and engineering of their indoor cultivation facilities. CEA facilities are resource intensive, and a growing list of states have implemented building code changes that limit energy consumption in cultivation facilities. Energy and resource efficiency is a high priority to us as engineers, and the senior engineers on our team hold the Leadership in Energy and Environmental Design (“LEED”) credential. We believe this sustainability-focused technical experience is crucial in the value we provide to our customers.

 

We have three core assets that we believe will support us as we pursue our business strategy. First, we enjoy strong relationships with relevant stakeholders in the CEA industry. Largely focused in the cannabis segment, our partnerships include relationships with new and existing growers, capital providers, consultants, independent contractors, and numerous other providers in the segment. These partnerships include agreements reached in 2022 with Merida Capital and Hydrobuilder Holdings LLC. In June we announced a marketing arrangement with Merida Capital, a cannabis-focused private equity firm, whereby Merida will use CEA Industries Inc. as its sole provider of certain products and services for its indoor cultivation facilities. This relationship resulted in a new contract in October 2022 with one of Merida’s Connecticut based clients. In November of 2022 we announced a strategic alliance with Hydrobuilder Holdings that we believe will result in more project opportunities.

 

Second, our experience in this industry over time has built up specialized engineering know-how and experience. We have been serving indoor cultivators since 2006 and designing CEA cultivation facilities since 2016. Since then, we have tested and solidified best practices from designing environmental control systems for CEA cultivation facilities.

 

Third, we have a line of proprietary environmental control products that support the specific growing environments that our customers want. We believe these products offer significant benefits to our customers.

 

Shares of our common stock and warrants are traded on the Nasdaq Capital Markets under the ticker symbols “CEAD” and “CEADW”, respectively.

 

Impact of the COVID-19 Pandemic on Our Business

 

As a result of the government measures to control the COVID-19 pandemic, there continue to be disruptions in business operations around the world, with a persistent impact on our business.

 

We still are experiencing delays with our international supply of products and shipments from vendors. While these delays have improved in recent months, we, along with many other importers of goods across all industries, continue to experience supply chain disruption. Also, shipping times are still longer than they were prior to the COVID-19 pandemic. We continue to work diligently with our network of freight partners and suppliers to expedite delivery dates and provide solutions to reduce further impact and delays. However, we are unable to determine the full impact of these delays and how long they will continue as they are out of our control.

 

27
 

 

Impact of Ukrainian Conflict

 

We believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it is having a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflation resulting from the conflict and government spending for the Ukraine and funding of our country’s response. As our operations are related only to the North American controlled agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to this conflict. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.

 

Our Bookings, Backlog and Revenue

 

During the three months ended March 31, 2023, we executed new sales contracts with a total contract value of $767,000. During this same period, we had positive change orders of $59,000. After adjustments for these change orders, our net bookings in the three months ended March 31, 2023 were $826,000, representing an increase of $619,000 (or 300%) from net bookings of $206,000 in the fourth quarter of 2022.

 

Our backlog at March 31, 2023 was $1,869,000, a decrease of $3,709,000, or 67%, from December 31, 2022. The decrease in backlog is the result of higher revenue in the first quarter and lower bookings in the second half of 2022. Our backlog at March 31, 2023 includes booked sales orders of $379,000 (20% of the total backlog) from three customers that we do not expect to be realized until 2024, if at all. Included in the 2024 projected revenue is one booked sales order of $279,000 (15% of the total backlog) from one customer that we believe is at risk of cancellation based on conversations with this customer. We believe the sales orders in these portions of our backlog have an elevated level of risk and may, ultimately, be delayed or cancelled by our customers. Therefore, investors should not view backlog as earned revenue.

 

The following table sets forth: (i) our beginning backlog (the remaining contract value of outstanding sales contracts for which we have received an initial deposit as of the previous period), (ii) our net bookings for the period (new sales contracts executed during the period for which we received an initial deposit, net of any adjustments including cancellations and change orders during the period), (iii) our recognized revenue for the period, and (iv) our ending backlog for the period (the sum of the beginning backlog and net bookings, less recognized revenue). Based on the current economic climate and our cost cutting measures, there is no assurance that we will be able to continue to obtain the level of bookings that we have had in the past and or fulfill our current backlog, and we may experience contract cancellations, project scope reductions and project delays.

 

Our recognized revenue for the quarter ended March 31, 2023, in the table below, excludes $148,776 in revenue arising from the forfeiture of non-refundable deposits from former customers on previously cancelled contracts. The contracts were removed from the backlog at the time of cancellation.

 

   For the quarter ended 
  

March 31,

2022

  

June 30,

2022

  

September 30,

2022

  

December 31,

2022

  

March 31,

2023

 
Backlog, beginning balance  $10,818,000   $11,179,000   $9,698,000   $6,832,000   $5,577,000 
Net bookings, current period  $2,105,000   $1,534,000   $2,197,000   $206,000   $826,000 
Recognized revenue, current period  $1,744,000   $3,015,000   $5,063,000   $1,461,000   $4,534,000 
Backlog, ending balance  $11,179,000   $9,698,000   $6,832,000   $5,577,000   $1,869,000 

 

28
 

 

The completion of a customer’s new build facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for these customers to complete a new build project, which corresponds to when we are able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation systems; (vii) the availability of power; and (viii) delays that are typical in completing any construction project.

 

As has historically been the case for the Company at each quarter-end, there remains significant uncertainty regarding the timing of revenue recognition of our backlog as of March 31, 2023.

 

We have provided an estimate in our condensed consolidated financial statements for when we expect to recognize revenue on our remaining performance obligations (i.e., our Q1 2023 backlog), using separate time bands, with respect to engineering only paid contracts and partial equipment paid contracts. There continues to be significant uncertainty regarding the timing of our recognition of revenue on our Q1 2023 backlog. Refer to the Revenue Recognition section of Note 1 in our condensed consolidated financial statements, included as part of this Quarterly Report for additional information on our estimate of future revenue recognition on our remaining performance obligations.

 

Our backlog, remaining performance obligations, and net bookings may not be indicative of future operating results, and our customers may attempt to renegotiate or terminate their contracts for a number of reasons, including delays in or inability to obtain project financing or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included in backlog or remaining performance obligations will generate revenues or when the revenues will be generated. Net bookings and backlog are considered non-GAAP financial measures, and therefore, they should be considered in addition to, rather than as a substitute for, our GAAP measures for recognized revenue, deferred revenue, and remaining performance obligations. Further, we can provide no assurance as to the profitability of our contracts reflected in remaining performance obligations, backlog and net bookings.

 

Results of Operations

 

Comparison of Three Months Ended March 31, 2023 and March 31, 2022

 

Revenues and Cost of Goods Sold

 

Revenue for the three months ended March 31, 2023 was $4,683,000, compared to $1,744,000 for the three months ended March 31, 2022, representing an increase of $2,939,000, or 169%. The increase was primarily due to improvements in our supply chain and the ability to deliver products with fewer delays on contract fulfillment and revenue recognition on existing contracts.

 

Cost of revenue increased by $2,175,000, or 132%, from $1,654,000 for the three months ended March 31, 2022 to $3,829,000 for the three months ended March 31, 2023. The increase was primarily due to an increase in revenue and a decrease in fixed costs as a percentage of revenue, as discussed below.

 

Our gross profit for the three months ended March 31, 2023 was $853,000 compared to $91,000 for the three months ended March 31, 2022, an increase of 837%. Gross profit margin increased by 13 percentage points from 5.2% for the three months ended March 31, 2022 to 18.2% for the three months ended March 31, 2023 primarily due to higher revenue and a decrease in fixed costs as a percentage of revenue, as described below. Additionally, total revenue in the three months ended March 31, 2023 includes $149,000 from forfeited, non-refundable deposits from former customers on previously cancelled contracts.

 

Our fixed costs (which include engineering, service, manufacturing and project management salaries and benefits and manufacturing overhead) totaled $391,000, or 8.3% of total revenue, for the three months ended March 31, 2023 as compared to $359,000, or 21% of total revenue, for the three months ended March 31, 2022. The increase of $32,000 was primarily due to an increase in salaries and benefits (including stock-based compensation) of $30,000.

 

29
 

 

Our variable costs (which include the cost of equipment, outside engineering costs, shipping and handling, travel and warranty costs) totaled $3,439,000, or 73% of total revenue, during the three months ended March 31, 2023, as compared to $1,295,000, or 74% of total revenue, in the three months ended March 31, 2022. The increase in variable costs was primarily due to: (i) an increase in equipment costs of $2,136,000 driven by higher revenue and slightly lower equipment margins, (ii) an increase in excess and obsolete inventory expense of $30,000, (iii) an increase in warranty expense of $6,000, offset by, (iv) a decrease in outside engineering costs of $17,000, and (v) a decrease in travel of $13,000.

 

We continue to focus on gross margin improvement through a combination of efforts, including more disciplined pricing, better absorption of our fixed costs as we convert our bookings into revenue, and the implementation over time of lower-cost supplier alternatives.

 

Operating Expenses

 

Operating expenses decreased to $1,299,000 for the three months ended March 31, 2023, from $1,702,000 for the three months ended March 31, 2022, a decrease of $403,000, or 24%. The operating expense decrease consisted of: (i) a decrease in selling, general and administrative expenses (“SG&A expenses”) of $291,000, (ii) a decrease in product development of $63,000, and (iii) a decrease in advertising and marketing expenses of $49,000.

 

Our decrease in SG&A expenses for the three months ended March 31, 2023 compared to the three months ended March 31, 2022, was primarily due to: (i) a decrease of $202,000 in salaries and benefits (including stock-based compensation) and other employee related costs, (ii) a decrease in accounting and other professional fees of $127,000, (iii) a decrease in travel of $21,000, (iv) a decrease of $12,000 for facility and office expenses, (v) a decrease in loss on asset disposal of $5,000, offset by (i) an increase in insurance of $21,000, (ii) an increase for investor relations and board fees of $21,000, (iii) an increase in bad debt expense of $20,000, (iv) an increase of $11,000 for commissions, and (v) an increase in business taxes and licenses of $3,000.

 

The decrease in product development costs was due to (i) a decrease in salaries and benefits (including stock-based compensation) of $47,000, (ii) a decrease in R&D consulting and materials expense of $10,000, and a decrease in travel of $6,000.

 

The decrease in marketing expenses was primarily due to (i) a decrease in outside services and other marketing expenses of $31,000, (ii) a decrease in advertising and promotion of $28,000, offset by (iii) an increase of $11,000 in salaries and benefits, primarily due to severance payments from our reduction in force in February.

 

Operating Income (Loss)

 

We recognized an operating loss of $446,000 for the three months ended March 31, 2023, as compared to an operating loss of $1,611,000 for the three months ended March 31, 2022, a decrease of $1,165,000 or 72%. The operating loss for the three months ended March 31, 2023 included $147,000 of non-cash, stock-based compensation, and $6,000 of depreciation expense, compared to $93,000 of non-cash, stock-based compensation and $7,000 of depreciation expense for the three months ended March 31, 2022. Excluding these non-cash items, our operating loss decreased by $1,219,000.

 

Other Income (Expense)

 

We recognized other income (net) of $15,000 for the three months ended March 31, 2023, compared to other income (net) of $188,000 for the three months ended March 31, 2022. Other income for the three months ended March 31, 2023 primarily consisted of interest income on a money market account. Other income for the three months ended March 31, 2022 primarily consisted of proceeds from an insurance settlement.

 

30
 

 

Net Income (Loss)

 

Overall, we recognized a net loss of $431,000 for the three months ended March 31, 2023, as compared to a net loss of $1,423,000 for the three months ended March 31, 2022, a decrease of $992,000 or 70%. The net loss for the three months ended March 31, 2023 included $147,000 of non-cash, stock-based compensation, and $6,000 of depreciation expense, compared to $93,000 of non-cash, stock-based compensation and $7,000 of depreciation expense for the three months ended March 31, 2022. Excluding these non-cash items, our net loss decreased by $1,045,000.

 

Financial Condition, Liquidity and Capital Resources

 

Cash, Cash Equivalents

 

As of March 31, 2023, we had cash and cash equivalents of $15,948,000, compared to cash and cash equivalents of $18,637,000 as of December 31, 2022. The $2,689,000 decrease in cash and cash equivalents during the three months ended March 31, 2023, was primarily the result of cash used in operations. Our cash is held in bank depository accounts in a financial institution. During the three months ended March 31, 2023, we held deposits in this financial institution that exceeded the federally insured amount.

 

As of March 31, 2023, we had accounts receivable (net of allowance for doubtful accounts) of $62,000, inventory (net of excess and obsolete allowance) of $441,000, and prepaid expenses and other assets of $471,000 (including $219,000 in advance payments on inventory purchases). While we typically require advance payment before we commence engineering services or ship equipment to our customers, we have made exceptions requiring us to record accounts receivable, which carry a risk of non-collectability especially since most of our customers are funded on an as-needed basis to complete facility construction. We expect our exposure to accounts receivable risk to increase as we continue to pursue larger projects.

 

As of March 31, 2023, we had total accounts payable and accrued expenses of $1,164,000, deferred revenue of $1,103,000, and the current portion of operating lease liability of $120,000. As of March 31, 2023, we had working capital of $14,535,000, compared to working capital of $14,724,000 as of December 31, 2022. The decrease in our working capital was primarily related to (i) a decrease in deferred revenue of $3,236,000, (ii) a decrease in cash of $2,689,000, and (iii) a decrease in prepaid expense of $1,019,000.

 

We currently intend to retain all available funds and any future earnings for use in the operation and expansion of our business. We have never declared or paid any cash dividends on our common stock and do not anticipate paying any cash dividends in the foreseeable future.

 

Because of the post-pandemic macro-economic and CEA industry economy that has developed during 2021 and 2022, and is continuing into 2023, we cannot predict the continuing level of working capital that we will have in the future. Additionally, we cannot predict that our future financial position will not deteriorate due to cancelled or delayed contract fulfillment, reduced sales and our ability to perform our contracts. As mentioned elsewhere, we have taken steps to conserve our cash resources by reducing staff and taking other cost-cutting measures.

 

Summary of Cash Flows

 

The following summarizes our approximate cash flows for the three months ended March 31, 2023 and March 31, 2022:

 

  

For the Three Months Ended

March 31,

 
   2023   2022 
Net cash used in operating activities  $(2,689,000)  $193,000 
Net cash used in investing activities   -    (14,000)
Net cash provided by financing activities   -    19,695,000 
Net increase (decrease) in cash  $(2,689,000)  $19,874,000 

 

31
 

 

Operating Activities

 

We incurred a net loss for the three months ended March 31, 2023 of $431,000 and have an accumulated deficit of $34,710,000 as of March 31, 2023.

 

Cash used in operations for the three months ended March 31, 2023 was $2,689,000 compared to cash provided from operating activities of $193,000 for the three months ended March 31, 2022, an increase in cash usage of $2,882,000.

 

The increase in cash used in operating activities during the three months ended March 31, 2023 as compared to the three months ended March 31, 2022, was primarily attributable to: (i) an increase in cash used to fund working capital of $4,063,000, (ii) a decrease in net loss of $992,000, and (iii) an increase in non-cash operating charges of $189,000.

 

The decrease in our working capital was primarily related to (i) a decrease in deferred revenue of $3,236,000, (ii) a decrease in cash of $2,689,000, and (iii) a decrease in prepaid expense of $1,019,000.

 

The increase in non-cash operating charges was primarily due to higher share-based compensation of $145,000 and an increase in the provision for excess and obsolete inventory of $30,000.

 

Investing Activities

 

Cash used in investing activities during the three months ended March 31, 2023 was $0. Cash used in investing activities during the three months ended March 31, 2022 of $14,000 was related to the purchase of property and equipment.

 

Financing Activities

 

There were no cash flows from financing activities during the three months ended March 31, 2023.

 

Cash flows from financing activities during the three months ended March 31, 2022, was the result of cash proceeds from the sale of common stock and warrants (net of issuance costs) of $21,711,000, offset by a cash payment of $2,016,000 for the redemption of series B preferred stock, including related dividends.

 

Common Stock Equity Offering

 

On February 10, 2022, the Company signed a firm commitment underwriting agreement for the public offering of shares of common stock and warrants, which closed on February 15, 2022. The Company received net proceeds of approximately $21,711,000 for the sale of 5,811,138 shares of common stock and 6,572,808 warrants, each warrant to purchase one share of common stock for five years, exercisable immediately, at an exercise price of $5.00. The Company also issued to the representative of the underwriters 290,557 warrants, each warrant to purchase one share of common stock at an exercise price of $5.16, during the period commencing August 9, 2022, and expiring on February 10, 2027.

 

The net proceeds from the offering will be used to advance the Company’s organic growth and new product initiatives, to pursue select acquisitions, and for general corporate and working capital purposes. In connection with this offering, we received approval to list our common stock on the Nasdaq Capital Market under the symbol “CEAD” and our warrants under the symbol “CEADW”. Effective February 10, 2022, trading of both shares of the Company’s common stock and certain of the Company’s warrants commenced on the Nasdaq.

 

32
 

 

Inflation

 

Recently, our operations have started to be influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build facilities in which we operate. We are likely to continue to face inflationary increases on the cost of products and our operations, which may adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment and other products that we have contracted to provide to our customers, and generally higher prices across all sectors of the economy. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.

 

Contractual Payment Obligations

 

As of March 31, 2023, our contractual payment obligations consisted of a building lease. Refer to Note 2Leases of the notes to the condensed consolidated financial statements, included as part of this Quarterly Report for a discussion of building lease.

 

Commitments and Contingencies

 

Refer to Note 6 – Commitments and Contingencies of the notes to the condensed consolidated financial statements, included as part of this Quarterly Report for a discussion of commitments and contingencies.

 

Off-Balance Sheet Arrangements

 

We are required to disclose any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that are material to investors. As of March 31, 2023, we had no off-balance sheet arrangements. During the three months ended March 31, 2023, we did not engage in any off-balance sheet financing activities other than those included in the “Contractual Payment Obligations” discussed above and those reflected in Note 6 of our condensed consolidated financial statements.

 

Recent Developments

 

Refer to Note 12 - Subsequent Events of the notes to condensed consolidated financial statements, included as part of this Quarterly Report for certain significant events occurring since March 31, 2023.

 

Critical Accounting Estimates

 

This discussion and analysis of our financial condition and results of operations is based upon our condensed consolidated financial statements, which have been prepared in conformity with accounting principles generally accepted in the United States of America. Certain accounting policies are particularly important to the understanding of our financial position and results of operations and require the application of significant judgment by our management or can be materially affected by changes from period to period in economic factors or conditions that are outside of our control. As a result, they are subject to an inherent degree of uncertainty. In applying these policies, management uses their judgment to determine the appropriate assumptions to be used in the determination of certain estimates. Those estimates are based on our historical operations, our future business plans and projected financial results, the terms of existing contracts, observance of trends in the industry, information provided by our customers, and information available from other outside sources, as appropriate. Actual results could materially differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company, as defined by Rule 12b-2 of the Exchange Act, therefore are not required to provide the information under this item.

 

33
 

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Chief Executive Officer and our Principal Financial and Accounting Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our Chief Executive Officer and Principal Financial and Accounting Officer concluded that as a result of material weakness in our internal control over financial reporting as described in Item 9A of our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC, our disclosure controls and procedures were not effective as of March 31, 2023.

 

We did not maintain effective controls over certain aspects of the financial reporting process because: (i) we lack a sufficient complement of personnel with a level of accounting expertise and an adequate supervisory review structure that is commensurate with our financial reporting requirements, (ii) there is inadequate segregation of duties due to our limited number of accounting personnel, and (iii) we have insufficient controls and processes in place to adequately verify the accuracy and completeness of spreadsheets that we use for a variety of purposes including revenue, taxes, stock-based compensation and other areas, and place significant reliance on, for our financial reporting.

 

We intend to take appropriate and reasonable steps to make the necessary improvements to remediate these deficiencies. We are committed to continuing to improve our financial organization including, without limitation, expanding our accounting staff and improving our systems and controls to reduce our reliance on the manual nature of our existing systems. However, due to our size and our financial resources, remediating the several identified weaknesses has not been possible and may not be economically feasible now or in the future.

 

Changes in Internal Control over Financial Reporting

 

There were no changes identified in connection with our internal control over financial reporting during the three months ended March 31, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II — OTHER INFORMATION

 

Item 1. Legal Proceedings

 

We are not currently a party to any material legal proceedings, nor are we aware of any pending or threatened litigation that would have a material adverse effect on our business, operating results, cash flows, or financial condition should such litigation be resolved unfavorably. We have and will continue to have commercial disputes arising in the ordinary course of our business.

 

Item 1A. Risk Factors

 

In addition to the information set forth in this Form 10-Q, you should also carefully review and consider the risk factors contained in our other reports and periodic filings with the SEC, including, without limitation, the risk factors and uncertainties contained under the caption “Item 1A—Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022 that could materially and adversely affect our business, financial condition, and results of operations. The risk factors discussed in that Form 10-K do not identify all risks that we face because our business operations could also be affected by additional factors that are not known to us or that we currently consider to be immaterial to our operations.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

34
 

 

Item 3. Defaults upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

On April 10, 2023, the Company received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between February 24, 2023, through April 6, 2023, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated that the Company will be provided with a compliance period of 180 calendar days, or until October 9, 2023 (the “Compliance Period”), in which to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A).

 

In order to regain compliance with Nasdaq’s minimum bid price requirement, the Company’s common stock must maintain a minimum closing bid price of $1.00 for at least ten consecutive business days during the Compliance Period. In the event the Company does not regain compliance by the end of the Compliance Period, the Company may be eligible for additional time to regain compliance. To qualify for the additional time, the Company will be required to meet the continued listing requirement for the market value of its publicly held shares and all the other listing standards for The Nasdaq Capital Market and will need to provide written plan to cure the deficiency during the second compliance period. The Company may be granted an additional 180 calendar days to regain compliance if the plan is accepted by Nasdaq. However, if it appears to Nasdaq that the Company will be unable to cure the deficiency, or if the Company is not otherwise eligible for the additional cure period, Nasdaq will provide notice that the Company’s common stock will be subject to delisting.

 

The letter has no immediate impact on the listing of the Company’s common stock, which will continue to be listed and traded on The Nasdaq Capital Market, subject to the Company’s compliance with the other listing requirements of The Nasdaq Capital Market.

 

 

Item 6. Exhibits

 

The documents listed in the Exhibit Index of this Form 10-Q are incorporated by reference or are filed with this Form 10-Q, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).

 

35
 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  CEA INDUSTRIES INC.
  (the “Registrant”)
     
Dated: May 15, 2023 By: /s/ Anthony K. McDonald
    Anthony K. McDonald
    Chief Executive Officer and President
    (Principal Executive Officer)
     
Dated: May 15, 2023 By: /s/ Ian K. Patel
    Ian K. Patel
    Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

36
 

 

EXHIBIT INDEX

 

Exhibit    
Number   Description of Exhibit
     
31.1 *   Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
31.2 *   Certification of Principal Financial and Accounting Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
32.1**   Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
32.2**   Certification of Principal Financial and Accounting, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
 101.INS*   Inline XBRL Instance Document
     
101.SCH*   Inline XBRL Taxonomy Schema
     
101.CAL*   Inline XBRL Taxonomy Calculation Linkbase
     
101.DEF*   Inline XBRL Taxonomy Definition Linkbase
     
101.LAB*   Inline XBRL Taxonomy Label Linkbase
     
101.PRE*   Inline XBRL Taxonomy Presentation Linkbase
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

* Filed herewith.
** Furnished herewith.

 

37

EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION PURSUANT TO RULE 13a-14(a) and 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

 

I, Anthony K. McDonald, the Chief Executive Officer of CEA Industries Inc. certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of CEA Industries Inc. for the quarterly period ended March 31, 2023;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated May 15, 2023.

 

By: /s/ Anthony K. McDonald  
 

Anthony K. McDonald

Chief Executive Officer

 

 

 

EX-31.2 3 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATION PURSUANT TO RULE 13a-14(a) and 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

 

I, Ian K. Patel, the Principal Financial and Accounting Officer of CEA Industries Inc. certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of CEA Industries Inc. for the quarterly period ended March 31, 2023;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated May 15, 2023.

 

By: /s/ Ian K. Patel  
 

Ian K. Patel

Chief Financial Officer

 

 

 

EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the “Report”) of CEA Industries Inc. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, Anthony K. McDonald, the Chief Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

    /s/ Anthony K. McDonald
  Name: Anthony K. McDonald,
    Chief Executive Officer
  Date: May 15, 2023

 

This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

 

 

EX-32.2 5 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the “Report”) of CEA Industries Inc. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, Ian K. Patel, the Principal Financial and Accounting Officer of the Registrant, hereby certify, to the best of my knowledge, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

    /s/ Ian K. Patel
  Name: Ian K. Patel,
    Chief Financial Officer
  Date: May 15, 2023

 

This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

 

 

EX-101.SCH 6 cead-20230331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Nature of Operations and Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Accounts Payable and Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Stockholders’ Equity (Deficit) link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Equity Incentive Plans link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Nature of Operations and Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Nature of Operations and Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Equity Incentive Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Schedule of Revenue by Source (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Schedule of Share-based Compensation Costs (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Nature of Operations and Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Schedule of Lease Cost (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Leases (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Schedule of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Inventory (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Schedule of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Property and Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Stockholders’ Equity (Deficit) (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Schedule of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Schedule of Restricted Stock Units Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Equity Incentive Plans (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Schedule of Warrants Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 cead-20230331_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 cead-20230331_def.xml XBRL DEFINITION FILE EX-101.LAB 9 cead-20230331_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, $0.00001 par value Warrants to purchase common stock Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Series B Preferred Stock [Member] Title of Individual [Axis] Director And Staff [Member] Product and Service [Axis] Miscellaneous [Member] Award Date [Axis] 2023 [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Booked Sales Orders From Three Customers [Member] One Customer [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Customer [Axis] Customer One [Member] Customer Two [Member] Customer Three [Member] Accounts Receivable [Member] Equipment And Systems Sales [Member] Engineering And Other Services [Member] Shipping and Handling [Member] 2024 [Member] Income Statement Location [Axis] Cost of Sales [Member] Advertising And Marketing Expenses [Member] Product Development Costs [Member] Selling, General and Administrative Expenses [Member] New Facility Lease [Member] Long-Lived Tangible Asset [Axis] Furniture and Fixtures [Member] Vehicles [Member] Property, Plant and Equipment [Member] Inventory [Member] Award Type [Axis] Non-Qualified Stock Options [Member] Plan Name [Axis] 2021 Equity Incentive Plan [Member] Restricted Stock Units (RSUs) [Member] January 17, 2022 [Member] January 17, 2023 [Member] Directors [Member] 2021 Equity Plan [Member] Director [Member] Audit Committee Chairman [Member] Committee Chairman [Member] Board of Directors Chairman [Member] Warrant [Member] Underwriters [Member] 2017 Equity Incentive Plan [Member] Restricted Stock [Member] Derivative Instrument [Axis] Non Qualified Stock Option [Member] Five Employees [Member] Incentive Stock Option [Member] 2017 Equity Plan and 2021 Equity Plan [Member] Related Party, Type [Axis] Employees And Consultants [Member] Employees, Directors and Consultants [Member] 2017 Equity Plan and 2021 Equity Plan [Member] Exercise Price Range [Axis] Warrants Range [Member] Warrants Range One [Member] Warrants Range Two [Member] Warrants Range Three [Member] Investment, Name [Axis] Ownership [Member] Consulting Agreement [Member] Legal Entity [Axis] Lone Star Bioscience Inc [Member] Chief Executive Officer [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current Assets Cash and cash equivalents Accounts receivable, net Inventory, net Prepaid expenses and other Total Current Assets Noncurrent Assets Property and equipment, net Intangible assets, net Deposits Operating lease right-of-use asset Total Noncurrent Assets TOTAL ASSETS LIABILITIES AND SHAREHOLDERS’ EQUITY LIABILITIES Current Liabilities Accounts payable and accrued liabilities Deferred revenue Accrued equity compensation Current portion of operating lease liability Total Current Liabilities Noncurrent Liabilities Operating lease liability, net of current portion Total Noncurrent Liabilities TOTAL LIABILITIES Commitments and Contingencies (Note 6) SHAREHOLDERS’ EQUITY Preferred stock, $0.00001 par value; 25,000,000 shares authorized; 0 shares issued and outstanding Common stock, $0.00001 par value; 200,000,000 authorized; 8,076,372 and 7,953,974 shares issued and outstanding, respectively Additional paid in capital Accumulated deficit Total Shareholders’ Equity TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY Preferred stock, par or stated value per share Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par or stated value per share Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue, net Cost of revenue Gross profit Operating expenses: Advertising and marketing expenses Product development costs Selling, general and administrative expenses Total operating expenses Operating loss Other income (expense): Other income (expense), net Interest income (expense), net Total other income (expense) Loss before provision for income taxes Income taxes Net loss Convertible preferred series B stock dividends Deemed dividend on convertible preferred series B stock on down round Net loss available to common shareholders Loss per common share – basic and diluted Weighted average number of common shares outstanding, basic and diluted Balance Balance, shares Fair value of vested stock options granted to employees Common shares issued in settlement of restricted stock units issued to directors Common shares issued in settlement of restricted stock units issued to directors, shares Fair value of restricted stock units issued to directors Fair value of restricted stock units issued to directors, shares Net loss Fair value of vested stock options granted to directors Issuance of common shares to round up partial shares following reverse split Issuance of common shares to round up partial shares following reverse split, shares Common shares and warrants issued for cash Common shares and warrants issued for cash, shares Common shares issued and warrants on conversion of series B preferred stock Common shares issued and warrants on conversion of series B preferred stock, shares Dividends on series B preferred stock Balance Balance, shares Statement of Cash Flows [Abstract] Cash Flows From Operating Activities: Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Depreciation and intangible asset amortization expense Share-based compensation Provision for doubtful accounts Provision for excess and obsolete inventory Loss on disposal of assets Amortization of operating lease ROU asset Changes in operating assets and liabilities: Accounts receivable Inventory Prepaid expenses and other Accounts payable and accrued liabilities Deferred revenue Operating lease liability, net Net cash provided by (used in) operating activities Cash Flows From Investing Activities Purchases of property and equipment Proceeds from the sale of property and equipment Net cash provided by (used in) investing activities Cash Flows From Financing Activities Payment of dividends on series B preferred stock Redemption of series B preferred stock Net cash proceeds on sale of common stock and warrants, net of expenses Net cash provided by financing activities Net change in cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Supplemental cash flow information: Interest paid Income taxes paid Non-cash investing and financing activities: Conversion of series B preferred stock Deemed dividend on series B preferred stock arising on down round Options issued for accrued equity compensation liability Accounting Policies [Abstract] Nature of Operations and Significant Accounting Policies Leases Leases Inventory Disclosure [Abstract] Inventory Property, Plant and Equipment [Abstract] Property and Equipment Payables and Accruals [Abstract] Accounts Payable and Accrued Liabilities Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Equity [Abstract] Stockholders’ Equity (Deficit) Share-Based Payment Arrangement [Abstract] Equity Incentive Plans Warrants Warrants Income Tax Disclosure [Abstract] Income Taxes Related Party Transactions [Abstract] Related Party Transactions Subsequent Events [Abstract] Subsequent Events Description of Business Impact of the COVID-19 Pandemic on Our Business Impact of Ukrainian Conflict Inflation Financial Statement Presentation [custom:LiquidityPolicyTextBlock] Interim Financial Statements Principles of Consolidation [custom:ReverseStockSplitPolicyTextBlock] Use of Estimates Cash, Cash Equivalents, and Restricted Cash Income (Loss) Per Common Share Goodwill Temporary Equity Revenue Recognition Product Warranty Accounting for Share-Based Compensation Concentrations Recently Issued Accounting Pronouncements Schedule of Revenue by Source Schedule of Remaining Performance Obligations Expected to be Recognized Schedule of Share-based Compensation Costs Schedule of Lease Cost Schedule of Future Annual Minimum Lease Payments Schedule of Inventory Schedule of Property and Equipment Schedule of Accounts Payable and Accrued Liabilities Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Schedule of Stock Option Activity Summary of Non-vested Non-qualified Stock Option Activity Schedule of Restricted Stock Units Activity Schedule of Outstanding Warrants to Purchase Common Stock Schedule of Warrants Outstanding Schedule of Product Information [Table] Product Information [Line Items] Total revenue Remaining performance obligations related to engineering only paid contracts Remaining performance obligations related to partial equipment paid contracts Total remaining performance obligations Total share-based compensation expense included in consolidated statement of operations Federal insured amount Cash balance, amount Cash equivalent balance, amount Potentially dilutive equity instruments that are convertible into common stock Goodwill and intangible asset impairment Miscellaneous revenue Contract with customer liability current Revenue recognized Revenue remaining performance obligation Product warranty description Accrued warranty reserve amount Stock price volatility Expected Term Risk-free interest rate Concentration risk percentage Schedule Of Lease Cost Operating lease liability, current Operating lease liability, long-term Remaining lease term Discount rate Operating cash outflow from operating lease Schedule Of Future Annual Minimum Lease Payments 2023 (excluding the three months ended March 31, 2023) 2024 2025 2026 Thereafter Total minimum lease payments Less imputed interest Present value of minimum lease payments Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Area of land Operating lease term description Lease rental expense Increase in rent percent Security deposit Lease renew term Operating lease liability Finished goods Work in progress Raw materials Allowance for excess & obsolete inventory Inventory, net Overhead expenses Prepaid inventory expenses Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property and equipment, gross Accumulated depreciation Property and equipment, net Depreciation expenses Accounts payable Sales commissions payable Accrued payroll liabilities Product warranty accrual Other accrued expenses Total Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Preferred stock par value Common stock par value Number of stock options issued Exercise price Number of stock options issued Shares, vested Number of shares vested in period Management fee expense Share based compensation arrangement payment Vesting rights description Reverse stock split Reverse stock split Net proceeds from sale of common stock Number of shares sold Warrant term Exercise price Stock issued during period, shares, issued for services Warrants maturity date Number of shares issued Prefunded conversion warrants Number of Options, Outstanding Beginning Weighted Average Exercise Price, Outstanding Beginning Weighted Average Remaining Contractual Term, Beginning Aggregate Intrinsic Value, Outstanding Beginning Number of Options, Granted Weighted Average Exercise Price, Granted Weighted Average Remaining Contractual Term, Granted Number of Options, Exercised Weighted Average Exercise Price, Exercised Number of Options, Forfeited/Cancelled Weighted Average Exercise Price, Forfeited/Cancelled Weighted Average Remaining Contractual Term, Forfeited Number of Options, Expired Weighted Average Exercise Price, Expired Number of Options, Outstanding Ending Weighted Average Exercise Price, Outstanding Ending Weighted Average Remaining Contractual Term, Outstanding Ending Aggregate Intrinsic Value, Outstanding Ending Number of Options, Exercisable Ending Weighted Average Exercise Price, Exercisable Ending Weighted Average Remaining Contractual Term, Exercisable Ending Aggregate Intrinsic Value, Exercisable Ending Number of Options Nonvested, Beginning Weighted Average Grant-Date Fair Value, Nonvested, Beginning Aggregated Intrinsic Value, Nonvested Beginning Grant Date Fair Value Nonvested, Beginning Number of Options Nonvested, Granted Weighted Average Grant-Date Fair Value, Nonvested, Granted Grant Date Fair Value Nonvested, Granted Number of Options Nonvested, Vested Weighted Average Grant-Date Fair Value, Nonvested, Vested Grant Date Fair Value Nonvested, Vested Number of Options Nonvested, Forfeited Weighted Average Grant-Date Fair Value, Nonvested, Forfeited Grant Date Fair Value Nonvested, Forfeited Number of Options Nonvested, Expired Weighted Average Grant-Date Fair Value, Nonvested, Expired Grant Date Fair Value Nonvested, Expired Number of Options Nonvested, Ending Weighted Average Grant-Date Fair Value, Nonvested, Beginning Aggregated Intrinsic Value, Nonvested Ending Grant Date Fair Value Nonvested, Ending Number of Units Outstanding, beginning Weighted Average Grant-Date Fair Value Outstanding, Beginning Aggregate Intrinsic Value Outstanding, Beginning Number of Units, Granted Weighted Average Grant-Date Fair Value, Granted Aggregate Intrinsic Value Outstanding, Granted Number of Units, Vested and settled with share issuance Weighted Average Grant-Date Fair Value, Vested and settled with share issuance Aggregate Intrinsic Value Outstanding, Vested and settled with share issuance Number of Units, Forfeited/canceled Weighted Average Grant-Date Fair Value, Forfeited/Canceled Aggregate Intrinsic Value Outstanding, Forfeited/canceled Number of Units Outstanding, ending Weighted Average Grant-Date Fair Value Outstanding,ending Aggregate Intrinsic Value Outstanding, ending Number of options to purchase shares Number of shares authorized Number of shares issued Number of option remain outstanding Shares available for future equity awards Number of shares grant in period Shares issued during the period Number of share awards granted Weighted Average Remaining Contractual Term Exercise price per share Additional expense Number of shares authorized Unrecognized compensation expense Share based compensation Number of options to purchase shares Number of shares granted Schedule Of Outstanding Warrants To Purchase Common Stock Warrants Outstanding, Beginning Balance Warrants Exercisable, Beginning Balance Weighted Average Exercise Price, Beginning Balance Weighted Average Life of Outstanding Warrants in Months, Beginning Balance Aggregate Intrinsic Value, Beginning Balance Warrants, Granted Warrants, Granted Weighted Average Exercise Price, Granted Weighted Average Life of Outstanding Warrants in Months, Granted Aggregate Intrinsic Value, Granted Warrants, Exercised Warrants, Exercised Weighted Average Exercise Price, Exercised Weighted Average Remaining Life, Exercised Aggregate Intrinsic Value, Exercised Warrants, Expired Warrants, Expired Weighted Average Exercise Price, Expired Aggregate Intrinsic Value, Expired Warrants Outstanding, Ending Balance Warrants Exercisable, Ending Balance Weighted Average Exercise Price, Ending Balance Weighted Average Life of Outstanding Warrants in Months, Ending Balance Share-Based Payment Arrangement, Option, Exercise Price Range [Table] Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] Warrants Outstanding Warrants Exercisable Weighted Average Life of Outstanding Warrants in Months Operating loss carryforward Net operating loss carry forward expected to expire amount Net operating loss expiration term NOLs usage against taxable income, percentage Percentage of ownership change NOLs carryforwards term Payments for commissions Proceeds from deposits Proceeds from sales Cash payments Revenue Temporary Equity [Text Block] Series B Redeemable Convertible Preferred Stock [Member] Percentage of preferred stock conversion provision. Temporary equity noncash redemption value adjustment. Principal and accrued dividends. Warrant One [Member] Indefinite Term [Member] Pre Funded Conversion Warrants [Member] Conversion price reduced offering price, percentage Deemed dividend on series B preferred stock on down round. Convertible preferred stock redemption value adjustment. Non-qualified Stock Options [Member] 2021 Equity Incentive Plan [Member] Increase decrease in deferred compensation accrued equity compensation. January 17, 2022 [Member] January 17, 2023 [Member] Conversion of series B preferred stock. Deemed dividend on series B preferred stock arising on down round. Two Directors [Member] Share based compensation arrangement by share based payment award value issued period. Audit Committee Chairman [Member] Committee Chairman [Member] Underwriters [Member] 2017 Equity Incentive Plan [Member] Non Qualified Stock Option [Member] 2021 Equity Plan [Member] Employees [Member] Fair value of vested stock options granted to employees Fair value of restricted stock units issued to directors Common shares issued in settlement of restricted stock units issued to directors. Common shares issued in settlement of restricted stock units issued to directors 21 Employees [Member] Fair value of vested stock options granted to employees. Fair value of vested stock options granted to directors. Dividends on series B preferred stock Issuance of common shares to round up partial shares following reverse split Common shares issued in settlement of legal dispute, shares. Share-based compensation arrangement by share-based payment award, number of shares authorized. Incentive Stock Option [Member] Directors [Member] 2017 Equity Plan and 2021 Equity Plan [Member] Weighted average remaining contractual term, granted. Weighted Average Remaining Contractual Term, Ending. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Granted. Number of Options, Expired. Number of Options, price per share. Fair value of options nonvested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested. Sharebased compensation arrangement by sharebased payment award options nonvested grant date fair values Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Vested. 2023 [Member] Booked Sales Orders From Several Customers [Member] One Customer [Member] 2022 [Member] Remaining performance obligations related to engineering only paid contracts. Remaining performance obligations related to partial equipment paid contracts. 2017 Equity Plan and 2021 Equity Plan [Member] Customer One [Member] Customer Two [Member] Customer Three [Member] New Facility Lease [Member] Weighted Average Remaining Contractual Term,Forfeited. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Forfeited. Increase in rent percent. Therafter Prepaid inventory expenses Inventory [Member] 2024 [Member] Employees, Directors and Consultants [Member] Intrinsic value of granted under share-based payment arrangement. Excludes share and unit options. Intrinsic value of forfeited under share-based payment arrangement. Excludes share and unit options. Warrants Disclosure [Text Block] Schedule Of Outstanding Warrants To Purchase Common Stock [Table Text Block] Number of equity instruments other than options exercisable, including both vested and non-vested instruments. Weighted average life of outstanding warrants in months, beginning balance. Aggregate intrinsic value of outstanding warrants. Net number of non-option equity instruments granted to participants. Warrants weighted average exercise price granted. Warrants weighted average remaining contractual terms. Class of Warrant or Right Exercised Number of non-option equity instruments exercised by participants. Weighted average exercise price of warrants exercised. Weighted Average Remaining Life, Exercised Intrinsic value of exercised award under share-based payment arrangement. Excludes share and unit options. Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Weighted average exercise price of warrants expired. Intrinsic value of expirations award under share-based payment arrangement. Excludes share and unit options. Weighted average life of outstanding warrants in months, ending balance. Warrants Range [Member] Warrants Range One [Member] Warrants Range Two [Member] Warrants Range Three [Member] 2022 Investor Warrants [Member] 2022 Underwriterwarrants [Member] 2022 OverAllotment Warrants [Member] Exercise price, per share Series B Preferred Shares Pre Funded Conversion Warrants [Member] Series B Preferred Shares Conversion Warrants [Member] Net operating loss carry forward expected to expire amount. Net operating loss expiration term. Nols usage against taxable income percentage. Ownership [Member]. Nols carryforwards term description. Proceeds fom deposit. Consulting Agreement [Member] Lone Star Bioscience Inc [Member] Proceeds fom sales. Redemption of series B preferred stock Cash proceeds from sale of common stock and warrants net of issuance costs. Convertible preferred stock converted to securities. Adjustments to additional paid in capital fair value of vested stock options granted to directors. Common shares and warrants issued value for cash. Common shares and warrants issued shares for cash. Stock issued during period shares fair value of restricted stock units issued to directors. Director And Staff [Member] 2017 Equity Plan and 2021 Equity Plan [Member] [Default Label] Assets, Current Assets, Noncurrent Assets Liabilities, Current Liabilities, Noncurrent Liabilities Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Nonoperating Income (Expense) ConvertiblePreferredStockConvertedToSecurities Deemed dividend on series B preferred stock on down round Net Income (Loss) Available to Common Stockholders, Basic Shares, Outstanding Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expenses, Other Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Contract with Customer, Liability Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Payments of Ordinary Dividends, Preferred Stock and Preference Stock Redemption of series B preferred stock Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Lessee, Operating Leases [Text Block] Outstanding Warrants Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Inventory Valuation Reserves Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Stock Issued During Period, Shares, Stock Splits Class of Warrant or Right, Exercise Price of Warrants or Rights Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Aggregated Intrinsic Value, Nonvested Beginning Aggregated Intrinsic Value, Nonvested Beginning [Default Label] Grant Date Fair Value Nonvested, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Grant Date Fair Value Nonvested, Forfeited SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Number of shares authorized [Default Label] Aggregate intrinsic value of outstanding warrants ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised Weighted Average Exercise Price, Exercised [Default Label] ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations Weighted Average Exercise Price, Expired [Default Label] EX-101.PRE 10 cead-20230331_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - shares
3 Months Ended
Mar. 31, 2023
May 15, 2023
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2023  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 001-41266  
Entity Registrant Name CEA INDUSTRIES INC.  
Entity Central Index Key 0001482541  
Entity Tax Identification Number 27-3911608  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 385 South Pierce Avenue  
Entity Address, Address Line Two Suite C  
Entity Address, City or Town Louisville  
Entity Address, State or Province CO  
Entity Address, Postal Zip Code 80027  
City Area Code (303)  
Local Phone Number 993-5271  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   8,076,372
Common Stock, $0.00001 par value    
Title of 12(b) Security Common Stock, $0.00001 par value  
Trading Symbol CEAD  
Security Exchange Name NASDAQ  
Warrants to purchase common stock    
Title of 12(b) Security Warrants to purchase common stock  
Trading Symbol CEADW  
Security Exchange Name NASDAQ  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 15,948,077 $ 18,637,114
Accounts receivable, net 61,774 2,649
Inventory, net 441,133 348,411
Prepaid expenses and other 471,137 1,489,921
Total Current Assets 16,922,121 20,478,095
Noncurrent Assets    
Property and equipment, net 60,713 68,513
Intangible assets, net 1,830 1,830
Deposits 14,747 14,747
Operating lease right-of-use asset 436,549 462,874
Total Noncurrent Assets 513,839 547,964
TOTAL ASSETS 17,435,960 21,026,059
Current Liabilities    
Accounts payable and accrued liabilities 1,164,134 1,207,258
Deferred revenue 1,102,601 4,338,570
Accrued equity compensation 89,970
Current portion of operating lease liability 120,245 118,235
Total Current Liabilities 2,386,980 5,754,033
Noncurrent Liabilities    
Operating lease liability, net of current portion 348,179 376,851
Total Noncurrent Liabilities 348,179 376,851
TOTAL LIABILITIES 2,735,159 6,130,884
Commitments and Contingencies (Note 6)
SHAREHOLDERS’ EQUITY    
Preferred stock, $0.00001 par value; 25,000,000 shares authorized; 0 shares issued and outstanding
Common stock, $0.00001 par value; 200,000,000 authorized; 8,076,372 and 7,953,974 shares issued and outstanding, respectively 81 80
Additional paid in capital 49,410,899 49,173,836
Accumulated deficit (34,710,179) (34,278,741)
Total Shareholders’ Equity 14,700,801 14,895,175
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 17,435,960 $ 21,026,059
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Preferred stock, par or stated value per share $ 0.00001 $ 0.00001
Preferred stock, shares authorized 25,000,000 25,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par or stated value per share $ 0.00001 $ 0.00001
Common stock, shares authorized 200,000,000 200,000,000
Common stock, shares issued 8,076,372 7,953,974
Common stock, shares outstanding 8,076,372 7,953,974
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Revenue, net $ 4,682,573 $ 1,744,427
Cost of revenue 3,829,297 1,653,919
Gross profit 853,276 90,508
Operating expenses:    
Advertising and marketing expenses 202,323 251,015
Product development costs 76,413 138,918
Selling, general and administrative expenses 1,020,702 1,311,777
Total operating expenses 1,299,438 1,701,710
Operating loss (446,162) (1,611,202)
Other income (expense):    
Other income (expense), net 5,704 185,000
Interest income (expense), net 9,020 3,260
Total other income (expense) 14,724 188,260
Loss before provision for income taxes (431,438) (1,422,942)
Income taxes
Net loss (431,438) (1,422,942)
Convertible preferred series B stock dividends (35,984)
Deemed dividend on convertible preferred series B stock on down round (439,999)
Net loss available to common shareholders $ (431,438) $ (1,898,925)
Loss per common share – basic and diluted $ (0.05) $ (0.41)
Weighted average number of common shares outstanding, basic and diluted 8,071,731 4,622,427
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2021 $ 16 $ 25,211,017 $ (28,781,566) $ (3,570,533)
Balance, shares at Dec. 31, 2021 1,600,835      
Fair value of vested stock options granted to employees 32,938 32,938
Common shares issued in settlement of restricted stock units issued to directors 24,994 24,994
Common shares issued in settlement of restricted stock units issued to directors, shares 3,367      
Fair value of restricted stock units issued to directors 4,928 4,928
Net loss (1,422,942) (1,422,942)
Fair value of vested stock options granted to directors 29,656 29,656
Issuance of common shares to round up partial shares following reverse split  
Issuance of common shares to round up partial shares following reverse split, shares 6,798      
Common shares and warrants issued for cash $ 58 21,711,073 21,711,131
Common shares and warrants issued for cash, shares 5,811,138      
Common shares issued and warrants on conversion of series B preferred stock $ 4 1,979,996 1,980,000
Common shares issued and warrants on conversion of series B preferred stock, shares 362,306      
Dividends on series B preferred stock (35,984) (35,984)
Balance at Mar. 31, 2022 $ 78 48,958,618 (30,204,508) 18,754,188
Balance, shares at Mar. 31, 2022 7,784,444      
Balance at Dec. 31, 2022 $ 80 49,173,836 (34,278,741) 14,895,175
Balance, shares at Dec. 31, 2022 7,953,974      
Fair value of vested stock options granted to employees 135,748 135,748
Common shares issued in settlement of restricted stock units issued to directors $ 1 (1)
Common shares issued in settlement of restricted stock units issued to directors, shares 123,398      
Fair value of restricted stock units issued to directors   101,316   101,316
Fair value of restricted stock units issued to directors, shares      
Net loss (431,438) (431,438)
Balance at Mar. 31, 2023 $ 81 $ 49,410,899 $ (34,710,179) $ 14,700,801
Balance, shares at Mar. 31, 2023 8,077,372      
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash Flows From Operating Activities:    
Net loss $ (431,438) $ (1,422,942)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and intangible asset amortization expense 7,500 8,556
Share-based compensation 147,094 92,517
Provision for doubtful accounts (1,705) (22,168)
Provision for excess and obsolete inventory 33,638 3,676
Loss on disposal of assets 100 5,499
Amortization of operating lease ROU asset 26,325 25,433
Changes in operating assets and liabilities:    
Accounts receivable (57,420) 10,610
Inventory (126,360) (631,269)
Prepaid expenses and other 1,018,785 (551,261)
Accounts payable and accrued liabilities (43,124) 43,438
Deferred revenue (3,235,970) 2,645,579
Operating lease liability, net (26,662) (14,811)
Net cash provided by (used in) operating activities (2,689,237) 192,857
Cash Flows From Investing Activities    
Purchases of property and equipment (13,948)
Proceeds from the sale of property and equipment 200
Net cash provided by (used in) investing activities 200 (13,948)
Cash Flows From Financing Activities    
Payment of dividends on series B preferred stock (35,984)
Redemption of series B preferred stock (1,980,000)
Net cash proceeds on sale of common stock and warrants, net of expenses 21,711,131
Net cash provided by financing activities 19,695,147
Net change in cash and cash equivalents (2,689,037) 19,874,056
Cash and cash equivalents, beginning of period 18,637,114 2,159,608
Cash and cash equivalents, end of period 15,948,077 22,033,664
Supplemental cash flow information:    
Interest paid
Income taxes paid
Non-cash investing and financing activities:    
Conversion of series B preferred stock 1,980,000
Deemed dividend on series B preferred stock arising on down round 439,999
Options issued for accrued equity compensation liability $ 89,970
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Nature of Operations and Significant Accounting Policies
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Nature of Operations and Significant Accounting Policies

Note 1 – Nature of Operations and Significant Accounting Policies

 

Description of Business

 

CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the fastest-growing sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, and tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) air sanitation products, (v) LED lighting, (vi) benching and racking solutions for indoor cultivation, (vii) proprietary and third party controls systems and technologies used for environmental, lighting, and climate control, and (viii) preventive maintenance services, through our partnership with a certified service contractor network, for CEA facilities. Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services, and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.

 

Impact of the COVID-19 Pandemic on Our Business

 

The impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, and working capital.

 

The resulting effects and uncertainties from the COVID-19 pandemic, including the depth and duration of the disruptions to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, cannot be predicted. We expect that the economic disruptions will continue to have an effect on our business over the longer term. Despite this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2022, and continuing into the current fiscal quarter, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Impact of Ukrainian Conflict

 

Currently, we believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it has a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflationary results of the conflict and government spending for and funding of our country’s response. As our operations are related only to the North American controlled environment agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to this conflict. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.

 

Inflation

 

Recently, our operations have started to be influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build facilities in which we operate. We are likely to continue to face inflationary increases on the cost of products and our operations, which may adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment and other products that we have contracted to provide to our customers, and generally higher prices across all sectors of the economy. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.

 

Financial Statement Presentation

 

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.

 

Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2023. The balance sheet information as of December 31, 2022 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2022.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.

 

Use of Estimates

 

Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets and goodwill, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.

 

Cash, Cash Equivalents, and Restricted Cash

 

All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount of $250,000. As of March 31, 2023, the balance in the Company’s accounts was approximately $15,948,000, consequently approximately $15,698,000 of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.

 

Income (Loss) Per Common Share

 

Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

As of March 31, 2023, and March 31, 2022, there were respectively, 8,010,957 and 8,021,057, potentially dilutive equity instruments outstanding in respect of options outstanding to purchase Company common stock, warrants, and restricted stock units that were convertible into shares of the Company’s common stock. Of these potentially dilutive equity instruments outstanding, 7,623,772 as of March 31, 2023 and 7,794,154 as of March 31, 2022 related to warrants issued in connection with the sale of our shares of series B Preferred stock and common stock in prior periods. The remaining 387,185 potentially dilutive equity instruments outstanding as of March 31, 2023 and 226,903 as of March 31, 2022 related to options and restricted stock units issued to our directors and staff.

 

Goodwill

 

The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its carrying amount, including goodwill. The Company’s fair value is calculated using a market valuation technique whereby an appropriate control premium is applied to the Company’s market capitalization as calculated by applying its publicly quoted share price to the number of its common shares issued and outstanding. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.

 

As of June 30, 2022, the Company experienced a triggering event due to a drop in its stock price and performed a quantitative analysis for potential impairment of its goodwill. Based on this analysis, the Company determined that its carrying value exceeded its fair value. As a result, the Company recorded a non-cash goodwill impairment charge of $631,064 at June 30, 2022. No income tax benefit related to this goodwill impairment charge was recorded at June 30, 2022.

 

Temporary Equity

 

Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the Company. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.

 

Revenue Recognition

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

The following table sets forth the Company’s revenue by source:

 

   2023   2022 
  

For the Three Months Ended

March 31,

 
   2023   2022 
Equipment and systems sales  $4,396,827   $1,642,572 
Engineering and other services   124,410    86,049 
Shipping and handling   12,560    15,806 
Miscellaneous   148,776    - 
Total revenue  $4,682,573   $1,744,427 

 

Miscellaneous revenue of $148,776 represents non-refundable deposits, forfeited by former customers on previously cancelled contracts.

 

Revenue Recognition Accounting Policy Summary

 

The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.

 

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on the standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.

 

Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.

 

The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.

 

Disaggregation of Revenue

 

In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).

 

Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by sales, services, shipping and handling, and miscellaneous was required.

 

Other Judgments and Assumptions

 

The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.

 

Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Contract Assets and Contract Liabilities

 

Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.

 

Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of March 31, 2023 and December 31, 2022, the Company had no contract assets.

 

Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited. As of March 31, 2023, and December 31, 2022, deferred revenue, which was classified as a current liability, was $1,102,601 and $4,338,570, respectively.

 

For the three months ended March 31, 2023, the Company recognized revenue of $3,852,906 related to the deferred revenue at January 1, 2023. For the three months ended March 31, 2022, the Company recognized revenue of $1,162,374 related to the deferred revenue at January 1, 2022.

 

Remaining Performance Obligations

 

Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.

 

Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, the uncertainty regarding the COVID-19 virus, and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

As of March 31, 2023, the Company’s remaining performance obligations, or backlog, was approximately $1,869,000. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at March 31, 2023, includes booked sales orders of $379,000 from three customers that the Company does not expect to be realized until 2024, if at all. This 2024 projected revenue amount contains a booked sales order of $279,000 (15% of the total backlog) from one customer that we believe is at risk of cancellation based on conversations with this customer. Given the current supply chain and bottleneck issues that are still being worked through by the Company’s supply chain partners, the Company believes that some of its current contracts could be delayed.

 

The remaining performance obligations expected to be recognized through 2024 are as follows:

 

   2023   2024   Total 
Remaining performance obligations related to engineering only paid contracts  $172,000   $-   $172,000 
Remaining performance obligations related to partial equipment paid contracts   1,318,000    379,000    1,697,000 
Total remaining performance obligations  $1,490,000   $379,000   $1,869,000 

 

Product Warranty

 

The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.

 

The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of March 31, 2023, and December 31, 2022, the Company had an accrued warranty reserve amount of $188,738 and $180,457, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.

 

Accounting for Share-Based Compensation

 

The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.

 

The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the three months ended March 31, 2023, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility of 152.23%; expected term in years of 10 and risk-free interest rate of 3.48%.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.

 

The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.

 

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2023 and March 31, 2022:

 

   2023   2022 
  

For the Three Months Ended

March 31,

 
   2023   2022 
Share-based compensation expense included in:          
Cost of revenue  $4,898   $791 
Advertising and marketing expenses   1,113    2,762 
Product development costs   3,570    - 
Selling, general and administrative expenses   137,513    88,964 
Total share-based compensation expense included in consolidated statement of operations  $147,094   $92,517 

 

Concentrations

 

Three customers accounted for 39%, 28%, and 17% of the Company’s revenue for the three months ended March 31, 2023. One customer accounted for 35% of the Company’s revenue for the three months ended March 31, 2022.

 

Three customers accounted for 68%, 20%, and 10% of the Company’s accounts receivable as of March 31, 2023. Two customers accounted for 57% and 43% of the Company’s accounts receivable as of December 31, 2022.

 

Recently Issued Accounting Pronouncements

 

In March 2023, the FASB issued ASU 2023-01 to require entities to classify and account for leases with related parties on the basis of legally enforceable terms and conditions of the arrangement. The amendments are effective in periods beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

In December 2022, the FASB issued ASU No. 2022-06, which defers the sunset date of Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”) from December 31, 2022 to December 31, 2024. ASU No. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In September 2022, the FASB issued Update 2022-04, “Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations”. The update was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in Update 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this update do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard on Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.

 

In March 2020, the FAS issued ASU No. 2020-04 “Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Leases
3 Months Ended
Mar. 31, 2023
Leases  
Leases

Note 2 – Leases

 

In February 2016 the FASB issued ASU 2016-02, Leases (Topic 842) (“ASC 842” or the “new lease standard”). The Company adopted ASC 842 as of January 1, 2019, using the effective date method.

 

The new standard provides a number of optional practical expedients in transition. The Company has elected to apply the “package of practical expedients” which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii) the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.

 

On July 28, 2021, the Company entered into an agreement to lease 11,491 square feet of office and manufacturing space (the “New Facility Lease”), in Louisville, CO. The New Facility Lease commenced on November 1, 2021 and continues through January 31, 2027. From November 2021 through January 2022, the monthly rent was abated. Beginning February 2022, the monthly rent is $10,055 and will increase by 3% annually every November through the end of the New Facility Lease term. Pursuant to the New Facility Lease, the Company made a security deposit of $14,747. The Company has the option to renew the New Facility Lease for an additional five years. Additionally, the Company pays the actual amounts for property taxes, insurance, and common area maintenance. The New Facility Lease agreement contains customary events of default, representations, warranties, and covenants.

 

Upon commencement of the New Facility Lease, the Company recognized on the balance sheet an operating lease right-of-use asset and lease liability in the amount of $582,838. The lease liability was initially measured as the present value of the unpaid lease payments at commencement and the ROU asset was initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The renewal option to extend the New Facility Lease is not included in the right-of-use asset or lease liability, as the option is not reasonably certain to be exercised. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will include the renewal period in its lease term.

 

The lease cost, cash flows and other information related to the New Facility Lease were as follows:

 

  

As of

March 31, 2023

 
Operating lease right-of-use asset  $436,549 
Operating lease liability, current  $120,245 
Operating lease liability, long-term  $348,179 
      
Remaining lease term   3.8 years 
Discount rate   3.63%

 

  

For the Three

Months Ended

March 31, 2023

 
Operating cash outflow from operating lease  $31,069 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Future annual minimum lease payments on the New Facility Lease as of March 31, 2023 are as follows:

 

Years ended December 31,    
2023 (excluding the three months ended March 31, 2023)  $124,897 
2024   128,643 
2025   132,503 
2026   136,473 
Thereafter   11,654 
Total minimum lease payments   534,170 
Less imputed interest   (65,746)
Present value of minimum lease payments  $468,424 

 

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Inventory
3 Months Ended
Mar. 31, 2023
Inventory Disclosure [Abstract]  
Inventory

Note 3 – Inventory

 

Inventory consisted of the following:

 

   2023   2022 
   March 31,   December 31, 
   2023   2022 
Finished goods  $410,208   $270,555 
Work in progress   154    155 
Raw materials   135,316    148,608 
Allowance for excess & obsolete inventory   (104,545)   (70,907)
Inventory, net  $441,133   $348,411 

 

Overhead expenses of $14,101 and $12,770 were included in the inventory balance as of March 31, 2023, and December 31, 2022, respectively.

 

Advance payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses included approximately $219,000 and $1,176,000 in advance payments for inventory for the periods ended March 31, 2023, and December 31, 2022, respectively.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Property and Equipment
3 Months Ended
Mar. 31, 2023
Property, Plant and Equipment [Abstract]  
Property and Equipment

Note 4 – Property and Equipment

 

Property and equipment consisted of the following:

 

   2023   2022 
   March 31,   December 31, 
   2023   2022 
Furniture and equipment  $275,994   $278,389 
Vehicles   15,000    15,000 
Property and equipment, gross   290,994    293,389 
Accumulated depreciation   (230,281)   (224,876)
Property and equipment, net  $60,713   $68,513 

 

Depreciation expense was $7,500 for the three months ended March 31, 2023. For the three months ended March 31, 2023, $1,214 was allocated to cost of sales, $304 was allocated to inventory with the remainder recorded as selling, general, and administrative expense.

 

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Accounts Payable and Accrued Liabilities
3 Months Ended
Mar. 31, 2023
Payables and Accruals [Abstract]  
Accounts Payable and Accrued Liabilities

Note 5 – Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities consisted of the following:

 

   2023   2022 
   March 31,   December 31, 
   2023   2022 
Accounts payable  $714,586   $311,162 
Sales commissions payable   24,468    25,951 
Accrued payroll liabilities   167,697    465,094 
Product warranty accrual   188,738    180,457 
Other accrued expenses   68,645    224,594 
Total  $1,164,134   $1,207,258 

 

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 6 – Commitments and Contingencies

 

Litigation

 

From time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company’s view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company’s operations or its financial position, liquidity or results of operations.

 

Leases

 

The Company has a lease agreement for its manufacturing and office space. Refer to Note 2 Leases above.

 

Other Commitments

 

In the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Deficit)
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Stockholders’ Equity (Deficit)

Note 7 – Stockholders’ Equity (Deficit)

 

As of March 31, 2023, the Company had 200,000,000 shares of common stock and 25,000,000 shares of preferred stock authorized at a $0.00001 par value.

 

As of March 31, 2023, 8,076,372 shares of common stock were issued and outstanding and no shares of preferred stock were issued and outstanding.

 

Directors Remuneration

 

On January 3, 2022, the Company issued 3,125 non-qualified stock options under the 2021 Equity Incentive Plan to each of two existing directors. The options had an exercise price of $4.80, vested immediately and had a term ending at the earlier of five years after the date on which the optionee’s continuous service ends, or the tenth anniversary on which the option was granted.

 

On January 17, 2022, the Company issued an RSU grant of 3,367 shares of common stock under the 2021 Equity Incentive Plan to each of two new directors, 1,684 shares of common stock vested immediately on grant date and the remaining 1,683 shares of common stock vested on January 17, 2023. 1,684 shares of common stock were issued on January 17, 2022 to each of the two new directors in settlement of the RSUs that vested immediately and a further 1,683 shares of common stock were issued to each of the two new directors on January 17, 2023 in settlement of the remainder.

 

On January 3, 2023, the Company issued an RSU grant of 29,758 shares of common stock under the 2021 Equity Incentive Plan to each of its four independent directors. The RSUs were granted as an equity retention award pursuant to the Company’s compensation plan for independent directors effective January 17, 2022 and vested immediately on the grant date. A total of 119,032 shares of the Company’s common stock were issued in settlement of the RSUs.

 

Revised Compensation Plan

 

On January 17, 2022, the Board of Directors revised the previously adopted compensation plan. This plan superseded the plan adopted on August 20, 2021. The Plan was effective retroactively for the then current independent directors and for independent directors elected or appointed after the Effective Date.

 

The plan is divided into two phases: from the Effective Date of the Plan until February 9, 2022, the day prior to the listing of the Company securities on Nasdaq. (“Pre-uplist”) and from February 10, 2022, the uplist date forward (“Post-uplist”).

 

Pre-uplist phase: The Company paid its independent directors an annual cash fee of $15,000, payable quarterly in advance on the first business day of each quarter, as consideration for their participation in: (i) any regular or special meetings of the Board or any committee thereof attended in person, (ii) any telephonic meeting of the Board or any committee thereof in which the director is a member, (iii) any non-meeting consultations with the Company’s management, and (iv) any other services provided by them in their capacities as directors (other than services as the Chairman of the Board, the Chairman of the Company’s Audit Committee, and the Committee Chairman).

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

At the time of initial election or appointment, each independent director received an equity retention award in the form of restricted stock units (“RSUs”). The aggregate value of the RSUs at the time of grant was to be $25,000, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. Vesting of the RSUs was as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date.

 

In addition, on the first business day of January each year, each independent director will also receive an equity retention award in the form of RSUs. The aggregate value of the RSUs at the time of grant will be $25,000, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. These RSUs will be fully vested at date of grant.

 

The Company pays the Audit Committee Chairman an additional annual fee of $10,000, payable quarterly in advance, for services as the Audit Committee Chairman.

 

The Company pays the Chairmen of any other committees of the Board an additional annual fee of $5,000, payable quarterly in advance, for services as a Committee Chairman.

 

There is no additional compensation paid to members of any committee of the Board. Interested (i.e. Executive directors) serving on the Board do not receive compensation for their Board service.

 

Post-uplist phase: The Company will pay its independent directors an annual cash fee of $25,000, payable quarterly in advance on the first business day of each quarter. All other terms remain the same.

 

Each director is responsible for the payment of any and all income taxes arising with respect to the issuance of common stock and the vesting and settlement of RSUs.

 

The Company reimburses independent directors for out-of-pocket expenses incurred in attending Board and committee meetings and undertaking certain matters on the Company’s behalf.

 

All independent directors, Messrs. Shipley, Etten, Reisner, and Mariathasan are subject to the Plan.

 

Each independent director is responsible for the payment of any and all income taxes arising with respect to the issuance of any equity awarded under the plan, including the exercise of any non-qualified stock options.

 

Employee directors do not receive separate fees for their services as directors.

 

Reverse Stock Split

 

On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. The reverse stock split was implemented effective January 27, 2022. The par value for the Common Stock was not affected.

 

An additional 6,798 shares of common stock were issued to round up partial shares following the reverse split.

 

As a result of this reverse stock split, the number of the Company’s shares of common stock issued and outstanding at December 31, 2021 was reduced from 240,125,224 to 1,600,835. All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split for all periods presented.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Change in Authorized Share Capital

 

In connection with the aforementioned reverse stock split, the Company’s Board of Directors approved the reduction of the authorized capital of the Company to 200,000,000 shares of common stock and 25,000,000 shares of preferred stock.

 

Equity Raise

 

On February 10, 2022, the Company signed a firm commitment underwriting agreement for the public offering of shares of common stock and warrants, which closed on February 15, 2022. The Company received net proceeds of approximately $22 million for the sale of 5,811,138 shares of common stock and 6,572,808 warrants, each warrant to purchase one share of common stock for five years, exercisable immediately, at an exercise price of $5.00. The Company also issued to the representative of the underwriters 290,557 warrants, each warrant to purchase one share of common stock at an exercise price of $5.1625, during the period commencing August 9, 2022, and expiring on February 10, 2027.

 

Warrant Exercise

 

On June 21, 2022, the Company issued 169,530 shares of its common stock in connection with the cashless exercise of 170,382 prefunded conversion warrants.

 

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Incentive Plans
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Equity Incentive Plans

Note 8 – Equity Incentive Plans

 

2017 Equity Incentive Plan

 

Under the Company’s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the “2017 Equity Plan”), the Board of Directors (the “Board”) (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock unit awards (“RSUs”), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates 333,333 shares of the Company’s common stock (“Plan Shares”) for issuance of equity awards under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity Plan.

 

During the three months ended March 31, 2023, no shares or options were issued, or cancelled under the 2017 Plan.

 

As of March 31, 2023, of the 333,333 shares authorized under the 2017 Plan for equity awards, 163,692 shares have been issued, awards relating to 147,177 options remain outstanding, and 22,464 shares remain available for future equity awards.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

2021 Equity Incentive Plan

 

On March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the “2021 Equity Plan”), which was approved by the stockholders on July 22, 2021. The 2021 Equity Plan permits the Board to grant awards of up to 666,667 shares of common stock. The 2021 Equity Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), non-qualified stock options, stock appreciation rights (“SARs”), restricted stock awards and restricted stock unit awards and other equity linked awards to our employees, consultants, and directors. If an equity award (i) expires or otherwise terminates without having been exercised in full or (ii) is settled in cash (i.e., the holder of the award receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant to this Plan.

 

During the three months ended March 31, 2023, the Company issued 122,398 shares of its common stock in settlement of restricted stock units issued to its independent directors under the 2021 Equity Incentive Plan, pursuant to the Director Compensation plan adopted on January 17, 2022.

 

During the three months ended March 31, 2023,138,491 non-qualified stock options were issued to five employees and three former employees in respect of the Company’s 2021 Equity Incentive Plan. The options vested immediately, have a term of 10 years and an exercise price of $0.8955. An expense of $89,970 in respect of this issuance had been accrued in 2022. An additional expense of $32,376 was recognized in 2023 upon management and board finalization and approval of the awards.

 

As of March 31, 2023, of the 666,667 shares authorized under the 2021 Equity Plan, 132,568 shares have been issued in settlement of restricted stock units, awards relating to 183,615 non-qualified stock options, and 40,816 incentive stock options remain outstanding, and 309,668 shares remain available for future equity awards.

 

There was $45,919 in unrecognized compensation expense for unvested non-qualified stock options, and incentive stock options at March 31, 2023 which will be recognized over approximately 2 years.

 

Non-Qualified and Incentive Stock Options

 

A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the three months ended March 31, 2023, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value

 
                 
Outstanding, December 31, 2022   192,073   $8.94    7.6   $            - 
Granted   138,489   $0.90    8.4   $- 
Exercised   -   $-    -   $- 
Forfeited   (500)  $6.10    8.9   $- 
Expired   -   $-    -   $- 
Outstanding, March 31, 2023   330,062   $5.57    7.6   $- 
Exercisable, March 31, 2023   304,972   $5.59    8.2   $- 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the three months ended March 31, 2023, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic Value

  

Grant-Date

Fair Value

 
                
Nonvested, December 31, 2022   43,846   $5.65   $  -   $247,730 
Granted   138,489   $0.88   $-   $122,346 
Vested   (156,912)  $1.49   $-   $(234,296)
Forfeited   (333)  $6.67   $-   $(2,225)
Expired   -   $-   $-   $- 
Nonvested, March 31, 2023   25,090   $4.98   $-   $133,555 

 

For the three months ended March 31, 2023 and March 31, 2022, the Company recorded $45,778 and $32,939 as compensation expense related to vested options issued to employees and consultants, net of forfeitures, respectively.

 

A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the three months ended March 31, 2023, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value ($000)

 
                 
Outstanding, December 31, 2022   57,122   $9.44    6.0   $      - 
Granted   -    -    0.0   $- 
Exercised   -    -    -   $- 
Forfeited/Cancelled   -    -    -   $- 
Expired   -    -    -   $- 
Outstanding, March 31, 2023   57,122   $9.44    5.7   $- 
Exercisable, March 31, 2023   57,122   $9.44    5.7   $- 

 

There were no non-vested, non-qualified stock options issued to directors under the 2017 Equity Plan and the 2021 Equity Plan, for the three months ended March 31, 2023.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

During the three months ended March 31, 2023 and March 31, 2022, the Company incurred $0 and $29,656 respectively, as compensation expense related to 0 and 6,250 fully vested options issued to directors, respectively.

 

Restricted Stock Units

 

Effective January 3, 2023, the Company issued a total of 119,032 restricted stock units (RSUs) under the 2021 Equity Plan to its four independent directors. These RSUs vested upon grant.

 

Effective January 17, 2023, the Company settled 3,366 RSUs that had been issued on January 17, 2022 to two new directors and that vested after 12 months by the issuance of shares of common stock

 

During the three months ended March 31, 2023 and March 31, 2022, the Company recorded $101,316 and $29,923, respectively, as compensation expense related to vested RSUs issued to directors.

 

  

Number of

Units

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

 
            
Outstanding, December 31, 2022   3,366   $7.42   $- 
Granted   119,032   $0.84   $- 
Vested and settled with share issuance   (122,398)  $1.02   $- 
Forfeited/canceled   -   $-   $- 
Outstanding, March 31, 2023   -   $-   $- 

 

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Warrants
3 Months Ended
Mar. 31, 2023
Warrants  
Warrants

Note 9 - Warrants

 

The following table summarizes information with respect to outstanding warrants to purchase common stock during the three months ended March 31, 2023:

 

           Weighted   Weighted     
           Average   Average   Aggregate 
   Warrants   Exercise   Remaining Life   Intrinsic 
   Outstanding   Exercisable   Price   In Months   Value 
                     
Outstanding at December 31, 2022   7,623,772    7,623,772   $5.14    49         - 
                          
Granted   -    -    -    -    - 
                          
Exercised   -    -    -    -    - 
                          
Expired   -    -    -    -    - 
                          
Outstanding at March 31, 2023   7,623,772    7,623,772   $5.14    46    - 

 

The following table summarizes information about warrants outstanding at March 31, 2023:

 

    Warrants   Weighted Average 
Exercise price   Outstanding   Exercisable   Months Outstanding 
              
 9.45    192,982    192,982    18 
                  
 10.40    34,737    34,737    19 
                  
 5.00    7,105,496    7,105,496    47 
                  
 5.16    290,557    290,557    47 
                  
      7,623,772    7,623,772    46 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes
3 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
Income Taxes

Note 10 – Income Taxes

 

As of March 31, 2023, the Company has U.S. federal and state net operating losses (“NOLs”) of approximately $26,380,000, of which $11,196,000 will expire, if not utilized, in the years 2034 through 2037, however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to 80%.

 

In addition, pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of the Company’s NOLs carryforwards may be limited in the event of cumulative changes in ownership of more than 50% within a three-year period. In addition, under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”), and corresponding provisions of state law, if a corporation undergoes an “ownership change,” which is generally defined as a greater than 50% change, by value, in its equity ownership over a three-year period, the corporation’s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. Our sale of securities, both in September 2021 and February 2022, will need to be considered for determination of any “ownership change” that we have undergone during a determination period. If an ownership change occurs and our ability to use our net operating loss carryforwards is materially limited, it would harm our future bottom-line operating results by effectively increasing our future tax obligations.

 

The Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the Company believes that recovery is not likely, the Company establishes a valuation allowance. Management’s judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against the net deferred tax assets. The Company recorded a full valuation allowance as of March 31, 2023 and December 31, 2022. Based on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions that are consistent with the Company’s plans. Should the actual amounts differ from the Company’s estimates, the carrying value of the Company’s deferred tax assets could be materially impacted.

 

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions
3 Months Ended
Mar. 31, 2023
Related Party Transactions [Abstract]  
Related Party Transactions

Note 11 – Related Party Transactions

 

The Company entered into a manufacturer representative agreement with RSX Enterprises (“RSX”) in March 2021 to become a non-exclusive representative for the Company to assist in marketing and soliciting orders. James R. Shipley, a current director of the Company, has a significant ownership interest in RSX.

 

Under the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada and Mexico and may receive a commission for qualified customer leads. The agreement had an initial term through December 31, 2021 with automatic one-year renewal terms unless notice is given 90 days prior to each annual expiration. During the three months ended March 31, 2023 and March 31, 2022, the Company paid $18,273 and $7,555, respectively, in commissions under this agreement.

 

On October 13, 2022, the Company entered into an agreement with Lone Star Bioscience, Inc. (Lone Star) to provide engineering design services. Nicholas Etten, one of our independent directors, is the Chief Executive Officer of Lone Star. The agreement totaled $2,500 with $1,250 received as a deposit in 2022. Another agreement for engineering services was signed on December 20, 2022, in the amount of $10,900. We entered into positive change orders in March of $3,577 increasing the total of the second sales order to $14,477. During the three months ended March 31, 2023, the Company received $14,035 in cash payments for these contracts. Revenue of $16,977 was recorded in the three months ended March 31, 2023 in respect of these agreements.

 

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events
3 Months Ended
Mar. 31, 2023
Subsequent Events [Abstract]  
Subsequent Events

Note 12 – Subsequent Events

 

In accordance with ASC 855, Subsequent Events, the Company has evaluated all subsequent events through the date of issuance of these financial statements issued and determined no material subsequent events occurred after March 31, 2023 for which disclosure was required.

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Nature of Operations and Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Description of Business

Description of Business

 

CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the fastest-growing sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, and tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) air sanitation products, (v) LED lighting, (vi) benching and racking solutions for indoor cultivation, (vii) proprietary and third party controls systems and technologies used for environmental, lighting, and climate control, and (viii) preventive maintenance services, through our partnership with a certified service contractor network, for CEA facilities. Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services, and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.

 

Impact of the COVID-19 Pandemic on Our Business

Impact of the COVID-19 Pandemic on Our Business

 

The impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, and working capital.

 

The resulting effects and uncertainties from the COVID-19 pandemic, including the depth and duration of the disruptions to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, cannot be predicted. We expect that the economic disruptions will continue to have an effect on our business over the longer term. Despite this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2022, and continuing into the current fiscal quarter, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Impact of Ukrainian Conflict

Impact of Ukrainian Conflict

 

Currently, we believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it has a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflationary results of the conflict and government spending for and funding of our country’s response. As our operations are related only to the North American controlled environment agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to this conflict. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.

 

Inflation

Inflation

 

Recently, our operations have started to be influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build facilities in which we operate. We are likely to continue to face inflationary increases on the cost of products and our operations, which may adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment and other products that we have contracted to provide to our customers, and generally higher prices across all sectors of the economy. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.

 

Financial Statement Presentation

Financial Statement Presentation

 

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.

 

[custom:LiquidityPolicyTextBlock]

Interim Financial Statements

Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2023. The balance sheet information as of December 31, 2022 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2022.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Principles of Consolidation

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.

[custom:ReverseStockSplitPolicyTextBlock]

 

Use of Estimates

Use of Estimates

 

Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets and goodwill, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.

 

Cash, Cash Equivalents, and Restricted Cash

Cash, Cash Equivalents, and Restricted Cash

 

All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount of $250,000. As of March 31, 2023, the balance in the Company’s accounts was approximately $15,948,000, consequently approximately $15,698,000 of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.

 

Income (Loss) Per Common Share

Income (Loss) Per Common Share

 

Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

As of March 31, 2023, and March 31, 2022, there were respectively, 8,010,957 and 8,021,057, potentially dilutive equity instruments outstanding in respect of options outstanding to purchase Company common stock, warrants, and restricted stock units that were convertible into shares of the Company’s common stock. Of these potentially dilutive equity instruments outstanding, 7,623,772 as of March 31, 2023 and 7,794,154 as of March 31, 2022 related to warrants issued in connection with the sale of our shares of series B Preferred stock and common stock in prior periods. The remaining 387,185 potentially dilutive equity instruments outstanding as of March 31, 2023 and 226,903 as of March 31, 2022 related to options and restricted stock units issued to our directors and staff.

 

Goodwill

Goodwill

 

The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its carrying amount, including goodwill. The Company’s fair value is calculated using a market valuation technique whereby an appropriate control premium is applied to the Company’s market capitalization as calculated by applying its publicly quoted share price to the number of its common shares issued and outstanding. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.

 

As of June 30, 2022, the Company experienced a triggering event due to a drop in its stock price and performed a quantitative analysis for potential impairment of its goodwill. Based on this analysis, the Company determined that its carrying value exceeded its fair value. As a result, the Company recorded a non-cash goodwill impairment charge of $631,064 at June 30, 2022. No income tax benefit related to this goodwill impairment charge was recorded at June 30, 2022.

 

Temporary Equity

Temporary Equity

 

Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the Company. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.

 

Revenue Recognition

Revenue Recognition

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

The following table sets forth the Company’s revenue by source:

 

   2023   2022 
  

For the Three Months Ended

March 31,

 
   2023   2022 
Equipment and systems sales  $4,396,827   $1,642,572 
Engineering and other services   124,410    86,049 
Shipping and handling   12,560    15,806 
Miscellaneous   148,776    - 
Total revenue  $4,682,573   $1,744,427 

 

Miscellaneous revenue of $148,776 represents non-refundable deposits, forfeited by former customers on previously cancelled contracts.

 

Revenue Recognition Accounting Policy Summary

 

The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.

 

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on the standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.

 

Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.

 

The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.

 

Disaggregation of Revenue

 

In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).

 

Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by sales, services, shipping and handling, and miscellaneous was required.

 

Other Judgments and Assumptions

 

The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.

 

Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

Contract Assets and Contract Liabilities

 

Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.

 

Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of March 31, 2023 and December 31, 2022, the Company had no contract assets.

 

Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited. As of March 31, 2023, and December 31, 2022, deferred revenue, which was classified as a current liability, was $1,102,601 and $4,338,570, respectively.

 

For the three months ended March 31, 2023, the Company recognized revenue of $3,852,906 related to the deferred revenue at January 1, 2023. For the three months ended March 31, 2022, the Company recognized revenue of $1,162,374 related to the deferred revenue at January 1, 2022.

 

Remaining Performance Obligations

 

Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.

 

Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, the uncertainty regarding the COVID-19 virus, and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

As of March 31, 2023, the Company’s remaining performance obligations, or backlog, was approximately $1,869,000. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at March 31, 2023, includes booked sales orders of $379,000 from three customers that the Company does not expect to be realized until 2024, if at all. This 2024 projected revenue amount contains a booked sales order of $279,000 (15% of the total backlog) from one customer that we believe is at risk of cancellation based on conversations with this customer. Given the current supply chain and bottleneck issues that are still being worked through by the Company’s supply chain partners, the Company believes that some of its current contracts could be delayed.

 

The remaining performance obligations expected to be recognized through 2024 are as follows:

 

   2023   2024   Total 
Remaining performance obligations related to engineering only paid contracts  $172,000   $-   $172,000 
Remaining performance obligations related to partial equipment paid contracts   1,318,000    379,000    1,697,000 
Total remaining performance obligations  $1,490,000   $379,000   $1,869,000 

 

Product Warranty

Product Warranty

 

The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.

 

The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of March 31, 2023, and December 31, 2022, the Company had an accrued warranty reserve amount of $188,738 and $180,457, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.

 

Accounting for Share-Based Compensation

Accounting for Share-Based Compensation

 

The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.

 

The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the three months ended March 31, 2023, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility of 152.23%; expected term in years of 10 and risk-free interest rate of 3.48%.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.

 

The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.

 

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2023 and March 31, 2022:

 

   2023   2022 
  

For the Three Months Ended

March 31,

 
   2023   2022 
Share-based compensation expense included in:          
Cost of revenue  $4,898   $791 
Advertising and marketing expenses   1,113    2,762 
Product development costs   3,570    - 
Selling, general and administrative expenses   137,513    88,964 
Total share-based compensation expense included in consolidated statement of operations  $147,094   $92,517 

 

Concentrations

Concentrations

 

Three customers accounted for 39%, 28%, and 17% of the Company’s revenue for the three months ended March 31, 2023. One customer accounted for 35% of the Company’s revenue for the three months ended March 31, 2022.

 

Three customers accounted for 68%, 20%, and 10% of the Company’s accounts receivable as of March 31, 2023. Two customers accounted for 57% and 43% of the Company’s accounts receivable as of December 31, 2022.

 

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

 

In March 2023, the FASB issued ASU 2023-01 to require entities to classify and account for leases with related parties on the basis of legally enforceable terms and conditions of the arrangement. The amendments are effective in periods beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2023

(in US Dollars except share numbers)

(Unaudited)

 

In December 2022, the FASB issued ASU No. 2022-06, which defers the sunset date of Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”) from December 31, 2022 to December 31, 2024. ASU No. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In September 2022, the FASB issued Update 2022-04, “Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations”. The update was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in Update 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this update do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard on Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.

 

In March 2020, the FAS issued ASU No. 2020-04 “Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Nature of Operations and Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Schedule of Revenue by Source

The following table sets forth the Company’s revenue by source:

 

   2023   2022 
  

For the Three Months Ended

March 31,

 
   2023   2022 
Equipment and systems sales  $4,396,827   $1,642,572 
Engineering and other services   124,410    86,049 
Shipping and handling   12,560    15,806 
Miscellaneous   148,776    - 
Total revenue  $4,682,573   $1,744,427 
Schedule of Remaining Performance Obligations Expected to be Recognized

The remaining performance obligations expected to be recognized through 2024 are as follows:

 

   2023   2024   Total 
Remaining performance obligations related to engineering only paid contracts  $172,000   $-   $172,000 
Remaining performance obligations related to partial equipment paid contracts   1,318,000    379,000    1,697,000 
Total remaining performance obligations  $1,490,000   $379,000   $1,869,000 
Schedule of Share-based Compensation Costs

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2023 and March 31, 2022:

 

   2023   2022 
  

For the Three Months Ended

March 31,

 
   2023   2022 
Share-based compensation expense included in:          
Cost of revenue  $4,898   $791 
Advertising and marketing expenses   1,113    2,762 
Product development costs   3,570    - 
Selling, general and administrative expenses   137,513    88,964 
Total share-based compensation expense included in consolidated statement of operations  $147,094   $92,517 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Leases (Tables)
3 Months Ended
Mar. 31, 2023
Leases  
Schedule of Lease Cost

The lease cost, cash flows and other information related to the New Facility Lease were as follows:

 

  

As of

March 31, 2023

 
Operating lease right-of-use asset  $436,549 
Operating lease liability, current  $120,245 
Operating lease liability, long-term  $348,179 
      
Remaining lease term   3.8 years 
Discount rate   3.63%

 

  

For the Three

Months Ended

March 31, 2023

 
Operating cash outflow from operating lease  $31,069 
Schedule of Future Annual Minimum Lease Payments

Future annual minimum lease payments on the New Facility Lease as of March 31, 2023 are as follows:

 

Years ended December 31,    
2023 (excluding the three months ended March 31, 2023)  $124,897 
2024   128,643 
2025   132,503 
2026   136,473 
Thereafter   11,654 
Total minimum lease payments   534,170 
Less imputed interest   (65,746)
Present value of minimum lease payments  $468,424 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Inventory (Tables)
3 Months Ended
Mar. 31, 2023
Inventory Disclosure [Abstract]  
Schedule of Inventory

Inventory consisted of the following:

 

   2023   2022 
   March 31,   December 31, 
   2023   2022 
Finished goods  $410,208   $270,555 
Work in progress   154    155 
Raw materials   135,316    148,608 
Allowance for excess & obsolete inventory   (104,545)   (70,907)
Inventory, net  $441,133   $348,411 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Property and Equipment (Tables)
3 Months Ended
Mar. 31, 2023
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment

Property and equipment consisted of the following:

 

   2023   2022 
   March 31,   December 31, 
   2023   2022 
Furniture and equipment  $275,994   $278,389 
Vehicles   15,000    15,000 
Property and equipment, gross   290,994    293,389 
Accumulated depreciation   (230,281)   (224,876)
Property and equipment, net  $60,713   $68,513 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Accounts Payable and Accrued Liabilities (Tables)
3 Months Ended
Mar. 31, 2023
Payables and Accruals [Abstract]  
Schedule of Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consisted of the following:

 

   2023   2022 
   March 31,   December 31, 
   2023   2022 
Accounts payable  $714,586   $311,162 
Sales commissions payable   24,468    25,951 
Accrued payroll liabilities   167,697    465,094 
Product warranty accrual   188,738    180,457 
Other accrued expenses   68,645    224,594 
Total  $1,164,134   $1,207,258 
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Incentive Plans (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the three months ended March 31, 2023, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value

 
                 
Outstanding, December 31, 2022   192,073   $8.94    7.6   $            - 
Granted   138,489   $0.90    8.4   $- 
Exercised   -   $-    -   $- 
Forfeited   (500)  $6.10    8.9   $- 
Expired   -   $-    -   $- 
Outstanding, March 31, 2023   330,062   $5.57    7.6   $- 
Exercisable, March 31, 2023   304,972   $5.59    8.2   $- 
Summary of Non-vested Non-qualified Stock Option Activity

A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the three months ended March 31, 2023, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic Value

  

Grant-Date

Fair Value

 
                
Nonvested, December 31, 2022   43,846   $5.65   $  -   $247,730 
Granted   138,489   $0.88   $-   $122,346 
Vested   (156,912)  $1.49   $-   $(234,296)
Forfeited   (333)  $6.67   $-   $(2,225)
Expired   -   $-   $-   $- 
Nonvested, March 31, 2023   25,090   $4.98   $-   $133,555 
Schedule of Restricted Stock Units Activity

 

  

Number of

Units

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

 
            
Outstanding, December 31, 2022   3,366   $7.42   $- 
Granted   119,032   $0.84   $- 
Vested and settled with share issuance   (122,398)  $1.02   $- 
Forfeited/canceled   -   $-   $- 
Outstanding, March 31, 2023   -   $-   $- 
2017 Equity Plan and 2021 Equity Plan [Member] | Directors [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the three months ended March 31, 2023, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value ($000)

 
                 
Outstanding, December 31, 2022   57,122   $9.44    6.0   $      - 
Granted   -    -    0.0   $- 
Exercised   -    -    -   $- 
Forfeited/Cancelled   -    -    -   $- 
Expired   -    -    -   $- 
Outstanding, March 31, 2023   57,122   $9.44    5.7   $- 
Exercisable, March 31, 2023   57,122   $9.44    5.7   $- 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Warrants (Tables)
3 Months Ended
Mar. 31, 2023
Warrants  
Schedule of Outstanding Warrants to Purchase Common Stock

The following table summarizes information with respect to outstanding warrants to purchase common stock during the three months ended March 31, 2023:

 

           Weighted   Weighted     
           Average   Average   Aggregate 
   Warrants   Exercise   Remaining Life   Intrinsic 
   Outstanding   Exercisable   Price   In Months   Value 
                     
Outstanding at December 31, 2022   7,623,772    7,623,772   $5.14    49         - 
                          
Granted   -    -    -    -    - 
                          
Exercised   -    -    -    -    - 
                          
Expired   -    -    -    -    - 
                          
Outstanding at March 31, 2023   7,623,772    7,623,772   $5.14    46    - 
Schedule of Warrants Outstanding

The following table summarizes information about warrants outstanding at March 31, 2023:

 

    Warrants   Weighted Average 
Exercise price   Outstanding   Exercisable   Months Outstanding 
              
 9.45    192,982    192,982    18 
                  
 10.40    34,737    34,737    19 
                  
 5.00    7,105,496    7,105,496    47 
                  
 5.16    290,557    290,557    47 
                  
      7,623,772    7,623,772    46 
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Revenue by Source (Details) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Product Information [Line Items]    
Total revenue $ 4,682,573 $ 1,744,427
Equipment And Systems Sales [Member]    
Product Information [Line Items]    
Total revenue 4,396,827 1,642,572
Engineering And Other Services [Member]    
Product Information [Line Items]    
Total revenue 124,410 86,049
Shipping and Handling [Member]    
Product Information [Line Items]    
Total revenue 12,560 15,806
Miscellaneous [Member]    
Product Information [Line Items]    
Total revenue $ 148,776
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Remaining Performance Obligations Expected to be Recognized (Details)
Mar. 31, 2023
USD ($)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Remaining performance obligations related to engineering only paid contracts $ 172,000
Remaining performance obligations related to partial equipment paid contracts 1,697,000
Total remaining performance obligations 1,869,000
2023 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Remaining performance obligations related to engineering only paid contracts 172,000
Remaining performance obligations related to partial equipment paid contracts 1,318,000
Total remaining performance obligations 1,490,000
2024 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Remaining performance obligations related to engineering only paid contracts
Remaining performance obligations related to partial equipment paid contracts 379,000
Total remaining performance obligations $ 379,000
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Share-based Compensation Costs (Details) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Total share-based compensation expense included in consolidated statement of operations $ 147,094 $ 92,517
Cost of Sales [Member]    
Total share-based compensation expense included in consolidated statement of operations 4,898 791
Advertising And Marketing Expenses [Member]    
Total share-based compensation expense included in consolidated statement of operations 1,113 2,762
Product Development Costs [Member]    
Total share-based compensation expense included in consolidated statement of operations 3,570
Selling, General and Administrative Expenses [Member]    
Total share-based compensation expense included in consolidated statement of operations $ 137,513 $ 88,964
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Nature of Operations and Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Jun. 30, 2022
Dec. 31, 2022
Product Information [Line Items]        
Federal insured amount $ 250,000      
Cash balance, amount 15,948,000      
Cash equivalent balance, amount $ 15,698,000      
Potentially dilutive equity instruments that are convertible into common stock 8,010,957 8,021,057    
Goodwill and intangible asset impairment     $ 631,064  
Miscellaneous revenue $ 4,682,573 $ 1,744,427    
Contract with customer liability current 1,102,601     $ 4,338,570
Revenue recognized 3,852,906 $ 1,162,374    
Revenue remaining performance obligation $ 1,869,000      
Product warranty description The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue.      
Accrued warranty reserve amount $ 188,738     $ 180,457
Stock price volatility 152.23%      
Expected Term 10 years      
Risk-free interest rate 3.48%      
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer One [Member]        
Product Information [Line Items]        
Concentration risk percentage 39.00% 35.00%    
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Two [Member]        
Product Information [Line Items]        
Concentration risk percentage 28.00%      
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Three [Member]        
Product Information [Line Items]        
Concentration risk percentage 17.00%      
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member]        
Product Information [Line Items]        
Concentration risk percentage 68.00%     57.00%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Two [Member]        
Product Information [Line Items]        
Concentration risk percentage 20.00%     43.00%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Three [Member]        
Product Information [Line Items]        
Concentration risk percentage 10.00%      
2023 [Member]        
Product Information [Line Items]        
Revenue remaining performance obligation $ 1,490,000      
2023 [Member] | Booked Sales Orders From Three Customers [Member]        
Product Information [Line Items]        
Revenue remaining performance obligation 379,000      
Miscellaneous [Member]        
Product Information [Line Items]        
Miscellaneous revenue $ 148,776    
Director And Staff [Member]        
Product Information [Line Items]        
Potentially dilutive equity instruments that are convertible into common stock 387,185 226,903    
One Customer [Member]        
Product Information [Line Items]        
Revenue remaining performance obligation $ 279,000      
Series B Preferred Stock [Member]        
Product Information [Line Items]        
Potentially dilutive equity instruments that are convertible into common stock 7,623,772 7,794,154    
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Lease Cost (Details) - USD ($)
3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Leases    
Operating lease right-of-use asset $ 436,549 $ 462,874
Operating lease liability, current 120,245 118,235
Operating lease liability, long-term $ 348,179 $ 376,851
Remaining lease term 3 years 9 months 18 days  
Discount rate 3.63%  
Operating cash outflow from operating lease $ 31,069  
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Future Annual Minimum Lease Payments (Details)
Mar. 31, 2023
USD ($)
Leases  
2023 (excluding the three months ended March 31, 2023) $ 124,897
2024 128,643
2025 132,503
2026 136,473
Thereafter 11,654
Total minimum lease payments 534,170
Less imputed interest (65,746)
Present value of minimum lease payments $ 468,424
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Leases (Details Narrative)
Jul. 28, 2021
USD ($)
ft²
Mar. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Lease renew term 5 years    
Operating lease right-of-use asset   $ 436,549 $ 462,874
Operating lease liability   $ 468,424  
New Facility Lease [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Area of land | ft² 11,491    
Operating lease term description The New Facility Lease commenced on November 1, 2021 and continues through January 31, 2027.    
Lease rental expense $ 10,055    
Increase in rent percent 3.00%    
Security deposit $ 14,747    
Operating lease right-of-use asset 582,838    
Operating lease liability $ 582,838    
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Inventory (Details) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Finished goods $ 410,208 $ 270,555
Work in progress 154 155
Raw materials 135,316 148,608
Allowance for excess & obsolete inventory (104,545) (70,907)
Inventory, net $ 441,133 $ 348,411
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Inventory (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Overhead expenses $ 14,101 $ 12,770
Prepaid inventory expenses $ 219,000 $ 1,176,000
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Property and Equipment (Details) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 290,994 $ 293,389
Accumulated depreciation (230,281) (224,876)
Property and equipment, net 60,713 68,513
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 275,994 278,389
Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 15,000 $ 15,000
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Property and Equipment (Details Narrative)
3 Months Ended
Mar. 31, 2023
USD ($)
Property, Plant and Equipment [Line Items]  
Depreciation expenses $ 7,500
Property, Plant and Equipment [Member] | Cost of Sales [Member]  
Property, Plant and Equipment [Line Items]  
Depreciation expenses 1,214
Property, Plant and Equipment [Member] | Inventory [Member]  
Property, Plant and Equipment [Line Items]  
Depreciation expenses $ 304
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Payables and Accruals [Abstract]    
Accounts payable $ 714,586 $ 311,162
Sales commissions payable 24,468 25,951
Accrued payroll liabilities 167,697 465,094
Product warranty accrual 188,738 180,457
Other accrued expenses 68,645 224,594
Total $ 1,164,134 $ 1,207,258
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Deficit) (Details Narrative) - USD ($)
3 Months Ended
Jan. 03, 2023
Jun. 21, 2022
Feb. 15, 2022
Jan. 17, 2022
Jan. 03, 2022
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 30, 2021
Mar. 22, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Common stock, shares authorized           200,000,000 200,000,000      
Preferred stock, shares authorized           25,000,000 25,000,000      
Preferred stock par value           $ 0.00001 $ 0.00001      
Common stock par value           $ 0.00001 $ 0.00001      
Common stock, shares issued           8,076,372 7,953,974 1,600,835 240,125,224  
Common stock, shares outstanding           8,076,372 7,953,974 1,600,835 240,125,224  
Reverse stock split       one-for-one hundred and fifty            
Reverse stock split       6,798            
Net proceeds from sale of common stock     $ 22,000,000              
Exercise price           $ 5.14 $ 5.14      
Number of shares issued   169,530                
Prefunded conversion warrants   170,382                
Common Stock [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of shares sold     5,811,138              
Warrant [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of shares sold     6,572,808              
Warrant term     5 years              
Exercise price     $ 5.00              
Director [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Management fee expense       $ 15,000   $ 25,000        
Audit Committee Chairman [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Management fee expense       10,000            
Committee Chairman [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Management fee expense       $ 5,000            
Board of Directors Chairman [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Common stock, shares authorized           200,000,000        
Preferred stock, shares authorized           25,000,000        
Underwriters [Member] | Warrant [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Exercise price     $ 5.1625              
Stock issued during period, shares, issued for services     290,557              
Warrants maturity date     Feb. 10, 2027              
2021 Equity Incentive Plan [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Exercise price         $ 4.80          
2021 Equity Plan [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of stock options issued                   666,667
Number of shares issued           122,398        
Non-Qualified Stock Options [Member] | 2021 Equity Incentive Plan [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of stock options issued         3,125          
Restricted Stock Units (RSUs) [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Vesting rights description       Vesting of the RSUs was as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date.            
Restricted Stock Units (RSUs) [Member] | Director [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Share based compensation arrangement payment       $ 25,000            
Restricted Stock Units (RSUs) [Member] | 2021 Equity Incentive Plan [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of stock options issued 29,758     3,367            
Restricted Stock Units (RSUs) [Member] | 2021 Equity Incentive Plan [Member] | January 17, 2022 [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of stock options issued       1,684            
Shares, vested       1,684            
Restricted Stock Units (RSUs) [Member] | 2021 Equity Incentive Plan [Member] | January 17, 2023 [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of stock options issued       1,683            
Shares, vested       1,683            
Restricted Stock Units (RSUs) [Member] | 2021 Equity Plan [Member] | Directors [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of shares vested in period 119,032                  
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Stock Option Activity (Details) - 2017 Equity Plan and 2021 Equity Plan [Member]
3 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Employees And Consultants [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options, Granted 138,489
Employees And Consultants [Member] | Non-Qualified Stock Options [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options, Outstanding Beginning 192,073
Weighted Average Exercise Price, Outstanding Beginning | $ / shares $ 8.94
Weighted Average Remaining Contractual Term, Beginning 7 years 7 months 6 days
Aggregate Intrinsic Value, Outstanding Beginning | $
Number of Options, Granted 138,489
Weighted Average Exercise Price, Granted | $ / shares $ 0.90
Weighted Average Remaining Contractual Term, Granted 8 years 4 months 24 days
Number of Options, Exercised
Weighted Average Exercise Price, Exercised | $ / shares
Number of Options, Forfeited/Cancelled (500)
Weighted Average Exercise Price, Forfeited/Cancelled | $ / shares $ 6.10
Weighted Average Remaining Contractual Term, Forfeited 8 years 10 months 24 days
Number of Options, Expired
Weighted Average Exercise Price, Expired | $ / shares
Number of Options, Outstanding Ending 330,062
Weighted Average Exercise Price, Outstanding Ending | $ / shares $ 5.57
Weighted Average Remaining Contractual Term, Outstanding Ending 7 years 7 months 6 days
Aggregate Intrinsic Value, Outstanding Ending | $
Number of Options, Exercisable Ending 304,972
Weighted Average Exercise Price, Exercisable Ending | $ / shares $ 5.59
Weighted Average Remaining Contractual Term, Exercisable Ending 8 years 2 months 12 days
Aggregate Intrinsic Value, Exercisable Ending | $
Directors [Member] | Non-Qualified Stock Options [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options, Outstanding Beginning 57,122
Weighted Average Exercise Price, Outstanding Beginning | $ / shares $ 9.44
Weighted Average Remaining Contractual Term, Beginning 6 years
Aggregate Intrinsic Value, Outstanding Beginning | $
Number of Options, Granted
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Remaining Contractual Term, Granted 0 years
Number of Options, Exercised
Weighted Average Exercise Price, Exercised | $ / shares
Number of Options, Forfeited/Cancelled
Weighted Average Exercise Price, Forfeited/Cancelled | $ / shares
Number of Options, Expired
Weighted Average Exercise Price, Expired | $ / shares
Number of Options, Outstanding Ending 57,122
Weighted Average Exercise Price, Outstanding Ending | $ / shares $ 9.44
Weighted Average Remaining Contractual Term, Outstanding Ending 5 years 8 months 12 days
Aggregate Intrinsic Value, Outstanding Ending | $
Number of Options, Exercisable Ending 57,122
Weighted Average Exercise Price, Exercisable Ending | $ / shares $ 9.44
Weighted Average Remaining Contractual Term, Exercisable Ending 5 years 8 months 12 days
Aggregate Intrinsic Value, Exercisable Ending | $
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Non-vested Non-qualified Stock Option Activity (Details) - Employees And Consultants [Member] - 2017 Equity Plan and 2021 Equity Plan [Member]
3 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options Nonvested, Beginning | shares 43,846
Weighted Average Grant-Date Fair Value, Nonvested, Beginning | $ / shares $ 5.65
Aggregated Intrinsic Value, Nonvested Beginning
Grant Date Fair Value Nonvested, Beginning $ 247,730
Number of Options Nonvested, Granted | shares 138,489
Weighted Average Grant-Date Fair Value, Nonvested, Granted | $ / shares $ 0.88
Grant Date Fair Value Nonvested, Granted $ 122,346
Number of Options Nonvested, Vested $ (156,912)
Weighted Average Grant-Date Fair Value, Nonvested, Vested | $ / shares $ 1.49
Grant Date Fair Value Nonvested, Vested $ (234,296)
Number of Options Nonvested, Forfeited | shares (333)
Weighted Average Grant-Date Fair Value, Nonvested, Forfeited | $ / shares $ 6.67
Grant Date Fair Value Nonvested, Forfeited $ (2,225)
Number of Options Nonvested, Expired | shares
Weighted Average Grant-Date Fair Value, Nonvested, Expired | $ / shares
Grant Date Fair Value Nonvested, Expired
Number of Options Nonvested, Ending | shares 25,090
Weighted Average Grant-Date Fair Value, Nonvested, Beginning | $ / shares $ 4.98
Aggregated Intrinsic Value, Nonvested Ending
Grant Date Fair Value Nonvested, Ending $ 133,555
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Restricted Stock Units Activity (Details)
3 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Aggregate Intrinsic Value Outstanding, Granted
Aggregate Intrinsic Value Outstanding, ending
2017 Equity Incentive Plan [Member] | Employees, Directors and Consultants [Member] | Restricted Stock Units (RSUs) [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Units Outstanding, beginning | shares 3,366
Weighted Average Grant-Date Fair Value Outstanding, Beginning | $ / shares $ 7.42
Aggregate Intrinsic Value Outstanding, Beginning
Number of Units, Granted | shares 119,032
Weighted Average Grant-Date Fair Value, Granted | $ / shares $ 0.84
Aggregate Intrinsic Value Outstanding, Granted
Number of Units, Vested and settled with share issuance | shares (122,398)
Weighted Average Grant-Date Fair Value, Vested and settled with share issuance | $ / shares $ 1.02
Aggregate Intrinsic Value Outstanding, Vested and settled with share issuance
Number of Units, Forfeited/canceled | shares
Weighted Average Grant-Date Fair Value, Forfeited/Canceled | $ / shares
Aggregate Intrinsic Value Outstanding, Forfeited/canceled
Number of Units Outstanding, ending | shares
Weighted Average Grant-Date Fair Value Outstanding,ending | $ / shares
Aggregate Intrinsic Value Outstanding, ending
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Incentive Plans (Details Narrative) - USD ($)
3 Months Ended
Jan. 17, 2023
Jan. 03, 2023
Jun. 21, 2022
Jan. 03, 2022
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Jan. 17, 2022
Mar. 22, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Shares issued during the period     169,530            
Accrued equity compensation           $ 89,970    
Additional expense         32,376        
Share based compensation         147,094 $ 92,517      
Restricted Stock Units (RSUs) [Member] | Employees, Directors and Consultants [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Share based compensation         $ 101,316 29,923      
2017 Equity Incentive Plan [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of options to purchase shares         333,333        
Number of shares authorized         333,333        
2017 Equity Incentive Plan [Member] | Director [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Share based compensation         $ 0 $ 29,656      
Number of options to purchase shares         0 6,250      
2017 Equity Incentive Plan [Member] | Non Qualified Stock Option [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of option remain outstanding         147,177        
Shares available for future equity awards         22,464        
2017 Equity Incentive Plan [Member] | Restricted Stock [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of shares issued         163,692        
2017 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | Employees, Directors and Consultants [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of shares vested in period         122,398        
Number of shares granted         119,032        
2021 Equity Plan [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Shares available for future equity awards         309,668        
Number of shares grant in period                 666,667
Shares issued during the period         122,398        
Weighted Average Remaining Contractual Term         2 years        
Number of shares authorized         666,667        
Unrecognized compensation expense         $ 45,919        
2021 Equity Plan [Member] | Non Qualified Stock Option [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of option remain outstanding         183,615        
2021 Equity Plan [Member] | Incentive Stock Option [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of option remain outstanding         40,816        
2021 Equity Plan [Member] | Restricted Stock [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of shares issued         132,568        
2021 Equity Plan [Member] | Restricted Stock Units (RSUs) [Member] | Directors [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of shares vested in period   119,032              
Number of shares granted 3,366                
2021 Equity Incentive Plan [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Exercise price per share       $ 4.80          
2021 Equity Incentive Plan [Member] | Five Employees [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of share awards granted         138,491        
Weighted Average Remaining Contractual Term         10 years        
Exercise price per share         $ 0.8955        
2021 Equity Incentive Plan [Member] | Non-Qualified Stock Options [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of shares issued       3,125          
2021 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of shares grant in period   29,758           3,367  
2017 Equity Plan and 2021 Equity Plan [Member] | Non-Qualified Stock Options [Member] | Employees And Consultants [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Share based compensation         $ 45,778 $ 32,939      
2017 Equity Plan and 2021 Equity Plan [Member] | Non-Qualified Stock Options [Member] | Directors [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of option remain outstanding         57,122   57,122    
Number of share awards granted                
Weighted Average Remaining Contractual Term         6 years        
Exercise price per share                
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Outstanding Warrants to Purchase Common Stock (Details)
3 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Warrants  
Warrants Outstanding, Beginning Balance 7,623,772
Warrants Exercisable, Beginning Balance 7,623,772
Weighted Average Exercise Price, Beginning Balance | $ / shares $ 5.14
Weighted Average Life of Outstanding Warrants in Months, Beginning Balance 49 months
Aggregate Intrinsic Value, Beginning Balance | $
Warrants, Granted
Warrants, Granted
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Life of Outstanding Warrants in Months, Granted
Aggregate Intrinsic Value, Granted | $
Warrants, Exercised
Warrants, Exercised
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Remaining Life, Exercised
Aggregate Intrinsic Value, Exercised | $
Warrants, Expired
Warrants, Expired
Weighted Average Exercise Price, Expired | $ / shares
Aggregate Intrinsic Value, Expired | $
Warrants Outstanding, Ending Balance 7,623,772
Warrants Exercisable, Ending Balance 7,623,772
Weighted Average Exercise Price, Ending Balance | $ / shares $ 5.14
Weighted Average Life of Outstanding Warrants in Months, Ending Balance 46 months
Aggregate Intrinsic Value Outstanding, ending | $
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Warrants Outstanding (Details) - $ / shares
3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 5.14 $ 5.14
Warrants Outstanding 7,623,772 7,623,772
Warrants Exercisable 7,623,772 7,623,772
Weighted Average Life of Outstanding Warrants in Months 46 months  
Warrants Range [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 9.45  
Warrants Outstanding 192,982  
Warrants Exercisable 192,982  
Weighted Average Life of Outstanding Warrants in Months 18 months  
Warrants Range One [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 10.40  
Warrants Outstanding 34,737  
Warrants Exercisable 34,737  
Weighted Average Life of Outstanding Warrants in Months 19 months  
Warrants Range Two [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 5.00  
Warrants Outstanding 7,105,496  
Warrants Exercisable 7,105,496  
Weighted Average Life of Outstanding Warrants in Months 47 months  
Warrants Range Three [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 5.16  
Warrants Outstanding 290,557  
Warrants Exercisable 290,557  
Weighted Average Life of Outstanding Warrants in Months 47 months  
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Details Narrative)
3 Months Ended
Mar. 31, 2023
USD ($)
Operating loss carryforward $ 26,380,000
Net operating loss carry forward expected to expire amount $ 11,196,000
Net operating loss expiration term 2034 through 2037
NOLs usage against taxable income, percentage 80.00%
NOLs carryforwards term three-year period
Ownership [Member]  
Percentage of ownership change 50.00%
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Dec. 20, 2022
Oct. 13, 2022
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Payments for commissions     $ 18,273 $ 7,555  
Cash payments     14,035    
Revenue     16,977    
Consulting Agreement [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Proceeds from deposits $ 10,900        
Consulting Agreement [Member] | Lone Star Bioscience Inc [Member] | Chief Executive Officer [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Proceeds from deposits   $ 2,500 3,577   $ 1,250
Proceeds from sales     $ 14,477    
XML 58 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001482541 2023-01-01 2023-03-31 0001482541 CEAD:CommonStock0.00001ParValueMember 2023-01-01 2023-03-31 0001482541 CEAD:WarrantsToPurchaseCommonStockMember 2023-01-01 2023-03-31 0001482541 2023-05-15 0001482541 2023-03-31 0001482541 2022-12-31 0001482541 2022-01-01 2022-03-31 0001482541 us-gaap:CommonStockMember 2022-12-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001482541 us-gaap:RetainedEarningsMember 2022-12-31 0001482541 us-gaap:CommonStockMember 2021-12-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001482541 us-gaap:RetainedEarningsMember 2021-12-31 0001482541 2021-12-31 0001482541 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001482541 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001482541 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001482541 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001482541 us-gaap:CommonStockMember 2023-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001482541 us-gaap:RetainedEarningsMember 2023-03-31 0001482541 us-gaap:CommonStockMember 2022-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001482541 us-gaap:RetainedEarningsMember 2022-03-31 0001482541 2022-03-31 0001482541 us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-03-31 0001482541 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-03-31 0001482541 CEAD:DirectorAndStaffMember 2023-01-01 2023-03-31 0001482541 CEAD:DirectorAndStaffMember 2022-01-01 2022-03-31 0001482541 2022-01-01 2022-06-30 0001482541 CEAD:MiscellaneousMember 2023-01-01 2023-03-31 0001482541 CEAD:TwoThousandAndTwentyThreeMember CEAD:BookedSalesOrdersFromThreeCustomersMember 2023-03-31 0001482541 CEAD:OneCustomerMember 2023-03-31 0001482541 CEAD:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001482541 CEAD:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001482541 CEAD:CustomerThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001482541 CEAD:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001482541 CEAD:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001482541 CEAD:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001482541 CEAD:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001482541 CEAD:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001482541 CEAD:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001482541 CEAD:EquipmentAndSystemsSalesMember 2023-01-01 2023-03-31 0001482541 CEAD:EquipmentAndSystemsSalesMember 2022-01-01 2022-03-31 0001482541 CEAD:EngineeringAndOtherServicesMember 2023-01-01 2023-03-31 0001482541 CEAD:EngineeringAndOtherServicesMember 2022-01-01 2022-03-31 0001482541 us-gaap:ShippingAndHandlingMember 2023-01-01 2023-03-31 0001482541 us-gaap:ShippingAndHandlingMember 2022-01-01 2022-03-31 0001482541 CEAD:MiscellaneousMember 2022-01-01 2022-03-31 0001482541 CEAD:TwoThousandAndTwentyThreeMember 2023-03-31 0001482541 CEAD:TwoThousandAndTwentyFourMember 2023-03-31 0001482541 us-gaap:CostOfSalesMember 2023-01-01 2023-03-31 0001482541 us-gaap:CostOfSalesMember 2022-01-01 2022-03-31 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2023-01-01 2023-03-31 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2022-01-01 2022-03-31 0001482541 CEAD:ProductDevelopmentCostsMember 2023-01-01 2023-03-31 0001482541 CEAD:ProductDevelopmentCostsMember 2022-01-01 2022-03-31 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-03-31 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-03-31 0001482541 CEAD:NewFacilityLeaseMember 2021-07-28 0001482541 CEAD:NewFacilityLeaseMember 2021-07-24 2021-07-28 0001482541 2021-07-28 0001482541 2022-01-01 2022-12-31 0001482541 us-gaap:FurnitureAndFixturesMember 2023-03-31 0001482541 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001482541 us-gaap:VehiclesMember 2023-03-31 0001482541 us-gaap:VehiclesMember 2022-12-31 0001482541 us-gaap:CostOfSalesMember us-gaap:PropertyPlantAndEquipmentMember 2023-01-01 2023-03-31 0001482541 CEAD:InventoryMember us-gaap:PropertyPlantAndEquipmentMember 2023-01-01 2023-03-31 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-01-03 0001482541 CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-01-03 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17 0001482541 CEAD:JanuarySeventeernTwoThousandTwentyTwoMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17 0001482541 CEAD:JanuarySeventeernTwoThousandTwentyThreeMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17 0001482541 CEAD:JanuarySeventeernTwoThousandTwentyTwoMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-12 2022-01-17 0001482541 CEAD:JanuarySeventeernTwoThousandTwentyThreeMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-12 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2023-01-03 0001482541 CEAD:DirectorsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityPlanMember 2023-01-02 2023-01-03 0001482541 srt:DirectorMember 2022-01-12 2022-01-17 0001482541 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-12 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember 2022-01-12 2022-01-17 0001482541 CEAD:AuditCommitteeChairmanMember 2022-01-12 2022-01-17 0001482541 CEAD:CommitteeChairmanMember 2022-01-12 2022-01-17 0001482541 srt:DirectorMember 2023-01-01 2023-03-31 0001482541 2022-01-12 2022-01-17 0001482541 2021-12-30 0001482541 srt:BoardOfDirectorsChairmanMember 2023-03-31 0001482541 2022-02-14 2022-02-15 0001482541 us-gaap:CommonStockMember 2022-02-14 2022-02-15 0001482541 us-gaap:WarrantMember 2022-02-14 2022-02-15 0001482541 us-gaap:WarrantMember 2022-02-15 0001482541 CEAD:UnderwritersMember us-gaap:WarrantMember 2022-02-14 2022-02-15 0001482541 CEAD:UnderwritersMember us-gaap:WarrantMember 2022-02-15 0001482541 2022-06-20 2022-06-21 0001482541 2022-06-21 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-01-01 2023-03-31 0001482541 us-gaap:RestrictedStockMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-01-01 2023-03-31 0001482541 CEAD:NonQualifiedStockOptionMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2021-03-22 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2023-01-01 2023-03-31 0001482541 CEAD:FiveEmployeesMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2023-01-01 2023-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2023-03-31 0001482541 us-gaap:RestrictedStockMember CEAD:TwoThousandTwentyOneEquityPlanMember 2023-01-01 2023-03-31 0001482541 CEAD:NonQualifiedStockOptionMember CEAD:TwoThousandTwentyOneEquityPlanMember 2023-03-31 0001482541 CEAD:IncentiveStockOptionMember CEAD:TwoThousandTwentyOneEquityPlanMember 2023-03-31 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2023-01-01 2023-03-31 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2022-01-01 2022-03-31 0001482541 srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-01-01 2023-03-31 0001482541 srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2022-01-01 2022-03-31 0001482541 CEAD:DirectorsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityPlanMember 2023-01-16 2023-01-17 0001482541 CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0001482541 CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0001482541 CEAD:DirectorsMember CEAD:TwoThousandSeventeenAndTwoThousandTwentyOneEquityPlanMember 2023-01-01 2023-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-12-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-03-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-12-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-03-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-12-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-01-01 2023-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2023-03-31 0001482541 CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2022-12-31 0001482541 CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-01-01 2023-03-31 0001482541 CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2023-03-31 0001482541 CEAD:WarrantsRangeMember 2023-03-31 0001482541 CEAD:WarrantsRangeMember 2023-01-01 2023-03-31 0001482541 CEAD:WarrantsRangeOneMember 2023-03-31 0001482541 CEAD:WarrantsRangeOneMember 2023-01-01 2023-03-31 0001482541 CEAD:WarrantsRangeTwoMember 2023-03-31 0001482541 CEAD:WarrantsRangeTwoMember 2023-01-01 2023-03-31 0001482541 CEAD:WarrantsRangeThreeMember 2023-03-31 0001482541 CEAD:WarrantsRangeThreeMember 2023-01-01 2023-03-31 0001482541 CEAD:OwnershipMember 2023-03-31 0001482541 srt:ChiefExecutiveOfficerMember CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember 2022-10-12 2022-10-13 0001482541 srt:ChiefExecutiveOfficerMember CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember 2022-01-01 2022-12-31 0001482541 CEAD:ConsultingAgreementMember 2022-12-19 2022-12-20 0001482541 srt:ChiefExecutiveOfficerMember CEAD:ConsultingAgreementMember CEAD:LoneStarBioscienceIncMember 2023-01-01 2023-03-31 iso4217:USD shares iso4217:USD shares pure utr:sqft CEAD:integer CEAD:Segment 0001482541 false --12-31 Q1 Yes Yes 10-Q true 2023-03-31 2023 false 001-41266 CEA INDUSTRIES INC. NV 27-3911608 385 South Pierce Avenue Suite C Louisville CO 80027 80027 (303) 993-5271 Common Stock, $0.00001 par value CEAD NASDAQ Warrants to purchase common stock CEADW NASDAQ Non-accelerated Filer true false false 8076372 15948077 18637114 61774 2649 441133 348411 471137 1489921 16922121 20478095 60713 68513 1830 1830 14747 14747 436549 462874 513839 547964 17435960 21026059 1164134 1207258 1102601 4338570 89970 120245 118235 2386980 5754033 348179 376851 348179 376851 2735159 6130884 0.00001 0.00001 25000000 25000000 0 0 0 0 0.00001 0.00001 200000000 200000000 8076372 8076372 7953974 7953974 81 80 49410899 49173836 -34710179 -34278741 14700801 14895175 17435960 21026059 4682573 1744427 3829297 1653919 853276 90508 202323 251015 76413 138918 1020702 1311777 1299438 1701710 -446162 -1611202 5704 185000 9020 3260 14724 188260 -431438 -1422942 -431438 -1422942 35984 439999 -431438 -1898925 -0.05 -0.41 8071731 4622427 7953974 80 49173836 -34278741 14895175 7953974 80 49173836 -34278741 14895175 135748 135748 123398 1 -1 101316 101316 -431438 -431438 8077372 81 49410899 -34710179 14700801 8077372 81 49410899 -34710179 14700801 1600835 16 25211017 -28781566 -3570533 1600835 16 25211017 -28781566 -3570533 32938 32938 29656 29656 3367 24994 24994 4928 4928 6798 5811138 58 21711073 21711131 362306 4 1979996 1980000 -35984 -35984 -1422942 -1422942 7784444 78 48958618 -30204508 18754188 7784444 78 48958618 -30204508 18754188 -431438 -1422942 7500 8556 147094 92517 -1705 -22168 33638 3676 -100 -5499 26325 25433 57420 -10610 126360 631269 -1018785 551261 -43124 43438 -3235970 2645579 -26662 -14811 -2689237 192857 13948 200 200 -13948 35984 1980000 21711131 19695147 -2689037 19874056 18637114 2159608 15948077 22033664 1980000 439999 89970 <p id="xdx_802_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zhNyQ12QUD3c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 –<span id="xdx_82E_zfRTW4KYL2Oj"> Nature of Operations and Significant Accounting Policies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--DescriptionOfBusinessPolicyTextBlock_z9seFJO43Nr6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zvbR4lb5kIBe">Description of Business</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the fastest-growing sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, and tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) air sanitation products, (v) LED lighting, (vi) benching and racking solutions for indoor cultivation, (vii) proprietary and third party controls systems and technologies used for environmental, lighting, and climate control, and (viii) preventive maintenance services, through our partnership with a certified service contractor network, for CEA facilities. Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services, and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_ecustom--ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_zKkUcQnUZL15" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_z0CL7saKJil5">Impact of the COVID-19 Pandemic on Our Business</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, and working capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The resulting effects and uncertainties from the COVID-19 pandemic, including the depth and duration of the disruptions to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, cannot be predicted. We expect that the economic disruptions will continue to have an effect on our business over the longer term. Despite this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2022, and continuing into the current fiscal quarter, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_847_ecustom--ImpactofUkrainianConflictPolicyTextBlock_zDVte9KJjNca" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zqj1TLuLJd59">Impact of Ukrainian Conflict</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently, we believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it has a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflationary results of the conflict and government spending for and funding of our country’s response. As our operations are related only to the North American controlled environment agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to this conflict. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_842_ecustom--InflationPolicyTextBlock_z23Xzo2qVMnb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Inflation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recently, our operations have started to be influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build facilities in which we operate. We are likely to continue to face inflationary increases on the cost of products and our operations, which may adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment and other products that we have contracted to provide to our customers, and generally higher prices across all sectors of the economy. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z7Mjd7Lm1TVj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zAl18lSaWr2d">Financial Statement Presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_ecustom--LiquidityPolicyTextBlock_zk1tib17c7l9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"/> <p id="xdx_844_ecustom--InterimFinancialStatementsPolicyTextBlock_zvtzCDTJg8ce" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_z62SAMXHBkQ9">Interim Financial Statements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2023. The balance sheet information as of December 31, 2022 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_84E_eus-gaap--ConsolidationPolicyTextBlock_zJ29qDP2US43" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zqIeVxN1TULl">Principles of Consolidation </span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.</span></p> <p id="xdx_841_ecustom--ReverseStockSplitPolicyTextBlock_zTShSyUAu40f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--UseOfEstimates_zvAhFusiLu2h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zR7Zo7876yeb">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets and goodwill, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_za9QawnktdJl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zXiiw3IGpuO4">Cash, Cash Equivalents, and Restricted Cash</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount of $<span id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_c20230331_zAuuHvzifwE" title="Federal insured amount">250,000</span>. As of March 31, 2023, the balance in the Company’s accounts was approximately $<span id="xdx_90A_eus-gaap--Cash_iI_c20230331_z0Ght31RnUZj" title="Cash balance, amount">15,948,000</span>, consequently approximately $<span id="xdx_90A_eus-gaap--CashEquivalentsAtCarryingValue_iI_c20230331_zZrxmoeVWrIa" title="Cash equivalent balance, amount">15,698,000</span> of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_z6u4Ha9GoHM4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_z82aFh2xcsv6">Income (Loss) Per Common Share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, and March 31, 2022, there were respectively,<span id="xdx_901_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230331_z9SskhrbORC3" title="Potentially dilutive equity instruments that are convertible into common stock"> 8,010,957</span> and <span id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20220101__20220331_z6dF2NiqFhn4" title="Potentially dilutive equity instruments that are convertible into common stock">8,021,057</span>, potentially dilutive equity instruments outstanding in respect of <span style="background-color: white">options outstanding to purchase Company common stock, warrants, and restricted stock units that were convertible into shares of the Company’s common stock.</span> Of these potentially dilutive equity instruments outstanding, <span id="xdx_904_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zTJLkOk7jFyl" title="Potentially dilutive equity instruments that are convertible into common stock">7,623,772 </span>as of March 31, 2023 and <span id="xdx_905_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zz8zHaYZMG0c" title="Potentially dilutive equity instruments that are convertible into common stock">7,794,154</span> as of March 31, 2022 related to warrants issued in connection with the sale of our shares of series B Preferred stock and common stock in prior periods. The remaining <span id="xdx_905_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorAndStaffMember_zJzO18XDCHc5" title="Potentially dilutive equity instruments that are convertible into common stock">387,185</span> potentially dilutive equity instruments outstanding as of March 31, 2023 and <span id="xdx_901_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorAndStaffMember_zZqoJb0BgJ12" title="Potentially dilutive equity instruments that are convertible into common stock">226,903</span> as of March 31, 2022 related to options and restricted stock units issued to our directors and staff.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zZII6UNOjSXa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zrSthyhRmET1">Goodwill</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its carrying amount, including goodwill. The Company’s fair value is calculated using a market valuation technique whereby an appropriate control premium is applied to the Company’s market capitalization as calculated by applying its publicly quoted share price to the number of its common shares issued and outstanding. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2022, the Company experienced a triggering event due to a drop in its stock price and performed a quantitative analysis for potential impairment of its goodwill. Based on this analysis, the Company determined that its carrying value exceeded its fair value. As a result, the Company recorded a non-cash goodwill impairment charge of $<span id="xdx_90B_eus-gaap--GoodwillAndIntangibleAssetImpairment_c20220101__20220630_z75rQdZclsqc" title="Goodwill and intangible asset impairment">631,064</span> at June 30, 2022. No income tax benefit related to this goodwill impairment charge was recorded at June 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--TemporaryEquityPolicyTextBlock_zfZ0DcXpRKne" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zaA4GO3ZzJh9">Temporary Equity</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the Company. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zn5OahXkplc6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zyZS99grOpvj">Revenue Recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_zmjtQyKWsxFb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the Company’s revenue by source:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_z1I4n6fQfjE4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Revenue by Source</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20230101__20230331_zsnXWeukM1Sg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220101__20220331_zfpewfMpjzh8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zy87mdkuKUt" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Equipment and systems sales</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">4,396,827</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,642,572</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zSJq0Wbqx4xl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Engineering and other services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">124,410</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">86,049</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zhmSbh0AS5u2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Shipping and handling</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,560</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,806</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--MiscellaneousMember_z8gDfFUopgAl" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Miscellaneous</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">148,776</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0548">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zArdmBRUzWW" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,682,573</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,744,427</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_ztdIa6atetB1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous revenue of $<span id="xdx_903_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20230331__srt--ProductOrServiceAxis__custom--MiscellaneousMember_z8fpS8jZqOCh" title="Miscellaneous revenue">148,776</span> represents non-refundable deposits, forfeited by former customers on previously cancelled contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revenue Recognition Accounting Policy Summary</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on the standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Disaggregation of Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by sales, services, shipping and handling, and miscellaneous was required.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Other Judgments and Assumptions</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Contract Assets and Contract Liabilities</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of March 31, 2023 and December 31, 2022, the Company had no contract assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited. As of March 31, 2023, and December 31, 2022, deferred revenue, which was classified as a current liability, was $<span id="xdx_900_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20230331_zG6YjB8NyIV5" title="Contract with customer liability current">1,102,601</span> and $<span id="xdx_90E_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20221231_zDLphVXcdYfj" title="Contract with customer liability current">4,338,570</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three months ended March 31, 2023, the Company recognized revenue of $<span id="xdx_905_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20230101__20230331_z0dQwtsIdD73" title="Revenue recognized">3,852,906</span> related to the deferred revenue at January 1, 2023. For the three months ended March 31, 2022, the Company recognized revenue of $<span id="xdx_909_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20220101__20220331_zW1Beh9Rfjl3">1,162,374 </span>related to the deferred revenue at January 1, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Remaining Performance Obligations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, the uncertainty regarding the COVID-19 virus, and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, the Company’s remaining performance obligations, or backlog, was approximately $<span id="xdx_90A_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230331_z1jk2LJYuQAh" title="Revenue remaining performance obligation">1,869,000</span>. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at March 31, 2023, includes booked sales orders of $<span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230331__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyThreeMember__us-gaap--TypeOfArrangementAxis__custom--BookedSalesOrdersFromThreeCustomersMember_zdagfbmwMjsa">379,000</span> from three customers that the Company does not expect to be realized until 2024, if at all. This 2024 projected revenue amount contains a booked sales order of $<span id="xdx_909_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230331__srt--TitleOfIndividualAxis__custom--OneCustomerMember_znE0vKlSeHu9">279,000</span> (15% of the total backlog) from one customer that we believe is at risk of cancellation based on conversations with this customer. Given the current supply chain and bottleneck issues that are still being worked through by the Company’s supply chain partners, the Company believes that some of its current contracts could be delayed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zqLlRn5kKLde" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remaining performance obligations expected to be recognized through 2024 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zhEMi7VXFfz4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Remaining Performance Obligations Expected to be Recognized</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230331__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyThreeMember_zxBEbTb750C5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20230331__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyFourMember_zASzgEpPKLMb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20230331_zYlZKL9zcqZ8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_zlGCFO3J4z41" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: left">Remaining performance obligations related to engineering only paid contracts</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">172,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0569">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">172,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_zVGOlRB1WGpe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Remaining performance obligations related to partial equipment paid contracts</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,318,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">379,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,697,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueRemainingPerformanceObligation_iI_z6iQjrOO1ZSb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total remaining performance obligations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,490,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">379,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,869,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_z1LJVNp07fHk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--StandardProductWarrantyPolicy_zqbKDqgbKLmj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span><span id="xdx_86A_zYLUn7Bs99lc">Product Warranty</span></span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--StandardProductWarrantyDescription_c20230101__20230331_zHGKBhe70VB5" title="Product warranty description">The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue.</span> The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of March 31, 2023, and December 31, 2022, the Company had an accrued warranty reserve amount of $<span id="xdx_909_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_c20230331_zthTNvu8TGfa" title="Accrued warranty reserve amount">188,738</span> and $<span id="xdx_90C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_c20221231_z2BcdL4FdQUe" title="Accrued warranty reserve amount">180,457</span>, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zSQ3bGynGADj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zXQdEqe0fZQi">Accounting for Share-Based Compensation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the three months ended March 31, 2023, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20230331_zg6yjEa93Xrc" title="Stock price volatility">152.23</span>%; expected term in years of <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230331_zkLu1VOJP8tk" title="Expected Term">10</span> and risk-free interest rate of <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20230331_z9LBR8C5FIv9" title="Risk-free interest rate">3.48</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 27.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_z2Icmw10OMJ1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2023 and March 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zMZqIykPjHU3" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Share-based Compensation Costs</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.75in"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20230101__20230331_zuhwUQjS6hQg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20220101__20220331_zXSB54LfrrE2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Share-based compensation expense included in:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zZMQG0A0Yjh3" style="vertical-align: bottom; background-color: White"> <td style="width: 64%">Cost of revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">4,898</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">791</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zhMU74n8HNJ9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Advertising and marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,113</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,762</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zLFqWJeF0g77" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product development costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,570</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0605">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zpkwAGZdPwyg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">137,513</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">88,964</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_zMU3B9IZAIoi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total share-based compensation expense included in consolidated statement of operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">147,094</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">92,517</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_znR3uL4H34J7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_z1eesnxzi9D4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zNovU5IlTtrb">Concentrations</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three customers accounted for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zNYdvRSY4pqk" title="Concentration risk percentage">39</span>%, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zp4xGlsN5APh" title="Concentration risk percentage">28</span>%, and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zt1dR6zKjLh1" title="Concentration risk percentage">17</span>% of the Company’s revenue for the three months ended March 31, 2023. One customer accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zPS2PeSFYeYa" title="Concentration risk percentage">35</span>% of the Company’s revenue for the three months ended March 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three customers accounted for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zjdyYv4Rz5g3" title="Concentration risk percentage">68</span>%, <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zQ3SBRtMBjml" title="Concentration risk percentage">20</span>%, and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zsbss9HRwcKd" title="Concentration risk percentage">10</span>% of the Company’s accounts receivable as of March 31, 2023. Two customers accounted for<span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zSsuZ45BhDWg" title="Concentration risk percentage"> 57</span>% and<span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zCqHsSuMSjRl" title="Concentration risk percentage"> 43</span>% of the Company’s accounts receivable as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zGsrssOAQgf4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zKAETdEJxO0d">Recently Issued Accounting Pronouncements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2023, the FASB issued ASU 2023-01 to require entities to classify and account for leases with related parties on the basis of legally enforceable terms and conditions of the arrangement. The amendments are effective in periods beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2022, the FASB issued ASU No. 2022-06, which defers the sunset date of <i>Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</i> (“ASU 2020-04”) from December 31, 2022 to December 31, 2024. ASU No. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2022, the FASB issued Update 2022-04, “Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations”. The update was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in Update 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this update do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2021, the FASB issued ASU 2021-08, “<i>Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”</i>, which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard on Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2020, the FAS issued ASU No. 2020-04 “<i>Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”).</i> ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p> <p id="xdx_852_zlivUTlSm35d" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_849_ecustom--DescriptionOfBusinessPolicyTextBlock_z9seFJO43Nr6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zvbR4lb5kIBe">Description of Business</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the fastest-growing sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, and tomatoes and cannabis and hemp, more and more producers consider or act to grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, we provide: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) air sanitation products, (v) LED lighting, (vi) benching and racking solutions for indoor cultivation, (vii) proprietary and third party controls systems and technologies used for environmental, lighting, and climate control, and (viii) preventive maintenance services, through our partnership with a certified service contractor network, for CEA facilities. Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services, and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although most of our customers do, we neither produce nor sell cannabis or its related products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_ecustom--ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_zKkUcQnUZL15" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_z0CL7saKJil5">Impact of the COVID-19 Pandemic on Our Business</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets and disrupted workflow and completion schedules on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, and working capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The resulting effects and uncertainties from the COVID-19 pandemic, including the depth and duration of the disruptions to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, cannot be predicted. We expect that the economic disruptions will continue to have an effect on our business over the longer term. Despite this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses, and reduced operating cash flows in our business. During the year ended December 31, 2022, and continuing into the current fiscal quarter, the Company experienced delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain. Consequently, our revenue recognition of some customer sales has been delayed until future periods when the shipment of orders can be completed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_847_ecustom--ImpactofUkrainianConflictPolicyTextBlock_zDVte9KJjNca" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zqj1TLuLJd59">Impact of Ukrainian Conflict</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently, we believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition, or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it has a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflationary results of the conflict and government spending for and funding of our country’s response. As our operations are related only to the North American controlled environment agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks related to this conflict. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukrainian conflict.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_842_ecustom--InflationPolicyTextBlock_z23Xzo2qVMnb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Inflation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recently, our operations have started to be influenced by the inflation existent in the larger economy and in the industries related to building renovations, retrofitting and new build facilities in which we operate. We are likely to continue to face inflationary increases on the cost of products and our operations, which may adversely affect our margins and financial results and the pricing of our service and product supply contracts. Inflation is reflected in higher wages, increased pricing of equipment and other products that we have contracted to provide to our customers, and generally higher prices across all sectors of the economy. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z7Mjd7Lm1TVj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zAl18lSaWr2d">Financial Statement Presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_ecustom--LiquidityPolicyTextBlock_zk1tib17c7l9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"/> <p id="xdx_844_ecustom--InterimFinancialStatementsPolicyTextBlock_zvtzCDTJg8ce" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_z62SAMXHBkQ9">Interim Financial Statements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2023. The balance sheet information as of December 31, 2022 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_84E_eus-gaap--ConsolidationPolicyTextBlock_zJ29qDP2US43" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zqIeVxN1TULl">Principles of Consolidation </span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.</span></p> <p id="xdx_841_ecustom--ReverseStockSplitPolicyTextBlock_zTShSyUAu40f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--UseOfEstimates_zvAhFusiLu2h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zR7Zo7876yeb">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets and goodwill, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_za9QawnktdJl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zXiiw3IGpuO4">Cash, Cash Equivalents, and Restricted Cash</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount of $<span id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_c20230331_zAuuHvzifwE" title="Federal insured amount">250,000</span>. As of March 31, 2023, the balance in the Company’s accounts was approximately $<span id="xdx_90A_eus-gaap--Cash_iI_c20230331_z0Ght31RnUZj" title="Cash balance, amount">15,948,000</span>, consequently approximately $<span id="xdx_90A_eus-gaap--CashEquivalentsAtCarryingValue_iI_c20230331_zZrxmoeVWrIa" title="Cash equivalent balance, amount">15,698,000</span> of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> 250000 15948000 15698000 <p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_z6u4Ha9GoHM4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_z82aFh2xcsv6">Income (Loss) Per Common Share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, and March 31, 2022, there were respectively,<span id="xdx_901_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230331_z9SskhrbORC3" title="Potentially dilutive equity instruments that are convertible into common stock"> 8,010,957</span> and <span id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20220101__20220331_z6dF2NiqFhn4" title="Potentially dilutive equity instruments that are convertible into common stock">8,021,057</span>, potentially dilutive equity instruments outstanding in respect of <span style="background-color: white">options outstanding to purchase Company common stock, warrants, and restricted stock units that were convertible into shares of the Company’s common stock.</span> Of these potentially dilutive equity instruments outstanding, <span id="xdx_904_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zTJLkOk7jFyl" title="Potentially dilutive equity instruments that are convertible into common stock">7,623,772 </span>as of March 31, 2023 and <span id="xdx_905_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zz8zHaYZMG0c" title="Potentially dilutive equity instruments that are convertible into common stock">7,794,154</span> as of March 31, 2022 related to warrants issued in connection with the sale of our shares of series B Preferred stock and common stock in prior periods. The remaining <span id="xdx_905_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorAndStaffMember_zJzO18XDCHc5" title="Potentially dilutive equity instruments that are convertible into common stock">387,185</span> potentially dilutive equity instruments outstanding as of March 31, 2023 and <span id="xdx_901_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorAndStaffMember_zZqoJb0BgJ12" title="Potentially dilutive equity instruments that are convertible into common stock">226,903</span> as of March 31, 2022 related to options and restricted stock units issued to our directors and staff.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 8010957 8021057 7623772 7794154 387185 226903 <p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zZII6UNOjSXa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zrSthyhRmET1">Goodwill</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its carrying amount, including goodwill. The Company’s fair value is calculated using a market valuation technique whereby an appropriate control premium is applied to the Company’s market capitalization as calculated by applying its publicly quoted share price to the number of its common shares issued and outstanding. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2022, the Company experienced a triggering event due to a drop in its stock price and performed a quantitative analysis for potential impairment of its goodwill. Based on this analysis, the Company determined that its carrying value exceeded its fair value. As a result, the Company recorded a non-cash goodwill impairment charge of $<span id="xdx_90B_eus-gaap--GoodwillAndIntangibleAssetImpairment_c20220101__20220630_z75rQdZclsqc" title="Goodwill and intangible asset impairment">631,064</span> at June 30, 2022. No income tax benefit related to this goodwill impairment charge was recorded at June 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 631064 <p id="xdx_840_ecustom--TemporaryEquityPolicyTextBlock_zfZ0DcXpRKne" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zaA4GO3ZzJh9">Temporary Equity</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the Company. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zn5OahXkplc6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zyZS99grOpvj">Revenue Recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_zmjtQyKWsxFb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the Company’s revenue by source:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_z1I4n6fQfjE4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Revenue by Source</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20230101__20230331_zsnXWeukM1Sg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220101__20220331_zfpewfMpjzh8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zy87mdkuKUt" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Equipment and systems sales</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">4,396,827</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,642,572</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zSJq0Wbqx4xl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Engineering and other services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">124,410</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">86,049</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zhmSbh0AS5u2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Shipping and handling</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,560</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,806</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--MiscellaneousMember_z8gDfFUopgAl" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Miscellaneous</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">148,776</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0548">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zArdmBRUzWW" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,682,573</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,744,427</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_ztdIa6atetB1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous revenue of $<span id="xdx_903_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20230331__srt--ProductOrServiceAxis__custom--MiscellaneousMember_z8fpS8jZqOCh" title="Miscellaneous revenue">148,776</span> represents non-refundable deposits, forfeited by former customers on previously cancelled contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revenue Recognition Accounting Policy Summary</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on the standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Disaggregation of Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 606-10-50-5 through 6, the Company considered the appropriate level of disaggregated revenue information that depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Additionally, per the implementation guidance in ASC 606-10-55-90 through 91, the Company also considered (a) disclosures presented outside of the financial statements such as earnings releases and investor presentations, (b) information regularly reviewed by the Chief Operating Decision Maker for evaluating the financial performance of operating segments and (c) other information that is similar to the types of information identified in (a) and (b) and that is used by the Company or users of the Company’s financial statements to evaluate financial performance or make resource allocation decisions. Finally, we considered the examples of categories found in the guidance that might be appropriate, including: (a) type of good or service (major product lines), (b) geographical region (country or region), (c) market or type of customer (government or non-government customers), (d) type of contract (fixed-price or time-and-materials), (e) contract duration (short- or long-term), (f) timing of transfer of goods or services (point-in-time or over time) and (g) sales channels (direct to customers or through intermediaries).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on the aforementioned guidance and considerations, the Company determined that disaggregation of revenue by sales, services, shipping and handling, and miscellaneous was required.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Other Judgments and Assumptions</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Contract Assets and Contract Liabilities</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of March 31, 2023 and December 31, 2022, the Company had no contract assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the Company generally expects to recognize revenue in less than one year. Non-refundable customer deposits are recognized as revenue when previously abandoned customer contracts have been forfeited. As of March 31, 2023, and December 31, 2022, deferred revenue, which was classified as a current liability, was $<span id="xdx_900_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20230331_zG6YjB8NyIV5" title="Contract with customer liability current">1,102,601</span> and $<span id="xdx_90E_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20221231_zDLphVXcdYfj" title="Contract with customer liability current">4,338,570</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three months ended March 31, 2023, the Company recognized revenue of $<span id="xdx_905_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20230101__20230331_z0dQwtsIdD73" title="Revenue recognized">3,852,906</span> related to the deferred revenue at January 1, 2023. For the three months ended March 31, 2022, the Company recognized revenue of $<span id="xdx_909_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20220101__20220331_zW1Beh9Rfjl3">1,162,374 </span>related to the deferred revenue at January 1, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Remaining Performance Obligations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, the uncertainty regarding the COVID-19 virus, and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, the Company’s remaining performance obligations, or backlog, was approximately $<span id="xdx_90A_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230331_z1jk2LJYuQAh" title="Revenue remaining performance obligation">1,869,000</span>. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at March 31, 2023, includes booked sales orders of $<span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230331__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyThreeMember__us-gaap--TypeOfArrangementAxis__custom--BookedSalesOrdersFromThreeCustomersMember_zdagfbmwMjsa">379,000</span> from three customers that the Company does not expect to be realized until 2024, if at all. This 2024 projected revenue amount contains a booked sales order of $<span id="xdx_909_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20230331__srt--TitleOfIndividualAxis__custom--OneCustomerMember_znE0vKlSeHu9">279,000</span> (15% of the total backlog) from one customer that we believe is at risk of cancellation based on conversations with this customer. Given the current supply chain and bottleneck issues that are still being worked through by the Company’s supply chain partners, the Company believes that some of its current contracts could be delayed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zqLlRn5kKLde" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remaining performance obligations expected to be recognized through 2024 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zhEMi7VXFfz4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Remaining Performance Obligations Expected to be Recognized</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230331__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyThreeMember_zxBEbTb750C5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20230331__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyFourMember_zASzgEpPKLMb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20230331_zYlZKL9zcqZ8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_zlGCFO3J4z41" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: left">Remaining performance obligations related to engineering only paid contracts</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">172,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0569">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">172,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_zVGOlRB1WGpe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Remaining performance obligations related to partial equipment paid contracts</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,318,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">379,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,697,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueRemainingPerformanceObligation_iI_z6iQjrOO1ZSb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total remaining performance obligations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,490,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">379,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,869,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_z1LJVNp07fHk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_zmjtQyKWsxFb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth the Company’s revenue by source:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_z1I4n6fQfjE4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Revenue by Source</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20230101__20230331_zsnXWeukM1Sg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220101__20220331_zfpewfMpjzh8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zy87mdkuKUt" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Equipment and systems sales</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">4,396,827</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,642,572</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zSJq0Wbqx4xl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Engineering and other services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">124,410</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">86,049</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zhmSbh0AS5u2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Shipping and handling</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,560</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,806</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--MiscellaneousMember_z8gDfFUopgAl" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Miscellaneous</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">148,776</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0548">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zArdmBRUzWW" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,682,573</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,744,427</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 4396827 1642572 124410 86049 12560 15806 148776 4682573 1744427 148776 1102601 4338570 3852906 1162374 1869000 379000 279000 <p id="xdx_898_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zqLlRn5kKLde" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remaining performance obligations expected to be recognized through 2024 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zhEMi7VXFfz4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Remaining Performance Obligations Expected to be Recognized</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230331__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyThreeMember_zxBEbTb750C5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20230331__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyFourMember_zASzgEpPKLMb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20230331_zYlZKL9zcqZ8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_zlGCFO3J4z41" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: left">Remaining performance obligations related to engineering only paid contracts</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">172,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0569">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">172,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_zVGOlRB1WGpe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Remaining performance obligations related to partial equipment paid contracts</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,318,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">379,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,697,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueRemainingPerformanceObligation_iI_z6iQjrOO1ZSb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total remaining performance obligations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,490,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">379,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,869,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 172000 172000 1318000 379000 1697000 1490000 379000 1869000 <p id="xdx_842_eus-gaap--StandardProductWarrantyPolicy_zqbKDqgbKLmj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span><span id="xdx_86A_zYLUn7Bs99lc">Product Warranty</span></span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--StandardProductWarrantyDescription_c20230101__20230331_zHGKBhe70VB5" title="Product warranty description">The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue.</span> The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of March 31, 2023, and December 31, 2022, the Company had an accrued warranty reserve amount of $<span id="xdx_909_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_c20230331_zthTNvu8TGfa" title="Accrued warranty reserve amount">188,738</span> and $<span id="xdx_90C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_c20221231_z2BcdL4FdQUe" title="Accrued warranty reserve amount">180,457</span>, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. 188738 180457 <p id="xdx_84A_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zSQ3bGynGADj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zXQdEqe0fZQi">Accounting for Share-Based Compensation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the three months ended March 31, 2023, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20230331_zg6yjEa93Xrc" title="Stock price volatility">152.23</span>%; expected term in years of <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230331_zkLu1VOJP8tk" title="Expected Term">10</span> and risk-free interest rate of <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20230331_z9LBR8C5FIv9" title="Risk-free interest rate">3.48</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 27.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_z2Icmw10OMJ1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2023 and March 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zMZqIykPjHU3" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Share-based Compensation Costs</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.75in"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20230101__20230331_zuhwUQjS6hQg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20220101__20220331_zXSB54LfrrE2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Share-based compensation expense included in:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zZMQG0A0Yjh3" style="vertical-align: bottom; background-color: White"> <td style="width: 64%">Cost of revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">4,898</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">791</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zhMU74n8HNJ9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Advertising and marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,113</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,762</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zLFqWJeF0g77" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product development costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,570</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0605">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zpkwAGZdPwyg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">137,513</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">88,964</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_zMU3B9IZAIoi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total share-based compensation expense included in consolidated statement of operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">147,094</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">92,517</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_znR3uL4H34J7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1.5223 P10Y 0.0348 <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_z2Icmw10OMJ1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2023 and March 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zMZqIykPjHU3" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Share-based Compensation Costs</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.75in"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20230101__20230331_zuhwUQjS6hQg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20220101__20220331_zXSB54LfrrE2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Share-based compensation expense included in:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zZMQG0A0Yjh3" style="vertical-align: bottom; background-color: White"> <td style="width: 64%">Cost of revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">4,898</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">791</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zhMU74n8HNJ9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Advertising and marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,113</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,762</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zLFqWJeF0g77" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product development costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,570</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0605">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zpkwAGZdPwyg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">137,513</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">88,964</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_zMU3B9IZAIoi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total share-based compensation expense included in consolidated statement of operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">147,094</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">92,517</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 4898 791 1113 2762 3570 137513 88964 147094 92517 <p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_z1eesnxzi9D4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zNovU5IlTtrb">Concentrations</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three customers accounted for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zNYdvRSY4pqk" title="Concentration risk percentage">39</span>%, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zp4xGlsN5APh" title="Concentration risk percentage">28</span>%, and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zt1dR6zKjLh1" title="Concentration risk percentage">17</span>% of the Company’s revenue for the three months ended March 31, 2023. One customer accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zPS2PeSFYeYa" title="Concentration risk percentage">35</span>% of the Company’s revenue for the three months ended March 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three customers accounted for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zjdyYv4Rz5g3" title="Concentration risk percentage">68</span>%, <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zQ3SBRtMBjml" title="Concentration risk percentage">20</span>%, and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zsbss9HRwcKd" title="Concentration risk percentage">10</span>% of the Company’s accounts receivable as of March 31, 2023. Two customers accounted for<span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zSsuZ45BhDWg" title="Concentration risk percentage"> 57</span>% and<span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zCqHsSuMSjRl" title="Concentration risk percentage"> 43</span>% of the Company’s accounts receivable as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.39 0.28 0.17 0.35 0.68 0.20 0.10 0.57 0.43 <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zGsrssOAQgf4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zKAETdEJxO0d">Recently Issued Accounting Pronouncements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2023, the FASB issued ASU 2023-01 to require entities to classify and account for leases with related parties on the basis of legally enforceable terms and conditions of the arrangement. The amendments are effective in periods beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2022, the FASB issued ASU No. 2022-06, which defers the sunset date of <i>Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</i> (“ASU 2020-04”) from December 31, 2022 to December 31, 2024. ASU No. 2022-06 was effective upon issuance. Topic 848 provides temporary optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting, providing optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2022, the FASB issued Update 2022-04, “Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations”. The update was issued in response to requests from financial statement users for increased transparency surrounding the use of supplier finance programs. The amendments in Update 2022-04 require that a buyer in a supplier finance program disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in this update do not affect the recognition, measurement, or financial statement presentation of obligations covered by supplier finance programs. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2021, the FASB issued ASU 2021-08, “<i>Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”</i>, which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard on Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2020, the FAS issued ASU No. 2020-04 “<i>Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”).</i> ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p> <p id="xdx_80C_eus-gaap--LesseeOperatingLeasesTextBlock_zVDvA6f5AfIi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2 – <span><span><span id="xdx_829_zSs0RzsjgKoc">Leases</span></span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2016 the FASB issued ASU 2016-02, <i>Leases (Topic 842) </i>(“ASC 842” or the “new lease standard”). The Company adopted ASC 842 as of January 1, 2019, using the effective date method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The new standard provides a number of optional practical expedients in transition. The Company has elected to apply the “package of practical expedients” which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii) the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 28, 2021, the Company entered into an agreement to lease <span id="xdx_906_eus-gaap--AreaOfLand_iI_uSquareFoot_c20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zzPKQAZedwV9" title="Area of land">11,491</span> square feet of office and manufacturing space (the “New Facility Lease”), in Louisville, CO. <span id="xdx_90B_eus-gaap--LesseeOperatingLeaseDescription_c20210724__20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zb9ZU1qSuzbh" title="Operating lease term description">The New Facility Lease commenced on November 1, 2021 and continues through January 31, 2027. </span>From November 2021 through January 2022, the monthly rent was abated. Beginning February 2022, the monthly rent is $<span id="xdx_90A_eus-gaap--PaymentsForRent_c20210724__20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zPg9kcXhkJv8" title="Lease rental expense">10,055</span> and will increase by <span id="xdx_909_ecustom--IncreaseInRentPercent_pid_dp_uPure_c20210724__20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_z8iIjFu41wQ7" title="Increase in rent percent">3</span>% annually every November through the end of the New Facility Lease term. Pursuant to the New Facility Lease, the Company made a security deposit of $<span id="xdx_90A_eus-gaap--SecurityDeposit_iI_c20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zshprgjmbwX1" title="Security deposit">14,747</span>. The Company has the option to renew the New Facility Lease for an additional <span id="xdx_909_eus-gaap--LesseeOperatingLeaseRenewalTerm_iI_dc_c20210728_zjNPaqGHVSXj" title="Lease renew term">five years</span>. Additionally, the Company pays the actual amounts for property taxes, insurance, and common area maintenance. The New Facility Lease agreement contains customary events of default, representations, warranties, and covenants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon commencement of the New Facility Lease, the Company recognized on the balance sheet an operating lease right-of-use asset and lease liability in the amount of $<span id="xdx_901_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zAtECTCQ2gXf" title="Operating lease right-of-use asset"><span id="xdx_90B_eus-gaap--OperatingLeaseLiability_iI_c20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zGSXD9NdUVVa" title="Operating lease liability">582,838</span></span>. The lease liability was initially measured as the present value of the unpaid lease payments at commencement and the ROU asset was initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The renewal option to extend the New Facility Lease is not included in the right-of-use asset or lease liability, as the option is not reasonably certain to be exercised. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will include the renewal period in its lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zTrNeJV4wWfh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The lease cost, cash flows and other information related to the New Facility Lease were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zMEeZMfeRg8g" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Lease Cost</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20230331_zdxcA724png3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of</p> <p style="margin-top: 0; margin-bottom: 0">March 31, 2023</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_z95JeLU70nrk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: left">Operating lease right-of-use asset</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">436,549</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zOHuWqhQg614" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Operating lease liability, current</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">120,245</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zhlZt2cRFDl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Operating lease liability, long-term</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">348,179</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining lease term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230331_zMGolRFAi2si" title="Remaining lease term">3.8</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Discount rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230331_zlRk2y6cxjIh" title="Discount rate">3.63</span></td><td style="text-align: left">%</td></tr> </table> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three</p> <p style="margin-top: 0; margin-bottom: 0">Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31, 2023</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: left">Operating cash outflow from operating lease</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--OperatingLeasePayments_c20230101__20230331_zKbVWQNzTPjb" style="width: 18%; text-align: right" title="Operating cash outflow from operating lease">31,069</td><td style="width: 1%; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zmFzMTs4coa9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zctwqlStRn4l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future annual minimum lease payments on the New Facility Lease as of March 31, 2023 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zkqnpZJ252Nb" style="display: none">Schedule of Future Annual Minimum Lease Payments</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify; font-weight: bold">Years ended December 31,</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20230331_zVQqjYv3XJxe"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_maLOLLPzNo0_zTs10oRKCEu1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; width: 78%">2023 (excluding the three months ended March 31, 2023)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">124,897</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzNo0_z5ZI0nAISHhj" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">128,643</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzNo0_zBZYSbJ6grA3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">132,503</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzNo0_zbMtNxtecm77" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">136,473</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_iI_pp0p0_maLOLLPzNo0_zDWuDhgcLc4c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,654</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzNo0_z225DMn3buhd" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Total minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">534,170</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zcsrRkguEoOc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Less imputed interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(65,746</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Present value of minimum lease payments</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">468,424</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zi67TTzDee51" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 11491 The New Facility Lease commenced on November 1, 2021 and continues through January 31, 2027. 10055 0.03 14747 P5Y 582838 582838 <p id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zTrNeJV4wWfh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The lease cost, cash flows and other information related to the New Facility Lease were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zMEeZMfeRg8g" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Lease Cost</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20230331_zdxcA724png3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of</p> <p style="margin-top: 0; margin-bottom: 0">March 31, 2023</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_iI_z95JeLU70nrk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: left">Operating lease right-of-use asset</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">436,549</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zOHuWqhQg614" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Operating lease liability, current</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">120,245</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zhlZt2cRFDl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Operating lease liability, long-term</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">348,179</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining lease term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230331_zMGolRFAi2si" title="Remaining lease term">3.8</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Discount rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230331_zlRk2y6cxjIh" title="Discount rate">3.63</span></td><td style="text-align: left">%</td></tr> </table> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three</p> <p style="margin-top: 0; margin-bottom: 0">Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31, 2023</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: left">Operating cash outflow from operating lease</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--OperatingLeasePayments_c20230101__20230331_zKbVWQNzTPjb" style="width: 18%; text-align: right" title="Operating cash outflow from operating lease">31,069</td><td style="width: 1%; text-align: left"> </td></tr> </table> 436549 120245 348179 P3Y9M18D 0.0363 31069 <p id="xdx_89E_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zctwqlStRn4l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future annual minimum lease payments on the New Facility Lease as of March 31, 2023 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zkqnpZJ252Nb" style="display: none">Schedule of Future Annual Minimum Lease Payments</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify; font-weight: bold">Years ended December 31,</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20230331_zVQqjYv3XJxe"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_maLOLLPzNo0_zTs10oRKCEu1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; width: 78%">2023 (excluding the three months ended March 31, 2023)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">124,897</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzNo0_z5ZI0nAISHhj" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">128,643</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzNo0_zBZYSbJ6grA3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">132,503</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzNo0_zbMtNxtecm77" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">136,473</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_iI_pp0p0_maLOLLPzNo0_zDWuDhgcLc4c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,654</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzNo0_z225DMn3buhd" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Total minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">534,170</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zcsrRkguEoOc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Less imputed interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(65,746</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Present value of minimum lease payments</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">468,424</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 124897 128643 132503 136473 11654 534170 65746 468424 <p id="xdx_80C_eus-gaap--InventoryDisclosureTextBlock_znh9bxvHv2Nh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 3 –<span id="xdx_821_z2lKd0WXxzr1"> Inventory</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zCowecCke4v2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span id="xdx_8B6_zgEcWLGGIgC7" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Inventory</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%; margin-left: 0.75in"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230331_zTGP8v0uWCJc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20221231_zGkVQ93CZCak" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINztRx_zUrpxjrw7rF7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Finished goods</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">410,208</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">270,555</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryWorkInProcess_iI_maINztRx_zLiCE9bwehuk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in progress</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">154</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">155</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryRawMaterials_iI_maINztRx_zGJ5U3wC0QG5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Raw materials</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">135,316</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">148,608</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InventoryValuationReserves_iNI_di_msINztRx_z7StDJkQ2y7c" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Allowance for excess &amp; obsolete inventory</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(104,545</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(70,907</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--InventoryNet_iTI_mtINztRx_znJQOotXFLNe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Inventory, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">441,133</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">348,411</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_z3cwVgE9UUA1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overhead expenses of $<span id="xdx_90D_eus-gaap--CostOfGoodsAndServicesSoldOverhead_c20230101__20230331_zx9yAUXcuetg" title="Overhead expenses">14,101</span> and $<span id="xdx_90C_eus-gaap--CostOfGoodsAndServicesSoldOverhead_c20220101__20221231_zTC7rEsKXMJ1" title="Overhead expenses">12,770</span> were included in the inventory balance as of March 31, 2023, and December 31, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses included approximately $<span id="xdx_90D_ecustom--PrepaidInventoryExpenses_iI_c20230331_zle5aNYeXOy9" title="Prepaid inventory expenses">219,000</span> and $<span id="xdx_90C_ecustom--PrepaidInventoryExpenses_iI_c20221231_zMtwm9a3m092" title="Prepaid inventory expenses">1,176,000</span> in advance payments for inventory for the periods ended March 31, 2023, and December 31, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zCowecCke4v2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span id="xdx_8B6_zgEcWLGGIgC7" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Inventory</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%; margin-left: 0.75in"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20230331_zTGP8v0uWCJc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20221231_zGkVQ93CZCak" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_maINztRx_zUrpxjrw7rF7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Finished goods</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">410,208</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">270,555</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryWorkInProcess_iI_maINztRx_zLiCE9bwehuk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in progress</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">154</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">155</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryRawMaterials_iI_maINztRx_zGJ5U3wC0QG5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Raw materials</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">135,316</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">148,608</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InventoryValuationReserves_iNI_di_msINztRx_z7StDJkQ2y7c" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Allowance for excess &amp; obsolete inventory</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(104,545</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(70,907</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--InventoryNet_iTI_mtINztRx_znJQOotXFLNe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Inventory, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">441,133</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">348,411</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 410208 270555 154 155 135316 148608 104545 70907 441133 348411 14101 12770 219000 1176000 <p id="xdx_80F_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zLMJbqeJlO4k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 4 – <span id="xdx_822_zLHZjlZBlTye">Property and Equipment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--PropertyPlantAndEquipmentTextBlock_zbKqze3Zr0j6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_z47q6zPAAlNh" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Property and Equipment</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.75in"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20230331_zR5uW4V5g9B" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20221231_z2QoSsk6yxLi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zwbqChD6VY7c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify">Furniture and equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">275,994</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">278,389</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zI9JzBu6IImd" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Vehicles</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzCtH_zAPV3b4EJ7id" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, gross</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">290,994</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">293,389</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzCtH_zG7AwOLKARu3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(230,281</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(224,876</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzCtH_zkw9fPKvIadi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">60,713</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">68,513</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_z743jHRP9Da4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense was $<span id="xdx_90F_eus-gaap--Depreciation_c20230101__20230331_zgZzd1FmoH25" title="Depreciation expenses">7,500</span> for the three months ended March 31, 2023. For the three months ended March 31, 2023, $<span id="xdx_90B_eus-gaap--Depreciation_c20230101__20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_z7ek8MRrBfLl" title="Depreciation expenses">1,214</span> was allocated to cost of sales, $<span id="xdx_907_eus-gaap--Depreciation_pp0p0_c20230101__20230331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__custom--InventoryMember_zbgb4mDwGPja" title="Depreciation expenses">304</span> was allocated to inventory with the remainder recorded as selling, general, and administrative expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--PropertyPlantAndEquipmentTextBlock_zbKqze3Zr0j6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_z47q6zPAAlNh" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Property and Equipment</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.75in"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20230331_zR5uW4V5g9B" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20221231_z2QoSsk6yxLi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zwbqChD6VY7c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify">Furniture and equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">275,994</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">278,389</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zI9JzBu6IImd" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Vehicles</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzCtH_zAPV3b4EJ7id" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, gross</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">290,994</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">293,389</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzCtH_zG7AwOLKARu3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(230,281</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(224,876</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzCtH_zkw9fPKvIadi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">60,713</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">68,513</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 275994 278389 15000 15000 290994 293389 230281 224876 60713 68513 7500 1214 304 <p id="xdx_808_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z2kPNBQ5ErBg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 5 –<span id="xdx_824_ztgkFUKlnQ05"> Accounts Payable and Accrued Liabilities</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z9Zl752bMbcf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable and accrued liabilities consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zyFC5UIHif1e" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Accounts Payable and Accrued Liabilities</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.75in"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230331_zYn0HhkMrb6l" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20221231_zSdAF4JxG7Tf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--AccountsPayableCurrent_iI_maAPAALztwN_zhCPp1JpEgTd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Accounts payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">714,586</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">311,162</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccruedSalesCommissionCurrent_iI_maAPAALztwN_zOoFlNbAFOFc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sales commissions payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24,468</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,951</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_maAPAALztwN_zIB1jTK5Kwpb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued payroll liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">167,697</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">465,094</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_maAPAALztwN_z2UfNdThQIpc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product warranty accrual</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">188,738</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">180,457</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maAPAALztwN_zK8oJYUCo363" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other accrued expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">68,645</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">224,594</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_mtAPAALztwN_zPdDfFCPSWB9" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,164,134</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,207,258</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zXrZdtDVAc8i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z9Zl752bMbcf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable and accrued liabilities consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zyFC5UIHif1e" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Accounts Payable and Accrued Liabilities</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.75in"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230331_zYn0HhkMrb6l" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20221231_zSdAF4JxG7Tf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--AccountsPayableCurrent_iI_maAPAALztwN_zhCPp1JpEgTd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Accounts payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">714,586</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">311,162</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccruedSalesCommissionCurrent_iI_maAPAALztwN_zOoFlNbAFOFc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sales commissions payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24,468</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,951</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_maAPAALztwN_zIB1jTK5Kwpb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued payroll liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">167,697</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">465,094</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_maAPAALztwN_z2UfNdThQIpc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product warranty accrual</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">188,738</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">180,457</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maAPAALztwN_zK8oJYUCo363" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other accrued expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">68,645</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">224,594</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_mtAPAALztwN_zPdDfFCPSWB9" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,164,134</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,207,258</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 714586 311162 24468 25951 167697 465094 188738 180457 68645 224594 1164134 1207258 <p id="xdx_80B_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_ziAaUl1xL5Uj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 6 – <span id="xdx_82C_zjD4EU4KRS5h">Commitments and Contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Litigation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company’s view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company’s operations or its financial position, liquidity or results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Leases</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has a lease agreement for its manufacturing and office space. Refer to <i>Note 2 Leases</i> above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other Commitments</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_807_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zb25wemGk2qe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 7 – <span id="xdx_82E_z1zAeON8Duwa">Stockholders’ Equity (Deficit)</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, the Company had <span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_iI_c20230331_zq3yvu8dR8w8" title="Common stock, shares authorized">200,000,000</span> shares of common stock and <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20230331_zInzqLUi5Vfb" title="Preferred stock, shares authorized">25,000,000</span> shares of preferred stock authorized at a $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20230331_zXD7kTzHJjPe" title="Preferred stock par value"><span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230331_zxnLLZVvCfFh" title="Common stock par value">0.00001</span></span> par value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, <span id="xdx_90C_eus-gaap--CommonStockSharesIssued_iI_c20230331_zTV3lr0ZzHTe" title="Common stock, shares issued"><span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_c20230331_zxoSSwWjOh7b" title="Common stock, shares outstanding">8,076,372</span></span> shares of common stock were issued and outstanding and no shares of preferred stock were issued and outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Directors Remuneration</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 3, 2022, the Company issued <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20220101__20220103__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zYhs5lDtEvX1" title="Number of stock options issued">3,125</span> non-qualified stock options under the 2021 Equity Incentive Plan to each of two existing directors. The options had an exercise price of $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220103__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zk1KraYm9iBe" title="Exercise price">4.80</span>, vested immediately and had a term ending at the earlier of five years after the date on which the optionee’s continuous service ends, or the tenth anniversary on which the option was granted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 17, 2022, the Company issued an RSU grant of <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zojaSrdF854d" title="Shares, granted">3,367</span> shares of common stock under the 2021 Equity Incentive Plan to each of two new directors, <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--AwardDateAxis__custom--JanuarySeventeernTwoThousandTwentyTwoMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zNZ2bJ0IQbW4" title="Shares, granted">1,684</span> shares of common stock vested immediately on grant date and the remaining <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember__us-gaap--AwardDateAxis__custom--JanuarySeventeernTwoThousandTwentyThreeMember_zd40O6p99Rfk" title="Shares, granted">1,683</span> shares of common stock vested on January 17, 2023. <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220112__20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember__us-gaap--AwardDateAxis__custom--JanuarySeventeernTwoThousandTwentyTwoMember_zK58ocUoZGSi" title="Shares, vested">1,684</span> shares of common stock were issued on January 17, 2022 to each of the two new directors in settlement of the RSUs that vested immediately and a further <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220112__20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember__us-gaap--AwardDateAxis__custom--JanuarySeventeernTwoThousandTwentyThreeMember_z1Grns6UyPBk" title="Shares, vested">1,683</span> shares of common stock were issued to each of the two new directors on January 17, 2023 in settlement of the remainder.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 3, 2023, the Company issued an RSU grant of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230103__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zGm7JdTIpare" title="Number of stock options issued">29,758</span> shares of common stock under the 2021 Equity Incentive Plan to each of its four independent directors. The RSUs were granted as an equity retention award pursuant to the Company’s compensation plan for independent directors effective January 17, 2022 and vested immediately on the grant date. A total of <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20230102__20230103__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zNI430AfThz7" title="Number of shares vested in period">119,032</span> shares of the Company’s common stock were issued in settlement of the RSUs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revised Compensation Plan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On January 17, 2022, the Board of Directors revised the previously adopted compensation plan. This plan superseded the plan adopted on August 20, 2021. The Plan was effective retroactively for the then current independent directors and for independent directors elected or appointed after the Effective Date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The plan is divided into two phases: from the Effective Date of the Plan until February 9, 2022, the day prior to the listing of the Company securities on Nasdaq. (“Pre-uplist”) and from February 10, 2022, the uplist date forward (“Post-uplist”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-uplist phase: The Company paid its independent directors an annual cash fee of $<span id="xdx_908_eus-gaap--ManagementFeeExpense_c20220112__20220117__srt--TitleOfIndividualAxis__srt--DirectorMember_zeDtPp7rFtVj" title="Annual cash fee">15,000</span>, payable quarterly in advance on the first business day of each quarter, as consideration for their participation in: (i) any regular or special meetings of the Board or any committee thereof attended in person, (ii) any telephonic meeting of the Board or any committee thereof in which the director is a member, (iii) any non-meeting consultations with the Company’s management, and (iv) any other services provided by them in their capacities as directors (other than services as the Chairman of the Board, the Chairman of the Company’s Audit Committee, and the Committee Chairman).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At the time of initial election or appointment, each independent director received an equity retention award in the form of restricted stock units (“RSUs”). The aggregate value of the RSUs at the time of grant was to be $<span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedPeriod_c20220112__20220117__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zM1NE53f8Z87" title="Share based compensation arrangement payment">25,000</span>, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20220112__20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3D7b3rw9Sv9" title="Vesting rights description">Vesting of the RSUs was as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, on the first business day of January each year, each independent director will also receive an equity retention award in the form of RSUs. The aggregate value of the RSUs at the time of grant will be $<span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedPeriod_c20220112__20220117__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zcCTg93bhdAg" title="Share based compensation arrangement payment">25,000</span>, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the date immediately prior to the date of grant. These RSUs will be fully vested at date of grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company pays the Audit Committee Chairman an additional annual fee of $<span id="xdx_905_eus-gaap--ManagementFeeExpense_c20220112__20220117__srt--TitleOfIndividualAxis__custom--AuditCommitteeChairmanMember_znqLK4eGfxX" title="Management fee expense">10,000</span>, payable quarterly in advance, for services as the Audit Committee Chairman.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company pays the Chairmen of any other committees of the Board an additional annual fee of $<span id="xdx_902_eus-gaap--ManagementFeeExpense_c20220112__20220117__srt--TitleOfIndividualAxis__custom--CommitteeChairmanMember_zmF3n1BVtbXl" title="Management fee expense">5,000</span>, payable quarterly in advance, for services as a Committee Chairman.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is no additional compensation paid to members of any committee of the Board. Interested (i.e. Executive directors) serving on the Board do not receive compensation for their Board service.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-uplist phase: The Company will pay its independent directors an annual cash fee of $<span id="xdx_908_eus-gaap--ManagementFeeExpense_c20230101__20230331__srt--TitleOfIndividualAxis__srt--DirectorMember_z5ZUc2kb3Wwf" title="Management fee expense">25,000</span>, payable quarterly in advance on the first business day of each quarter. All other terms remain the same.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each director is responsible for the payment of any and all income taxes arising with respect to the issuance of common stock and the vesting and settlement of RSUs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reimburses independent directors for out-of-pocket expenses incurred in attending Board and committee meetings and undertaking certain matters on the Company’s behalf.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All independent directors, Messrs. Shipley, Etten, Reisner, and Mariathasan are subject to the Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each independent director is responsible for the payment of any and all income taxes arising with respect to the issuance of any equity awarded under the plan, including the exercise of any non-qualified stock options.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee directors do not receive separate fees for their services as directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reverse Stock Split</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of <span id="xdx_90E_eus-gaap--StockholdersEquityReverseStockSplit_c20220112__20220117_z0BgTukwvlr3" title="Reverse stock split">one-for-one hundred and fifty</span>. The reverse stock split was implemented effective January 27, 2022. The par value for the Common Stock was not affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An additional <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesStockSplits_c20220112__20220117_zZAslxpc1RAa" title="Reverse stock split">6,798</span> shares of common stock were issued to round up partial shares following the reverse split.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of this reverse stock split, the number of the Company’s shares of common stock issued and outstanding at December 31, 2021 was reduced from <span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20211230_z43203U36utl" title="Common stock, shares issued"><span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211230_zf5FVVxOu0Wj" title="Common stock, shares outstanding">240,125,224</span></span> to <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_pid_c20211231_zbdkpKmcYBCc" title="Common stock, shares issued"><span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211231_zxqlj4tv2fxe" title="Common stock, shares outstanding">1,600,835</span></span>. All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split for all periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change in Authorized Share Capital</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the aforementioned reverse stock split, the Company’s Board of Directors approved the reduction of the authorized capital of the Company to <span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_c20230331__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_z50s62LGZnC3" title="Common stock, shares authorized">200,000,000</span> shares of common stock and <span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_c20230331__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zpdMP3zh91u4" title="Preferred stock, shares authorized">25,000,000</span> shares of preferred stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity Raise</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 10, 2022, the Company signed a firm commitment underwriting agreement for the public offering of shares of common stock and warrants, which closed on February 15, 2022. The Company received net proceeds of approximately $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn6n6_c20220214__20220215_zQzchbAmKsW8" title="Net proceeds from sale of common stock">22</span> million for the sale of <span id="xdx_900_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220214__20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zuUmt0t4Kvbb" title="Net proceeds from sale of common stock">5,811,138</span> shares of common stock and <span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220214__20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zq6TXZyvGFjf" title="Number of shares sold">6,572,808</span> warrants, each warrant to purchase one share of common stock for <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zCmB6pyxT0xh" title="Warrant term">five years</span>, exercisable immediately, at an exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zEtYeLb0K1Yg" title="Exercise price, per share">5.00</span>. The Company also issued to the representative of the underwriters <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220214__20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_z8LsehdSGur" title="Stock issued during period, shares, issued for services">290,557</span> warrants, each warrant to purchase one share of common stock at an exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_z554oltJc13c" title="Exercise price">5.1625</span>, during the period commencing August 9, 2022, and expiring on <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zbcnt3GzRvag" title="Warrants maturity date">February 10, 2027</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrant Exercise</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 21, 2022, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220620__20220621_zJ3cK9LCylwb" title="Number of shares issued">169,530</span> shares of its common stock in connection with the cashless exercise of <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20220621_zSsI00NWZlCa" title="Prefunded conversion warrants">170,382</span> prefunded conversion warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 200000000 25000000 0.00001 0.00001 8076372 8076372 3125 4.80 3367 1684 1683 1684 1683 29758 119032 15000 25000 Vesting of the RSUs was as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date. 25000 10000 5000 25000 one-for-one hundred and fifty 6798 240125224 240125224 1600835 1600835 200000000 25000000 22000000 5811138 6572808 P5Y 5.00 290557 5.1625 2027-02-10 169530 170382 <p id="xdx_80D_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zLqm4XG0Qa2f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 8 – <span id="xdx_820_zjmSM93RzTic">Equity Incentive Plans</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2017 Equity Incentive Plan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the Company’s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the “2017 Equity Plan”), the Board of Directors (the “Board”) (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock unit awards (“RSUs”), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z2C3rVZDJjKf" title="Number of options to purchase shares">333,333</span> shares of the Company’s common stock (“Plan Shares”) for issuance of equity awards under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023, no shares or options were issued, or cancelled under the 2017 Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, of the <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z3ACKFsTmRU5" title="Number of shares authorized">333,333</span> shares authorized under the 2017 Plan for equity awards, <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zbfghBz5Wwwb" title="Number of shares issued">163,692</span> shares have been issued, awards relating to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonQualifiedStockOptionMember_zS4i4OnXZIo6" title="Number of option remain outstanding">147,177</span> options remain outstanding, and <span id="xdx_90C_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonQualifiedStockOptionMember_zFcWtJVeCYia" title="Shares available for future equity awards">22,464</span> shares remain available for future equity awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2021 Equity Incentive Plan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the “2021 Equity Plan”), which was approved by the stockholders on July 22, 2021. The 2021 Equity Plan permits the Board to grant awards of up to <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210322__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zv1ZgQhpGhM5" title="Number of shares grant in period">666,667</span> shares of common stock. The 2021 Equity Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), non-qualified stock options, stock appreciation rights (“SARs”), restricted stock awards and restricted stock unit awards and other equity linked awards to our employees, consultants, and directors. If an equity award (i) expires or otherwise terminates without having been exercised in full or (ii) is settled in cash (<i>i.e.</i>, the holder of the award receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant to this Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023, the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zVQlymHIPe4d" title="Shares issued during the period">122,398</span> shares of its common stock in settlement of restricted stock units issued to its independent directors under the 2021 Equity Incentive Plan, pursuant to the Director Compensation plan adopted on January 17, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023,<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--FiveEmployeesMember_zBR9rVCJwQ9l" title="Number of share awards granted">138,491</span> non-qualified stock options were issued to five employees and three former employees in respect of the Company’s 2021 Equity Incentive Plan. The options vested immediately, have a term of <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230331__srt--TitleOfIndividualAxis__custom--FiveEmployeesMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_z1Puwvn1mIWh" title="Expected term years">10</span> years and an exercise price of $<span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230331__srt--TitleOfIndividualAxis__custom--FiveEmployeesMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zk0x4Ys9O0v5" title="Exercise price per share">0.8955</span>. An expense of $<span id="xdx_901_eus-gaap--DeferredCompensationLiabilityCurrent_iI_c20221231_zk9PWNxcmOoi" title="Accrued equity compensation">89,970</span> in respect of this issuance had been accrued in 2022. An additional expense of $<span id="xdx_906_ecustom--EmployeeStockOwnershipPlanAdditionalExpense_c20230101__20230331_z2etOnK51Qj6" title="Additional expense">32,376</span> was recognized in 2023 upon management and board finalization and approval of the awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, of the <span id="xdx_90F_ecustom--ShareBasedCompensationArrangemenByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zJ7JF3BbWC72" title="Number of shares authorized">666,667</span> shares authorized under the 2021 Equity Plan, <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zrX3FVpiRnKc" title="Number of shares issued">132,568</span> shares have been issued in settlement of restricted stock units, awards relating to <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonQualifiedStockOptionMember_zzMXc75Mxjx7" title="Number of option remain outstanding">183,615</span> non-qualified stock options, and <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--IncentiveStockOptionMember_zW7yp3coEhEf" title="Number of option remain outstanding">40,816</span> incentive stock options remain outstanding, and <span id="xdx_904_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zncbC8OsFcV9" title="Shares available for future equity awards">309,668</span> shares remain available for future equity awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There was $<span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zHPKceupYKLd" title="Unrecognized compensation expense">45,919</span> in unrecognized compensation expense for unvested non-qualified stock options, and incentive stock options at March 31, 2023 which will be recognized over approximately <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zcDhmdiz9x77" title="Weighted Average Remaining Contractual Term">2</span> years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Non-Qualified and Incentive Stock Options</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zNm0Ey2ckfJg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the three months ended March 31, 2023, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zqHCxzVlWODf" style="display: none">Schedule of Stock Option Activity</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p> <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Exercise</p> <p style="margin-top: 0; margin-bottom: 0">Price</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Remaining</p> <p style="margin-top: 0; margin-bottom: 0">Contractual</p> <p style="margin-top: 0; margin-bottom: 0">Term</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p> <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p> <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Outstanding, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zeICNbtd4vol" style="width: 10%; text-align: right" title="Number of Options, Outstanding Beginning">192,073</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zP49nCrCpuS2" style="width: 10%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning">8.94</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zk2Y8YrSJ2Ce" title="Weighted Average Remaining Contractual Term, Beginning">7.6</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zaMP6SCh1by2" style="width: 10%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">            <span style="-sec-ix-hidden: xdx2ixbrl0891">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zt8BVLmdfBhf" style="text-align: right" title="Number of Options, Granted">138,489</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zb0dO1w5dY0h" style="text-align: right" title="Weighted Average Exercise Price, Granted">0.90</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zylxrRTI02b5" title="Weighted Average Remaining Contractual Term, Granted">8.4</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zNrFyqq2kLyi" style="text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0899">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zhKATeOHU9Fh" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0901">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zWZIBiOi7Rhg" style="text-align: right" title="Number of Options, Forfeited">(500</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zMRt5BmopKa2" style="text-align: right" title="Weighted Average Exercise Price, Forfeited">6.10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited_dtY_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zQxqcxwEJ30j" title="Weighted Average Remaining Contractual Term, Forfeited">8.9</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zqhAYr158RGa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="-sec-ix-hidden: xdx2ixbrl0909">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_za4p8769JsCl" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-hidden: xdx2ixbrl0911">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z63SNlMfGhwb" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending">330,062</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zaSfkoGjScc9" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending">5.57</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zoUYJbvjtk28" title="Weighted Average Remaining Contractual Term, Outstanding Ending">7.6</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_za5olVvmknI4" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="-sec-ix-hidden: xdx2ixbrl0919">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable, March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zkXZ6VjwhNg2" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending">304,972</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z2pJpE2B1MWh" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending">5.59</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zPxpwAGZMzDk" title="Weighted Average Remaining Contractual Term, Exercisable Ending">8.2</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zNlIZyVFGcrf" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="-sec-ix-hidden: xdx2ixbrl0927">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zUMTJ2F5UW22" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_z5JRSO0DZWGb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the three months ended March 31, 2023, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zER5WiYYiqvc" style="display: none">Summary of Non-vested Non-qualified Stock Option Activity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p> <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Grant-Date</p> <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p> <p style="margin-top: 0; margin-bottom: 0">Intrinsic Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Grant-Date</p> <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td></td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Nonvested, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z9McXHXqecc4" style="width: 10%; text-align: right" title="Number of Options Nonvested, Beginning">43,846</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zE5NLfUVSNIj" style="width: 10%; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Beginning">5.65</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zrvXYXAG5YK1" style="width: 10%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning">  <span style="-sec-ix-hidden: xdx2ixbrl0935">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z9MRDm8Lxcwg" style="width: 10%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning">247,730</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zy8QsMmIzbga" style="text-align: right" title="Number of Options Nonvested, Granted">138,489</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zGvR1qYdLd96" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Granted">0.88</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValues_pp0p0_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zTGHRxdNNKu6" style="text-align: right" title="Grant Date Fair Value Nonvested, Granted">122,346</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_pp0p0_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zhiRS4C1zKK4" style="text-align: right" title="Number of Options Nonvested, Vested">(156,912</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zyJsAy4NciC6" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Vested">1.49</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_iN_pp0p0_di_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z2A35RLAs1Nf" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested">(234,296</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zEH6TVzZmJHa" style="text-align: right" title="Number of Options Nonvested, Forfeited">(333</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zJQvwPy4wP7e" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Forfeited">6.67</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_iN_pp0p0_di_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zwxCiNQmh0eb" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited">(2,225</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zKrWSuwi9pG8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl0957">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zO3TeznVRfG8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl0959">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired_iN_pp0p0_di_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zV6qBdaa5vS1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl0961">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Nonvested, March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z0ZiDpR4Wx1d" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending">25,090</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_ztr3eVDRYTn1" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Beginning">4.98</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pdp0_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zUBuMa72KEwb" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="-sec-ix-hidden: xdx2ixbrl0967">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zg8YmTv07kVa" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending">133,555</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zg9behtRuUad" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three months ended March 31, 2023 and March 31, 2022, the Company recorded $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20230101__20230331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zVNcIhRFhQf7" title="Compensation expense">45,778</span> and $<span id="xdx_908_eus-gaap--ShareBasedCompensation_c20220101__20220331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zLKOueWqJpla" title="Compensation expense">32,939</span> as compensation expense related to vested options issued to employees and consultants, net of forfeitures, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenAndTwoThousandTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zrKIxf3zTvv3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the three months ended March 31, 2023, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zcLt3OFrmHge" style="display: none">Schedule of Stock Option Activity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p> <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Exercise</p> <p style="margin-top: 0; margin-bottom: 0">Price</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Remaining</p> <p style="margin-top: 0; margin-bottom: 0">Contractual</p> <p style="margin-top: 0; margin-bottom: 0">Term</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p> <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p> <p style="margin-top: 0; margin-bottom: 0">Value ($000)</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Outstanding, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zIMfat1vhZN9" style="width: 10%; text-align: right" title="Number of Options, Outstanding Beginning">57,122</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z9TR7NuQiWb5" style="width: 10%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning">9.44</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zvBpAa6cJXwc" title="Weighted Average Remaining Contractual Term, Beginning">6.0</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zZ4aF04sASuj" style="width: 10%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">      <span style="-sec-ix-hidden: xdx2ixbrl0983">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zh5feBVmsIq9" style="text-align: right" title="Number of Options, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0985">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zGMW6HN8lKXe" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0987">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zSnhgmfdgQM9" title="Weighted Average Remaining Contractual Term, Granted">0.0</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_ztWoLOCcRmP3" style="text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0991">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zYOdn1VaojMh" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0993">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zOpMkZpXQWRf" style="text-align: right" title="Number of Options, Forfeited/Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl0995">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_za3HsHpIbzb1" style="text-align: right" title="Weighted Average Exercise Price, Forfeited/Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl0997">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zQL2gNECqCB9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="-sec-ix-hidden: xdx2ixbrl0999">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zUvCCy4KKbhi" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1001">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zHuWw7QxHn25" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending">57,122</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z38taFA90Ewb" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending">9.44</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zRI4lUZo12O" title="Weighted Average Remaining Contractual Term, Outstanding Ending">5.7</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zRfpTdp7pOae" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="-sec-ix-hidden: xdx2ixbrl1009">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable, March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zrykrijRECQ1" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending">57,122</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zW4seoV282ri" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending">9.44</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zzXmzo1FfCac" title="Weighted Average Remaining Contractual Term, Exercisable Ending">5.7</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zAQTQd9Wpund" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="-sec-ix-hidden: xdx2ixbrl1017">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zSgU4l9c3kHb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no non-vested, non-qualified stock options issued to directors under the 2017 Equity Plan and the 2021 Equity Plan, for the three months ended March 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023 and March 31, 2022, the Company incurred $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20230101__20230331__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zaX8U624V8Xb" title="Share based compensation">0</span> and $<span id="xdx_904_eus-gaap--ShareBasedCompensation_c20220101__20220331__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zoLCFohLqLNh" title="Share based compensation">29,656</span> respectively, as compensation expense related to <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20230101__20230331__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zKAIz1R9cE7a" title="Number of options to purchase shares">0</span> and <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20220331__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z91d2kkvtZD6" title="Number of options to purchase shares">6,250</span> fully vested options issued to directors, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Restricted Stock Units</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 3, 2023, the Company issued a total of <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20230102__20230103__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z686ujVUniNf" title="Number of shares vested in period">119,032</span> restricted stock units (RSUs) under the 2021 Equity Plan to its four independent directors. These RSUs vested upon grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 17, 2023, the Company settled <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230116__20230117__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zrxN3DVKJwJf" title="Number of shares granted">3,366</span> RSUs that had been issued on January 17, 2022 to two new directors and that vested after 12 months by the issuance of shares of common stock</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023 and March 31, 2022, the Company recorded $<span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zr162F1fVNo">101,316</span> and $<span id="xdx_904_eus-gaap--ShareBasedCompensation_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z8vJu8Di8u3h">29,923</span>, respectively, as compensation expense related to vested RSUs issued to directors.</span></p> <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zsgOfq8VwOad" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zw3ylWhBkb6g" style="display: none">Schedule of Restricted Stock Units Activity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p> <p style="margin-top: 0; margin-bottom: 0">Units</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Grant-Date</p> <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p> <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p> <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td></td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%">Outstanding, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zGpT1wgo0fj7" style="width: 12%; text-align: right" title="Number of Units Outstanding, beginning">3,366</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zPOMAGFb2fA" style="width: 12%; text-align: right" title="Weighted Average Grant-Date Fair Value Outstanding, Beginning">7.42</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z7TOFzPlYTO6" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value Outstanding, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1039">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zFci5TXq9HAd" style="text-align: right" title="Number of Units, Granted">119,032</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zrNr6kVGlqO2" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Granted">0.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z880sm2SSF01" style="text-align: right" title="Aggregate Intrinsic Value Outstanding, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1045">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Vested and settled with share issuance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQCmXgUVGtk5" style="text-align: right" title="Number of Units, Vested and settled with share issuance">(122,398</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zHc0x9fr6dzf" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested and settled with share issuance">1.02</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z4UzQ8uPN0Rl" style="text-align: right" title="Aggregate Intrinsic Value Outstanding, Vested and settled with share issuance"><span style="-sec-ix-hidden: xdx2ixbrl1051">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Forfeited/canceled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQ1f2Tj9L9Uc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Units, Forfeited/canceled"><span style="-sec-ix-hidden: xdx2ixbrl1053">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z1hA2I46ppRk" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited/Canceled"><span style="-sec-ix-hidden: xdx2ixbrl1055">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zLnefp4lXnie" style="padding-bottom: 1.5pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, Forfeited/canceled"><span style="-sec-ix-hidden: xdx2ixbrl1057">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding, March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zcq6yDkmt9V3" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Units Outstanding, ending"><span style="-sec-ix-hidden: xdx2ixbrl1059">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zos07tXwkP41" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value Outstanding,ending"><span style="-sec-ix-hidden: xdx2ixbrl1061">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkiDMj00Alog" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, ending"><span style="-sec-ix-hidden: xdx2ixbrl1063">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zV0zi0tcrt75" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 333333 333333 163692 147177 22464 666667 122398 138491 P10Y 0.8955 89970 32376 666667 132568 183615 40816 309668 45919 P2Y <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zNm0Ey2ckfJg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the three months ended March 31, 2023, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zqHCxzVlWODf" style="display: none">Schedule of Stock Option Activity</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p> <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Exercise</p> <p style="margin-top: 0; margin-bottom: 0">Price</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Remaining</p> <p style="margin-top: 0; margin-bottom: 0">Contractual</p> <p style="margin-top: 0; margin-bottom: 0">Term</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p> <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p> <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Outstanding, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zeICNbtd4vol" style="width: 10%; text-align: right" title="Number of Options, Outstanding Beginning">192,073</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zP49nCrCpuS2" style="width: 10%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning">8.94</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zk2Y8YrSJ2Ce" title="Weighted Average Remaining Contractual Term, Beginning">7.6</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zaMP6SCh1by2" style="width: 10%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">            <span style="-sec-ix-hidden: xdx2ixbrl0891">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zt8BVLmdfBhf" style="text-align: right" title="Number of Options, Granted">138,489</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zb0dO1w5dY0h" style="text-align: right" title="Weighted Average Exercise Price, Granted">0.90</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zylxrRTI02b5" title="Weighted Average Remaining Contractual Term, Granted">8.4</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zNrFyqq2kLyi" style="text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0899">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zhKATeOHU9Fh" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0901">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zWZIBiOi7Rhg" style="text-align: right" title="Number of Options, Forfeited">(500</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zMRt5BmopKa2" style="text-align: right" title="Weighted Average Exercise Price, Forfeited">6.10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited_dtY_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zQxqcxwEJ30j" title="Weighted Average Remaining Contractual Term, Forfeited">8.9</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zqhAYr158RGa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="-sec-ix-hidden: xdx2ixbrl0909">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_za4p8769JsCl" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-hidden: xdx2ixbrl0911">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z63SNlMfGhwb" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending">330,062</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zaSfkoGjScc9" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending">5.57</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zoUYJbvjtk28" title="Weighted Average Remaining Contractual Term, Outstanding Ending">7.6</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_za5olVvmknI4" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="-sec-ix-hidden: xdx2ixbrl0919">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable, March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zkXZ6VjwhNg2" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending">304,972</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z2pJpE2B1MWh" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending">5.59</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zPxpwAGZMzDk" title="Weighted Average Remaining Contractual Term, Exercisable Ending">8.2</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zNlIZyVFGcrf" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="-sec-ix-hidden: xdx2ixbrl0927">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 192073 8.94 P7Y7M6D 138489 0.90 P8Y4M24D 500 6.10 P8Y10M24D 330062 5.57 P7Y7M6D 304972 5.59 P8Y2M12D <p id="xdx_898_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_z5JRSO0DZWGb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the three months ended March 31, 2023, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zER5WiYYiqvc" style="display: none">Summary of Non-vested Non-qualified Stock Option Activity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p> <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Grant-Date</p> <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p> <p style="margin-top: 0; margin-bottom: 0">Intrinsic Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Grant-Date</p> <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td></td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Nonvested, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z9McXHXqecc4" style="width: 10%; text-align: right" title="Number of Options Nonvested, Beginning">43,846</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zE5NLfUVSNIj" style="width: 10%; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Beginning">5.65</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zrvXYXAG5YK1" style="width: 10%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning">  <span style="-sec-ix-hidden: xdx2ixbrl0935">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z9MRDm8Lxcwg" style="width: 10%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning">247,730</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zy8QsMmIzbga" style="text-align: right" title="Number of Options Nonvested, Granted">138,489</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zGvR1qYdLd96" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Granted">0.88</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValues_pp0p0_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zTGHRxdNNKu6" style="text-align: right" title="Grant Date Fair Value Nonvested, Granted">122,346</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_pp0p0_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zhiRS4C1zKK4" style="text-align: right" title="Number of Options Nonvested, Vested">(156,912</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zyJsAy4NciC6" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Vested">1.49</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_iN_pp0p0_di_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z2A35RLAs1Nf" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested">(234,296</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zEH6TVzZmJHa" style="text-align: right" title="Number of Options Nonvested, Forfeited">(333</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zJQvwPy4wP7e" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Forfeited">6.67</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_iN_pp0p0_di_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zwxCiNQmh0eb" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited">(2,225</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zKrWSuwi9pG8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl0957">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zO3TeznVRfG8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl0959">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired_iN_pp0p0_di_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zV6qBdaa5vS1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl0961">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Nonvested, March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z0ZiDpR4Wx1d" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending">25,090</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_ztr3eVDRYTn1" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant-Date Fair Value, Nonvested, Beginning">4.98</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pdp0_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zUBuMa72KEwb" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="-sec-ix-hidden: xdx2ixbrl0967">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zg8YmTv07kVa" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending">133,555</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 43846 5.65 247730 138489 0.88 122346 -156912 1.49 234296 333 6.67 2225 25090 4.98 133555 45778 32939 <p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenAndTwoThousandTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zrKIxf3zTvv3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the three months ended March 31, 2023, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zcLt3OFrmHge" style="display: none">Schedule of Stock Option Activity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p> <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Exercise</p> <p style="margin-top: 0; margin-bottom: 0">Price</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Remaining</p> <p style="margin-top: 0; margin-bottom: 0">Contractual</p> <p style="margin-top: 0; margin-bottom: 0">Term</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p> <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p> <p style="margin-top: 0; margin-bottom: 0">Value ($000)</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Outstanding, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zIMfat1vhZN9" style="width: 10%; text-align: right" title="Number of Options, Outstanding Beginning">57,122</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z9TR7NuQiWb5" style="width: 10%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning">9.44</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zvBpAa6cJXwc" title="Weighted Average Remaining Contractual Term, Beginning">6.0</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zZ4aF04sASuj" style="width: 10%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">      <span style="-sec-ix-hidden: xdx2ixbrl0983">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zh5feBVmsIq9" style="text-align: right" title="Number of Options, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0985">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zGMW6HN8lKXe" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0987">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zSnhgmfdgQM9" title="Weighted Average Remaining Contractual Term, Granted">0.0</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_ztWoLOCcRmP3" style="text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0991">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zYOdn1VaojMh" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0993">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zOpMkZpXQWRf" style="text-align: right" title="Number of Options, Forfeited/Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl0995">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_za3HsHpIbzb1" style="text-align: right" title="Weighted Average Exercise Price, Forfeited/Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl0997">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zQL2gNECqCB9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="-sec-ix-hidden: xdx2ixbrl0999">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zUvCCy4KKbhi" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1001">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zHuWw7QxHn25" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending">57,122</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z38taFA90Ewb" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending">9.44</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zRI4lUZo12O" title="Weighted Average Remaining Contractual Term, Outstanding Ending">5.7</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zRfpTdp7pOae" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="-sec-ix-hidden: xdx2ixbrl1009">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable, March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zrykrijRECQ1" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending">57,122</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zW4seoV282ri" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending">9.44</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zzXmzo1FfCac" title="Weighted Average Remaining Contractual Term, Exercisable Ending">5.7</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230101__20230331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zAQTQd9Wpund" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="-sec-ix-hidden: xdx2ixbrl1017">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 57122 9.44 P6Y P0Y 57122 9.44 P5Y8M12D 57122 9.44 P5Y8M12D 0 29656 0 6250 119032 3366 101316 29923 <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zsgOfq8VwOad" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zw3ylWhBkb6g" style="display: none">Schedule of Restricted Stock Units Activity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p> <p style="margin-top: 0; margin-bottom: 0">Units</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Grant-Date</p> <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p> <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p> <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td></td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%">Outstanding, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zGpT1wgo0fj7" style="width: 12%; text-align: right" title="Number of Units Outstanding, beginning">3,366</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zPOMAGFb2fA" style="width: 12%; text-align: right" title="Weighted Average Grant-Date Fair Value Outstanding, Beginning">7.42</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z7TOFzPlYTO6" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value Outstanding, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1039">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zFci5TXq9HAd" style="text-align: right" title="Number of Units, Granted">119,032</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zrNr6kVGlqO2" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Granted">0.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z880sm2SSF01" style="text-align: right" title="Aggregate Intrinsic Value Outstanding, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1045">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Vested and settled with share issuance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQCmXgUVGtk5" style="text-align: right" title="Number of Units, Vested and settled with share issuance">(122,398</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zHc0x9fr6dzf" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested and settled with share issuance">1.02</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z4UzQ8uPN0Rl" style="text-align: right" title="Aggregate Intrinsic Value Outstanding, Vested and settled with share issuance"><span style="-sec-ix-hidden: xdx2ixbrl1051">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Forfeited/canceled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQ1f2Tj9L9Uc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Units, Forfeited/canceled"><span style="-sec-ix-hidden: xdx2ixbrl1053">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z1hA2I46ppRk" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited/Canceled"><span style="-sec-ix-hidden: xdx2ixbrl1055">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zLnefp4lXnie" style="padding-bottom: 1.5pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, Forfeited/canceled"><span style="-sec-ix-hidden: xdx2ixbrl1057">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding, March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zcq6yDkmt9V3" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Units Outstanding, ending"><span style="-sec-ix-hidden: xdx2ixbrl1059">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zos07tXwkP41" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value Outstanding,ending"><span style="-sec-ix-hidden: xdx2ixbrl1061">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkiDMj00Alog" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, ending"><span style="-sec-ix-hidden: xdx2ixbrl1063">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3366 7.42 119032 0.84 122398 1.02 <p id="xdx_80D_ecustom--WarrantsDisclosureTextBlock_zUqkRFg65Iyc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 9 - <span id="xdx_826_zZEYM2SdsVfa">Warrants</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_zbvZeGJiaHgj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information with respect to outstanding warrants to purchase common stock during the three months ended March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zKMLkuvme7a4" style="display: none">Schedule of Outstanding Warrants to Purchase Common Stock</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="text-align: center; font-weight: bold">Aggregate</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Remaining Life</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Intrinsic</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Outstanding</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercisable</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">In Months</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%">Outstanding at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20230331_zlR3IUnH3536" style="width: 11%; text-align: right" title="Warrants Outstanding, Beginning Balance">7,623,772</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iS_c20230101__20230331_zduqOZAnMdAb" style="width: 11%; text-align: right" title="Warrants Exercisable, Beginning Balance">7,623,772</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20230101__20230331_zIHN6eLmivYf" style="width: 9%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance">5.14</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230331_zBcKe8hdIw0e" title="Weighted Average Life of Outstanding Warrants in Months, Beginning Balance">49</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20230101__20230331_zQm7q1Te9Ml" style="width: 9%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance">     <span style="-sec-ix-hidden: xdx2ixbrl1077">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20230101__20230331_zz4J3uphfxwe" style="text-align: right" title="Warrants, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1079">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted_c20230101__20230331_zHfhg2wFNfgc" style="text-align: right" title="Warrants, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1081">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceGranted_c20230101__20230331_zPDwgIzhVNl7" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1083">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms_dtM_c20230101__20230331_fKg_____zqIZdGepgW8h" title="Weighted Average Life of Outstanding Warrants in Months, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1085">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_c20230101__20230331_zL81zvP3dsa9" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1087">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ClassOfWarrantOrRightExercised_c20230101__20230331_z5cLcEPEN2E" style="text-align: right" title="Warrants, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1089">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised_c20230101__20230331_zz32tr0gCGY9" style="text-align: right" title="Warrants, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1091">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_c20230101__20230331_z2XjWHJKQUu2" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1093">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms_dtM_c20230101__20230331_fKg_____zNh53vFST0gl"><span style="-sec-ix-hidden: xdx2ixbrl1094">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised_pp0p0_c20230101__20230331_znGh8Vwnh4x7" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1096">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_pp0p0_c20230101__20230331_z8JYREuZZD2b" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1098">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations_pp0p0_c20230101__20230331_zfUMpPoLX9S6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1100">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_c20230101__20230331_zfqwZI8JGjni" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1102">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpirations_pp0p0_c20230101__20230331_zZ1SCWrMeTA6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1104">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding at March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20230101__20230331_zczYR6ybYov" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Ending Balance">7,623,772</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20230101__20230331_zN0la7GY1VE5" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Exercisable, Ending Balance">7,623,772</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20230101__20230331_zHpeAlMXrpX1" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Ending Balance">5.14</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20230101__20230331_zZScjpt1eY86" title="Weighted Average Life of Outstanding Warrants in Months, Ending Balance">46</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20230101__20230331_zn6Oo6BP6RR1" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"><span style="-sec-ix-hidden: xdx2ixbrl1114">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zT53bcVIP6Vd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zEMuex3eOg86" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information about warrants outstanding at March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zcM9bFbvC45c" style="display: none">Schedule of Warrants Outstanding</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted Average</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Exercise price</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Outstanding</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercisable</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Months Outstanding</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zP8qp8bUXb2i" style="width: 22%; text-align: right" title="Exercise price">9.45</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zjP8S47DtIbd" style="width: 22%; text-align: right" title="Warrants Outstanding">192,982</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_znoccLMGZxo6" style="width: 20%; text-align: right" title="Warrants Exercisable">192,982</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 22%; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zXZHAZAujG3h" title="Weighted average remaining contractual terms (in Months)">18</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zDJb0izZfj98" style="text-align: right" title="Exercise price">10.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_z2pSLg3uj6Fk" style="text-align: right" title="Warrants Outstanding">34,737</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zPyZJ9mI9vM8" style="text-align: right" title="Warrants Exercisable">34,737</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_ztggniLjujC4" title="Weighted average remaining contractual terms (in Months)">19</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zqvdXD3mgvkj" style="text-align: right" title="Exercise price">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_z58kEnrUc8Nl" style="text-align: right" title="Warrants Outstanding">7,105,496</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zTCXo1xYNJFe" style="text-align: right" title="Warrants Exercisable">7,105,496</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zyNunQjoP608" title="Weighted average remaining contractual terms (in Months)">47</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_z3j8EI5uT0t6" style="padding-bottom: 1.5pt; text-align: right" title="Exercise price">5.16</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zw6OMpJwquG3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants Outstanding">290,557</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zQMLTc97K8gc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants Exercisable">290,557</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zON9utp9Mfje" title="Weighted average remaining contractual terms (in Months)">47</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230331_zWHyJh4cqIq7" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding">7,623,772</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230331_zwY5naKJnnyb" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Exercisable">7,623,772</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230331_zH6J4F5b2969" title="Weighted Average Life of Outstanding Warrants in Months">46</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zIINUxEUoyk5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_893_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_zbvZeGJiaHgj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information with respect to outstanding warrants to purchase common stock during the three months ended March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zKMLkuvme7a4" style="display: none">Schedule of Outstanding Warrants to Purchase Common Stock</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="text-align: center; font-weight: bold">Aggregate</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Remaining Life</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Intrinsic</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Outstanding</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercisable</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">In Months</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%">Outstanding at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20230331_zlR3IUnH3536" style="width: 11%; text-align: right" title="Warrants Outstanding, Beginning Balance">7,623,772</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iS_c20230101__20230331_zduqOZAnMdAb" style="width: 11%; text-align: right" title="Warrants Exercisable, Beginning Balance">7,623,772</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20230101__20230331_zIHN6eLmivYf" style="width: 9%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance">5.14</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230331_zBcKe8hdIw0e" title="Weighted Average Life of Outstanding Warrants in Months, Beginning Balance">49</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20230101__20230331_zQm7q1Te9Ml" style="width: 9%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance">     <span style="-sec-ix-hidden: xdx2ixbrl1077">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20230101__20230331_zz4J3uphfxwe" style="text-align: right" title="Warrants, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1079">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted_c20230101__20230331_zHfhg2wFNfgc" style="text-align: right" title="Warrants, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1081">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceGranted_c20230101__20230331_zPDwgIzhVNl7" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1083">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms_dtM_c20230101__20230331_fKg_____zqIZdGepgW8h" title="Weighted Average Life of Outstanding Warrants in Months, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1085">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_c20230101__20230331_zL81zvP3dsa9" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1087">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ClassOfWarrantOrRightExercised_c20230101__20230331_z5cLcEPEN2E" style="text-align: right" title="Warrants, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1089">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised_c20230101__20230331_zz32tr0gCGY9" style="text-align: right" title="Warrants, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1091">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_c20230101__20230331_z2XjWHJKQUu2" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1093">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms_dtM_c20230101__20230331_fKg_____zNh53vFST0gl"><span style="-sec-ix-hidden: xdx2ixbrl1094">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised_pp0p0_c20230101__20230331_znGh8Vwnh4x7" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1096">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_pp0p0_c20230101__20230331_z8JYREuZZD2b" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1098">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations_pp0p0_c20230101__20230331_zfUMpPoLX9S6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1100">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_c20230101__20230331_zfqwZI8JGjni" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1102">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpirations_pp0p0_c20230101__20230331_zZ1SCWrMeTA6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1104">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding at March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20230101__20230331_zczYR6ybYov" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Ending Balance">7,623,772</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20230101__20230331_zN0la7GY1VE5" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Exercisable, Ending Balance">7,623,772</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20230101__20230331_zHpeAlMXrpX1" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Ending Balance">5.14</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20230101__20230331_zZScjpt1eY86" title="Weighted Average Life of Outstanding Warrants in Months, Ending Balance">46</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20230101__20230331_zn6Oo6BP6RR1" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"><span style="-sec-ix-hidden: xdx2ixbrl1114">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 7623772 7623772 5.14 P49M 7623772 7623772 5.14 P46M <p id="xdx_89A_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zEMuex3eOg86" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information about warrants outstanding at March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zcM9bFbvC45c" style="display: none">Schedule of Warrants Outstanding</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted Average</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Exercise price</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Outstanding</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercisable</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Months Outstanding</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zP8qp8bUXb2i" style="width: 22%; text-align: right" title="Exercise price">9.45</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zjP8S47DtIbd" style="width: 22%; text-align: right" title="Warrants Outstanding">192,982</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_znoccLMGZxo6" style="width: 20%; text-align: right" title="Warrants Exercisable">192,982</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 22%; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zXZHAZAujG3h" title="Weighted average remaining contractual terms (in Months)">18</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zDJb0izZfj98" style="text-align: right" title="Exercise price">10.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_z2pSLg3uj6Fk" style="text-align: right" title="Warrants Outstanding">34,737</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zPyZJ9mI9vM8" style="text-align: right" title="Warrants Exercisable">34,737</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_ztggniLjujC4" title="Weighted average remaining contractual terms (in Months)">19</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zqvdXD3mgvkj" style="text-align: right" title="Exercise price">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_z58kEnrUc8Nl" style="text-align: right" title="Warrants Outstanding">7,105,496</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zTCXo1xYNJFe" style="text-align: right" title="Warrants Exercisable">7,105,496</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zyNunQjoP608" title="Weighted average remaining contractual terms (in Months)">47</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_z3j8EI5uT0t6" style="padding-bottom: 1.5pt; text-align: right" title="Exercise price">5.16</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zw6OMpJwquG3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants Outstanding">290,557</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zQMLTc97K8gc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants Exercisable">290,557</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zON9utp9Mfje" title="Weighted average remaining contractual terms (in Months)">47</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20230331_zWHyJh4cqIq7" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding">7,623,772</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20230331_zwY5naKJnnyb" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Exercisable">7,623,772</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20230101__20230331_zH6J4F5b2969" title="Weighted Average Life of Outstanding Warrants in Months">46</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 9.45 192982 192982 P18M 10.40 34737 34737 P19M 5.00 7105496 7105496 P47M 5.16 290557 290557 P47M 7623772 7623772 P46M <p id="xdx_809_eus-gaap--IncomeTaxDisclosureTextBlock_zrfyryKNDxki" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 10 – <span id="xdx_82B_zsYa7W45tPO8">Income Taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, the Company has U.S. federal and state net operating losses (“NOLs”) of approximately $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_c20230331_zRRdFZWQM3Y1" title="Operating loss carryforward">26,380,000</span>, of which $<span id="xdx_906_ecustom--NetOperatingLossCarryForwardExpectedToExpireAmount_iI_c20230331_zQ3BSlb2haNh" title="Net operating loss carry forward expected to expire amount">11,196,000</span> will expire, if not utilized, in the years <span id="xdx_907_ecustom--NetOperatingLossExpirationTerm_c20230101__20230331_zhxhEUAbx0Sa" title="Net operating loss expiration term">2034 through 2037</span>, however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to <span id="xdx_901_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_dp_uPure_c20230331_zcbROLykbOZe" title="NOLs usage against taxable income, percentage">80</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of the Company’s NOLs carryforwards may be limited in the event of cumulative changes in ownership of more than <span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OwnershipMember_zbALMCyLXLbl" title="Percentage of ownership change">50</span>% within a <span id="xdx_90E_ecustom--NolsCarryforwardsTermDescription_c20230101__20230331_zrpU4QBxPfg2" title="NOLs carryforwards term">three-year period</span>. In addition, under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”), and corresponding provisions of state law, if a corporation undergoes an “ownership change,” which is generally defined as a greater than <span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OwnershipMember_zUEI7J9CQZc9" title="Percentage of ownership change">50</span>% change, by value, in its equity ownership over a three-year period, the corporation’s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. Our sale of securities, both in September 2021 and February 2022, will need to be considered for determination of any “ownership change” that we have undergone during a determination period. If an ownership change occurs and our ability to use our net operating loss carryforwards is materially limited, it would harm our future bottom-line operating results by effectively increasing our future tax obligations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the Company believes that recovery is not likely, the Company establishes a valuation allowance. Management’s judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against the net deferred tax assets. The Company recorded a full valuation allowance as of March 31, 2023 and December 31, 2022. Based on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions that are consistent with the Company’s plans. Should the actual amounts differ from the Company’s estimates, the carrying value of the Company’s deferred tax assets could be materially impacted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 26380000 11196000 2034 through 2037 0.80 0.50 three-year period 0.50 <p id="xdx_806_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z17d0ux6EKT9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 11 – <span id="xdx_829_zX64wIvs12c">Related Party Transactions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company entered into a manufacturer representative agreement with RSX Enterprises (“RSX”) in March 2021 to become a non-exclusive representative for the Company to assist in marketing and soliciting orders. James R. Shipley, a current director of the Company, has a significant ownership interest in RSX.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada and Mexico and may receive a commission for qualified customer leads. The agreement had an initial term through December 31, 2021 with automatic one-year renewal terms unless notice is given 90 days prior to each annual expiration. During the three months ended March 31, 2023 and March 31, 2022, the Company paid $<span id="xdx_909_eus-gaap--PaymentsForCommissions_c20230101__20230331_zA1lZe2VhTlj" title="Payments for commissions">18,273</span> and $<span id="xdx_902_eus-gaap--PaymentsForCommissions_c20220101__20220331_zYIl8oEL5ff7" title="Payments for commissions">7,555</span>, respectively, in commissions under this agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 13, 2022, the Company entered into an agreement with Lone Star Bioscience, Inc. (Lone Star) to provide engineering design services. Nicholas Etten, one of our independent directors, is the Chief Executive Officer of Lone Star. The agreement totaled $<span id="xdx_903_ecustom--ProceedsFomDeposit_c20221012__20221013__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__dei--LegalEntityAxis__custom--LoneStarBioscienceIncMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zQmB5MH6XQwa" title="Proceeds from deposits">2,500</span> with $<span id="xdx_905_ecustom--ProceedsFomDeposit_c20220101__20221231__dei--LegalEntityAxis__custom--LoneStarBioscienceIncMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zT51DJbMfjZ1" title="Proceeds from deposits">1,250</span> received as a deposit in 2022. Another agreement for engineering services was signed on December 20, 2022, in the amount of $<span id="xdx_901_ecustom--ProceedsFomDeposit_c20221219__20221220__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_z4puWYazg50g" title="Proceeds from deposits">10,900</span>. We entered into positive change orders in March of $<span id="xdx_901_ecustom--ProceedsFomDeposit_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__dei--LegalEntityAxis__custom--LoneStarBioscienceIncMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z1Cq8iJaZrh1" title="Proceeds from deposits">3,577</span> increasing the total of the second sales order to $<span id="xdx_901_ecustom--ProceedsFomSales_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__dei--LegalEntityAxis__custom--LoneStarBioscienceIncMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zGi8NgCTbtV5" title="Proceeds from sales">14,477</span>. During the three months ended March 31, 2023, the Company received $<span id="xdx_902_eus-gaap--PaymentsForDeposits_c20230101__20230331_zb3BnMgtpR4f" title="Cash payments">14,035</span> in cash payments for these contracts. Revenue of $<span id="xdx_901_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20230101__20230331_zdayLZ2HAKm3" title="Revenue">16,977</span> was recorded in the three months ended March 31, 2023 in respect of these agreements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 18273 7555 2500 1250 10900 3577 14477 14035 16977 <p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_z9huO9KCNqXl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 12 – <span id="xdx_828_zbRdBqjOCOgi">Subsequent Events</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 855, <i>Subsequent Events</i>, the Company has evaluated all subsequent events through the date of issuance of these financial statements issued and determined no material subsequent events occurred after March 31, 2023 for which disclosure was required.</span></p> EXCEL 59 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 61 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 62 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 140 312 1 false 61 0 false 7 false false R1.htm 00000001 - Document - Cover Sheet http://ceaindustries.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://ceaindustries.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://ceaindustries.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://ceaindustries.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited) Sheet http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://ceaindustries.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Nature of Operations and Significant Accounting Policies Sheet http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPolicies Nature of Operations and Significant Accounting Policies Notes 7 false false R8.htm 00000008 - Disclosure - Leases Sheet http://ceaindustries.com/role/Leases Leases Notes 8 false false R9.htm 00000009 - Disclosure - Inventory Sheet http://ceaindustries.com/role/Inventory Inventory Notes 9 false false R10.htm 00000010 - Disclosure - Property and Equipment Sheet http://ceaindustries.com/role/PropertyAndEquipment Property and Equipment Notes 10 false false R11.htm 00000011 - Disclosure - Accounts Payable and Accrued Liabilities Sheet http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilities Accounts Payable and Accrued Liabilities Notes 11 false false R12.htm 00000012 - Disclosure - Commitments and Contingencies Sheet http://ceaindustries.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 12 false false R13.htm 00000013 - Disclosure - Stockholders??? Equity (Deficit) Sheet http://ceaindustries.com/role/StockholdersEquityDeficit Stockholders??? Equity (Deficit) Notes 13 false false R14.htm 00000014 - Disclosure - Equity Incentive Plans Sheet http://ceaindustries.com/role/EquityIncentivePlans Equity Incentive Plans Notes 14 false false R15.htm 00000015 - Disclosure - Warrants Sheet http://ceaindustries.com/role/Warrants Warrants Notes 15 false false R16.htm 00000016 - Disclosure - Income Taxes Sheet http://ceaindustries.com/role/IncomeTaxes Income Taxes Notes 16 false false R17.htm 00000017 - Disclosure - Related Party Transactions Sheet http://ceaindustries.com/role/RelatedPartyTransactions Related Party Transactions Notes 17 false false R18.htm 00000018 - Disclosure - Subsequent Events Sheet http://ceaindustries.com/role/SubsequentEvents Subsequent Events Notes 18 false false R19.htm 00000019 - Disclosure - Nature of Operations and Significant Accounting Policies (Policies) Sheet http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies Nature of Operations and Significant Accounting Policies (Policies) Policies http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPolicies 19 false false R20.htm 00000020 - Disclosure - Nature of Operations and Significant Accounting Policies (Tables) Sheet http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables Nature of Operations and Significant Accounting Policies (Tables) Tables http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPolicies 20 false false R21.htm 00000021 - Disclosure - Leases (Tables) Sheet http://ceaindustries.com/role/LeasesTables Leases (Tables) Tables http://ceaindustries.com/role/Leases 21 false false R22.htm 00000022 - Disclosure - Inventory (Tables) Sheet http://ceaindustries.com/role/InventoryTables Inventory (Tables) Tables http://ceaindustries.com/role/Inventory 22 false false R23.htm 00000023 - Disclosure - Property and Equipment (Tables) Sheet http://ceaindustries.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://ceaindustries.com/role/PropertyAndEquipment 23 false false R24.htm 00000024 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) Sheet http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables Accounts Payable and Accrued Liabilities (Tables) Tables http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilities 24 false false R25.htm 00000025 - Disclosure - Equity Incentive Plans (Tables) Sheet http://ceaindustries.com/role/EquityIncentivePlansTables Equity Incentive Plans (Tables) Tables http://ceaindustries.com/role/EquityIncentivePlans 25 false false R26.htm 00000026 - Disclosure - Warrants (Tables) Sheet http://ceaindustries.com/role/WarrantsTables Warrants (Tables) Tables http://ceaindustries.com/role/Warrants 26 false false R27.htm 00000027 - Disclosure - Schedule of Revenue by Source (Details) Sheet http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails Schedule of Revenue by Source (Details) Details 27 false false R28.htm 00000028 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details) Sheet http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails Schedule of Remaining Performance Obligations Expected to be Recognized (Details) Details 28 false false R29.htm 00000029 - Disclosure - Schedule of Share-based Compensation Costs (Details) Sheet http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails Schedule of Share-based Compensation Costs (Details) Details 29 false false R30.htm 00000030 - Disclosure - Nature of Operations and Significant Accounting Policies (Details Narrative) Sheet http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative Nature of Operations and Significant Accounting Policies (Details Narrative) Details http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables 30 false false R31.htm 00000031 - Disclosure - Schedule of Lease Cost (Details) Sheet http://ceaindustries.com/role/ScheduleOfLeaseCostDetails Schedule of Lease Cost (Details) Details 31 false false R32.htm 00000032 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details) Sheet http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails Schedule of Future Annual Minimum Lease Payments (Details) Details 32 false false R33.htm 00000033 - Disclosure - Leases (Details Narrative) Sheet http://ceaindustries.com/role/LeasesDetailsNarrative Leases (Details Narrative) Details http://ceaindustries.com/role/LeasesTables 33 false false R34.htm 00000034 - Disclosure - Schedule of Inventory (Details) Sheet http://ceaindustries.com/role/ScheduleOfInventoryDetails Schedule of Inventory (Details) Details 34 false false R35.htm 00000035 - Disclosure - Inventory (Details Narrative) Sheet http://ceaindustries.com/role/InventoryDetailsNarrative Inventory (Details Narrative) Details http://ceaindustries.com/role/InventoryTables 35 false false R36.htm 00000036 - Disclosure - Schedule of Property and Equipment (Details) Sheet http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails Schedule of Property and Equipment (Details) Details 36 false false R37.htm 00000037 - Disclosure - Property and Equipment (Details Narrative) Sheet http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative Property and Equipment (Details Narrative) Details http://ceaindustries.com/role/PropertyAndEquipmentTables 37 false false R38.htm 00000038 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details) Sheet http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails Schedule of Accounts Payable and Accrued Liabilities (Details) Details 38 false false R39.htm 00000039 - Disclosure - Stockholders??? Equity (Deficit) (Details Narrative) Sheet http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative Stockholders??? Equity (Deficit) (Details Narrative) Details http://ceaindustries.com/role/StockholdersEquityDeficit 39 false false R40.htm 00000040 - Disclosure - Schedule of Stock Option Activity (Details) Sheet http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails Schedule of Stock Option Activity (Details) Details 40 false false R41.htm 00000041 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details) Sheet http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails Summary of Non-vested Non-qualified Stock Option Activity (Details) Details 41 false false R42.htm 00000042 - Disclosure - Schedule of Restricted Stock Units Activity (Details) Sheet http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails Schedule of Restricted Stock Units Activity (Details) Details 42 false false R43.htm 00000043 - Disclosure - Equity Incentive Plans (Details Narrative) Sheet http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative Equity Incentive Plans (Details Narrative) Details http://ceaindustries.com/role/EquityIncentivePlansTables 43 false false R44.htm 00000044 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details) Sheet http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails Schedule of Outstanding Warrants to Purchase Common Stock (Details) Details 44 false false R45.htm 00000045 - Disclosure - Schedule of Warrants Outstanding (Details) Sheet http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails Schedule of Warrants Outstanding (Details) Details 45 false false R46.htm 00000046 - Disclosure - Income Taxes (Details Narrative) Sheet http://ceaindustries.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://ceaindustries.com/role/IncomeTaxes 46 false false R47.htm 00000047 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://ceaindustries.com/role/RelatedPartyTransactions 47 false false All Reports Book All Reports form10-q.htm cead-20230331.xsd cead-20230331_cal.xml cead-20230331_def.xml cead-20230331_lab.xml cead-20230331_pre.xml ex31-1.htm ex31-2.htm ex32-1.htm ex32-2.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 64 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-q.htm": { "axisCustom": 0, "axisStandard": 18, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 505, "http://xbrl.sec.gov/dei/2023": 34 }, "contextCount": 140, "dts": { "calculationLink": { "local": [ "cead-20230331_cal.xml" ] }, "definitionLink": { "local": [ "cead-20230331_def.xml" ] }, "inline": { "local": [ "form10-q.htm" ] }, "labelLink": { "local": [ "cead-20230331_lab.xml" ] }, "presentationLink": { "local": [ "cead-20230331_pre.xml" ] }, "schema": { "local": [ "cead-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 484, "entityCount": 1, "hidden": { "http://ceaindustries.com/20230331": 47, "http://fasb.org/us-gaap/2023": 50, "http://xbrl.sec.gov/dei/2023": 6, "total": 103 }, "keyCustom": 70, "keyStandard": 242, "memberCustom": 41, "memberStandard": 19, "nsprefix": "CEAD", "nsuri": "http://ceaindustries.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://ceaindustries.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Property and Equipment", "menuCat": "Notes", "order": "10", "role": "http://ceaindustries.com/role/PropertyAndEquipment", "shortName": "Property and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Accounts Payable and Accrued Liabilities", "menuCat": "Notes", "order": "11", "role": "http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilities", "shortName": "Accounts Payable and Accrued Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "12", "role": "http://ceaindustries.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Stockholders\u2019 Equity (Deficit)", "menuCat": "Notes", "order": "13", "role": "http://ceaindustries.com/role/StockholdersEquityDeficit", "shortName": "Stockholders\u2019 Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Equity Incentive Plans", "menuCat": "Notes", "order": "14", "role": "http://ceaindustries.com/role/EquityIncentivePlans", "shortName": "Equity Incentive Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "CEAD:WarrantsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Warrants", "menuCat": "Notes", "order": "15", "role": "http://ceaindustries.com/role/Warrants", "shortName": "Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "CEAD:WarrantsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "16", "role": "http://ceaindustries.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "17", "role": "http://ceaindustries.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "18", "role": "http://ceaindustries.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "CEAD:DescriptionOfBusinessPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Nature of Operations and Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "19", "role": "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies", "shortName": "Nature of Operations and Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "CEAD:DescriptionOfBusinessPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://ceaindustries.com/role/BalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Nature of Operations and Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "20", "role": "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables", "shortName": "Nature of Operations and Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Leases (Tables)", "menuCat": "Tables", "order": "21", "role": "http://ceaindustries.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Inventory (Tables)", "menuCat": "Tables", "order": "22", "role": "http://ceaindustries.com/role/InventoryTables", "shortName": "Inventory (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Property and Equipment (Tables)", "menuCat": "Tables", "order": "23", "role": "http://ceaindustries.com/role/PropertyAndEquipmentTables", "shortName": "Property and Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)", "menuCat": "Tables", "order": "24", "role": "http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables", "shortName": "Accounts Payable and Accrued Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Equity Incentive Plans (Tables)", "menuCat": "Tables", "order": "25", "role": "http://ceaindustries.com/role/EquityIncentivePlansTables", "shortName": "Equity Incentive Plans (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - Warrants (Tables)", "menuCat": "Tables", "order": "26", "role": "http://ceaindustries.com/role/WarrantsTables", "shortName": "Warrants (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Schedule of Revenue by Source (Details)", "menuCat": "Details", "order": "27", "role": "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails", "shortName": "Schedule of Revenue by Source (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-012023-03-31_custom_EquipmentAndSystemsSalesMember", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "CEAD:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)", "menuCat": "Details", "order": "28", "role": "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "shortName": "Schedule of Remaining Performance Obligations Expected to be Recognized (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "CEAD:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - Schedule of Share-based Compensation Costs (Details)", "menuCat": "Details", "order": "29", "role": "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails", "shortName": "Schedule of Share-based Compensation Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://ceaindustries.com/role/BalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockSharesIssued", "span", "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - Nature of Operations and Significant Accounting Policies (Details Narrative)", "menuCat": "Details", "order": "30", "role": "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "shortName": "Nature of Operations and Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - Schedule of Lease Cost (Details)", "menuCat": "Details", "order": "31", "role": "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails", "shortName": "Schedule of Lease Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": null, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details)", "menuCat": "Details", "order": "32", "role": "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails", "shortName": "Schedule of Future Annual Minimum Lease Payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-07-28", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseRenewalTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - Leases (Details Narrative)", "menuCat": "Details", "order": "33", "role": "http://ceaindustries.com/role/LeasesDetailsNarrative", "shortName": "Leases (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-07-28", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseRenewalTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - Schedule of Inventory (Details)", "menuCat": "Details", "order": "34", "role": "http://ceaindustries.com/role/ScheduleOfInventoryDetails", "shortName": "Schedule of Inventory (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSoldOverhead", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - Inventory (Details Narrative)", "menuCat": "Details", "order": "35", "role": "http://ceaindustries.com/role/InventoryDetailsNarrative", "shortName": "Inventory (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSoldOverhead", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - Schedule of Property and Equipment (Details)", "menuCat": "Details", "order": "36", "role": "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails", "shortName": "Schedule of Property and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - Property and Equipment (Details Narrative)", "menuCat": "Details", "order": "37", "role": "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "shortName": "Property and Equipment (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details)", "menuCat": "Details", "order": "38", "role": "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails", "shortName": "Schedule of Accounts Payable and Accrued Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockSharesAuthorized", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - Stockholders\u2019 Equity (Deficit) (Details Narrative)", "menuCat": "Details", "order": "39", "role": "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative", "shortName": "Stockholders\u2019 Equity (Deficit) (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "menuCat": "Statements", "order": "4", "role": "http://ceaindustries.com/role/StatementsOfOperations", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-012023-03-31_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_EmployeesAndConsultantsMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - Schedule of Stock Option Activity (Details)", "menuCat": "Details", "order": "40", "role": "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "shortName": "Schedule of Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)", "menuCat": "Details", "order": "41", "role": "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails", "shortName": "Summary of Non-vested Non-qualified Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember_us-gaap_RestrictedStockUnitsRSUMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - Schedule of Restricted Stock Units Activity (Details)", "menuCat": "Details", "order": "42", "role": "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "shortName": "Schedule of Restricted Stock Units Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember_us-gaap_RestrictedStockUnitsRSUMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-06-202022-06-21", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - Equity Incentive Plans (Details Narrative)", "menuCat": "Details", "order": "43", "role": "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "shortName": "Equity Incentive Plans (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "lang": null, "name": "CEAD:EmployeeStockOwnershipPlanAdditionalExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details)", "menuCat": "Details", "order": "44", "role": "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "shortName": "Schedule of Outstanding Warrants to Purchase Common Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "lang": "en-US", "name": "CEAD:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - Schedule of Warrants Outstanding (Details)", "menuCat": "Details", "order": "45", "role": "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails", "shortName": "Schedule of Warrants Outstanding (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - Income Taxes (Details Narrative)", "menuCat": "Details", "order": "46", "role": "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative", "shortName": "Income Taxes (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsForCommissions", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - Related Party Transactions (Details Narrative)", "menuCat": "Details", "order": "47", "role": "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "Related Party Transactions (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsForCommissions", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited)", "menuCat": "Statements", "order": "5", "role": "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit", "shortName": "Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "menuCat": "Statements", "order": "6", "role": "http://ceaindustries.com/role/StatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - Nature of Operations and Significant Accounting Policies", "menuCat": "Notes", "order": "7", "role": "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPolicies", "shortName": "Nature of Operations and Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Leases", "menuCat": "Notes", "order": "8", "role": "http://ceaindustries.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Inventory", "menuCat": "Notes", "order": "9", "role": "http://ceaindustries.com/role/Inventory", "shortName": "Inventory", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 61, "tag": { "CEAD_AdjustmentsToAdditionalPaidInCapitalDividendsOnPreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Dividends on series B preferred stock", "label": "Dividends on series B preferred stock" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalDividendsOnPreferredStock", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "CEAD_AdjustmentsToAdditionalPaidInCapitalFairValueOfRestrictedStockUnitsIssuedToDirectors": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of restricted stock units issued to directors", "label": "Fair value of restricted stock units issued to directors" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalFairValueOfRestrictedStockUnitsIssuedToDirectors", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "CEAD_AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToDirectors": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments to additional paid in capital fair value of vested stock options granted to directors.", "label": "Fair value of vested stock options granted to directors" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToDirectors", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "CEAD_AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToEmployees": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of vested stock options granted to employees", "label": "Fair value of vested stock options granted to employees" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToEmployees", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "CEAD_AdvertisingAndMarketingExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Advertising And Marketing Expenses [Member]" } } }, "localname": "AdvertisingAndMarketingExpensesMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "CEAD_AuditCommitteeChairmanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Audit Committee Chairman [Member]", "label": "Audit Committee Chairman [Member]" } } }, "localname": "AuditCommitteeChairmanMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_BookedSalesOrdersFromThreeCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Booked Sales Orders From Three Customers [Member]" } } }, "localname": "BookedSalesOrdersFromThreeCustomersMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_CashProceedsFromSaleOfCommonStockAndWarrantsNetOfIssuanceCosts": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash proceeds from sale of common stock and warrants net of issuance costs.", "label": "Net cash proceeds on sale of common stock and warrants, net of expenses" } } }, "localname": "CashProceedsFromSaleOfCommonStockAndWarrantsNetOfIssuanceCosts", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CEAD_ClassOfWarrantOrRightExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of Warrant or Right Exercised", "label": "Warrants, Exercised" } } }, "localname": "ClassOfWarrantOrRightExercised", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "sharesItemType" }, "CEAD_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate intrinsic value of outstanding warrants.", "label": "Aggregate intrinsic value of outstanding warrants", "periodStartLabel": "Aggregate Intrinsic Value, Beginning Balance" } } }, "localname": "ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price of warrants exercised.", "label": "Weighted Average Exercise Price, Exercised [Default Label]", "verboseLabel": "Weighted Average Exercise Price, Exercised" } } }, "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceExercised", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "perShareItemType" }, "CEAD_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price of warrants expired.", "label": "Weighted Average Exercise Price, Expired [Default Label]", "verboseLabel": "Weighted Average Exercise Price, Expired" } } }, "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceExpired", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "perShareItemType" }, "CEAD_ClassOfWarrantOrRightWeightedAverageExercisePriceGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants weighted average exercise price granted.", "label": "Weighted Average Exercise Price, Granted" } } }, "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceGranted", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "perShareItemType" }, "CEAD_CommitteeChairmanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Committee Chairman [Member]", "label": "Committee Chairman [Member]" } } }, "localname": "CommitteeChairmanMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_CommonSharesAndWarrantsIssuedSharesForCash": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common shares and warrants issued shares for cash.", "label": "Common shares and warrants issued for cash, shares" } } }, "localname": "CommonSharesAndWarrantsIssuedSharesForCash", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "CEAD_CommonSharesAndWarrantsIssuedValueForCash": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common shares and warrants issued value for cash.", "label": "Common shares and warrants issued for cash" } } }, "localname": "CommonSharesAndWarrantsIssuedValueForCash", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "CEAD_CommonStock0.00001ParValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, $0.00001 par value" } } }, "localname": "CommonStock0.00001ParValueMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "domainItemType" }, "CEAD_ConsultingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consulting Agreement [Member]", "label": "Consulting Agreement [Member]" } } }, "localname": "ConsultingAgreementMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_ConvertiblePreferredStockConvertedToSecurities": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Convertible preferred stock converted to securities.", "label": "ConvertiblePreferredStockConvertedToSecurities", "negatedLabel": "Convertible preferred series B stock dividends" } } }, "localname": "ConvertiblePreferredStockConvertedToSecurities", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "CEAD_CustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer One [Member]", "label": "Customer One [Member]" } } }, "localname": "CustomerOneMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_CustomerThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Three [Member]", "label": "Customer Three [Member]" } } }, "localname": "CustomerThreeMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_CustomerTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Two [Member]", "label": "Customer Two [Member]" } } }, "localname": "CustomerTwoMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_DeemedDividendPreferredStockOnDownRound": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deemed dividend on series B preferred stock on down round.", "label": "Deemed dividend on series B preferred stock on down round", "negatedLabel": "Deemed dividend on convertible preferred series B stock on down round" } } }, "localname": "DeemedDividendPreferredStockOnDownRound", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "CEAD_DescriptionOfBusinessPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of Business" } } }, "localname": "DescriptionOfBusinessPolicyTextBlock", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "CEAD_DirectorAndStaffMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Director And Staff [Member]", "label": "Director And Staff [Member]" } } }, "localname": "DirectorAndStaffMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_DirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Directors [Member]", "label": "Directors [Member]" } } }, "localname": "DirectorsMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_DisclosureLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases", "terseLabel": "Schedule Of Future Annual Minimum Lease Payments", "verboseLabel": "Schedule Of Lease Cost" } } }, "localname": "DisclosureLeasesAbstract", "nsuri": "http://ceaindustries.com/20230331", "xbrltype": "stringItemType" }, "CEAD_DisclosureWarrantsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants", "verboseLabel": "Schedule Of Outstanding Warrants To Purchase Common Stock" } } }, "localname": "DisclosureWarrantsAbstract", "nsuri": "http://ceaindustries.com/20230331", "xbrltype": "stringItemType" }, "CEAD_EmployeeStockOwnershipPlanAdditionalExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Additional expense" } } }, "localname": "EmployeeStockOwnershipPlanAdditionalExpense", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "CEAD_EmployeesAndConsultantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Employees And Consultants [Member]" } } }, "localname": "EmployeesAndConsultantsMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "CEAD_EmployeesDirectorsandConsultantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employees, Directors and Consultants [Member]", "label": "Employees, Directors and Consultants [Member]" } } }, "localname": "EmployeesDirectorsandConsultantsMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "domainItemType" }, "CEAD_EngineeringAndOtherServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Engineering And Other Services [Member]" } } }, "localname": "EngineeringAndOtherServicesMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "domainItemType" }, "CEAD_EquipmentAndSystemsSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equipment And Systems Sales [Member]" } } }, "localname": "EquipmentAndSystemsSalesMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "domainItemType" }, "CEAD_FiveEmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Five Employees [Member]" } } }, "localname": "FiveEmployeesMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impact of the COVID-19 Pandemic on Our Business" } } }, "localname": "ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "CEAD_ImpactofUkrainianConflictPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impact of Ukrainian Conflict" } } }, "localname": "ImpactofUkrainianConflictPolicyTextBlock", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "CEAD_IncentiveStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Incentive Stock Option [Member]", "label": "Incentive Stock Option [Member]" } } }, "localname": "IncentiveStockOptionMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_IncreaseInRentPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Increase in rent percent.", "label": "Increase in rent percent" } } }, "localname": "IncreaseInRentPercent", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "xbrltype": "percentItemType" }, "CEAD_InflationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inflation" } } }, "localname": "InflationPolicyTextBlock", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "CEAD_InterimFinancialStatementsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interim Financial Statements" } } }, "localname": "InterimFinancialStatementsPolicyTextBlock", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "CEAD_InventoryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inventory [Member]", "label": "Inventory [Member]" } } }, "localname": "InventoryMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_JanuarySeventeernTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "January 17, 2023 [Member]", "label": "January 17, 2023 [Member]" } } }, "localname": "JanuarySeventeernTwoThousandTwentyThreeMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_JanuarySeventeernTwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "January 17, 2022 [Member]", "label": "January 17, 2022 [Member]" } } }, "localname": "JanuarySeventeernTwoThousandTwentyTwoMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Therafter", "label": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_LiquidityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:LiquidityPolicyTextBlock]" } } }, "localname": "LiquidityPolicyTextBlock", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "CEAD_LoneStarBioscienceIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lone Star Bioscience Inc [Member]", "label": "Lone Star Bioscience Inc [Member]" } } }, "localname": "LoneStarBioscienceIncMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_MiscellaneousMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Miscellaneous [Member]" } } }, "localname": "MiscellaneousMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "domainItemType" }, "CEAD_NetOperatingLossCarryForwardExpectedToExpireAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net operating loss carry forward expected to expire amount.", "label": "Net operating loss carry forward expected to expire amount" } } }, "localname": "NetOperatingLossCarryForwardExpectedToExpireAmount", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "CEAD_NetOperatingLossExpirationTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net operating loss expiration term.", "label": "Net operating loss expiration term" } } }, "localname": "NetOperatingLossExpirationTerm", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "CEAD_NewFacilityLeaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Facility Lease [Member]", "label": "New Facility Lease [Member]" } } }, "localname": "NewFacilityLeaseMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_NolsCarryforwardsTermDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nols carryforwards term description.", "label": "NOLs carryforwards term" } } }, "localname": "NolsCarryforwardsTermDescription", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "CEAD_NolsUsageAgainstTaxableIncomePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nols usage against taxable income percentage.", "label": "NOLs usage against taxable income, percentage" } } }, "localname": "NolsUsageAgainstTaxableIncomePercentage", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "percentItemType" }, "CEAD_NonQualifiedStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non Qualified Stock Option [Member]", "label": "Non Qualified Stock Option [Member]" } } }, "localname": "NonQualifiedStockOptionMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_NonQualifiedStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-qualified Stock Options [Member]", "label": "Non-Qualified Stock Options [Member]" } } }, "localname": "NonQualifiedStockOptionsMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_NoncashInvestingAndFinancingActivitiesConversionOfSeriesBPreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion of series B preferred stock.", "label": "Conversion of series B preferred stock" } } }, "localname": "NoncashInvestingAndFinancingActivitiesConversionOfSeriesBPreferredStock", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CEAD_NoncashInvestingAndFinancingActivitiesDeemedDividendPreferredStockArisingOnDownRound": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deemed dividend on series B preferred stock arising on down round.", "label": "Deemed dividend on series B preferred stock arising on down round" } } }, "localname": "NoncashInvestingAndFinancingActivitiesDeemedDividendPreferredStockArisingOnDownRound", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CEAD_OneCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One Customer [Member]", "label": "One Customer [Member]" } } }, "localname": "OneCustomerMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_OptionsIssuedForAccruedEquityCompensationLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Options issued for accrued equity compensation liability" } } }, "localname": "OptionsIssuedForAccruedEquityCompensationLiability", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CEAD_OwnershipMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ownership [Member].", "label": "Ownership [Member]" } } }, "localname": "OwnershipMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_PaymentsForRedemptionOfPreferredStock": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Redemption of series B preferred stock", "label": "Redemption of series B preferred stock", "negatedLabel": "Redemption of series B preferred stock" } } }, "localname": "PaymentsForRedemptionOfPreferredStock", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CEAD_PrepaidInventoryExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaid inventory expenses", "label": "Prepaid inventory expenses" } } }, "localname": "PrepaidInventoryExpenses", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/InventoryDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "CEAD_ProceedsFomDeposit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Proceeds fom deposit.", "label": "Proceeds from deposits" } } }, "localname": "ProceedsFomDeposit", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "CEAD_ProceedsFomSales": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds fom sales.", "label": "Proceeds from sales" } } }, "localname": "ProceedsFomSales", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "CEAD_ProductDevelopmentCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Product Development Costs [Member]" } } }, "localname": "ProductDevelopmentCostsMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "CEAD_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Remaining performance obligations related to engineering only paid contracts.", "label": "Remaining performance obligations related to engineering only paid contracts" } } }, "localname": "RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Remaining performance obligations related to partial equipment paid contracts.", "label": "Remaining performance obligations related to partial equipment paid contracts" } } }, "localname": "RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_ReverseStockSplitPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:ReverseStockSplitPolicyTextBlock]" } } }, "localname": "ReverseStockSplitPolicyTextBlock", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "CEAD_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Outstanding Warrants To Purchase Common Stock [Table Text Block]", "label": "Schedule of Outstanding Warrants to Purchase Common Stock" } } }, "localname": "ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/WarrantsTables" ], "xbrltype": "textBlockItemType" }, "CEAD_ShareBasedCompensationArrangemenByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award, number of shares authorized.", "label": "Number of shares authorized [Default Label]", "verboseLabel": "Number of shares authorized" } } }, "localname": "ShareBasedCompensationArrangemenByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "sharesItemType" }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised", "verboseLabel": "Warrants, Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExercised", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "sharesItemType" }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations", "verboseLabel": "Warrants, Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableExpirations", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "sharesItemType" }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted", "verboseLabel": "Warrants, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableGranted", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "sharesItemType" }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options exercisable, including both vested and non-vested instruments.", "label": "Warrants Exercisable", "periodEndLabel": "Warrants Exercisable, Ending Balance", "periodStartLabel": "Warrants Exercisable, Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "sharesItemType" }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedPeriod": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award value issued period.", "label": "Share based compensation arrangement payment" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedPeriod", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of exercised award under share-based payment arrangement. Excludes share and unit options.", "label": "Aggregate Intrinsic Value, Exercised" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpirations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of expirations award under share-based payment arrangement. Excludes share and unit options.", "label": "Aggregate Intrinsic Value, Expired" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpirations", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of forfeited under share-based payment arrangement. Excludes share and unit options.", "label": "Aggregate Intrinsic Value Outstanding, Forfeited/canceled" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of granted under share-based payment arrangement. Excludes share and unit options.", "label": "Aggregate Intrinsic Value Outstanding, Granted", "verboseLabel": "Aggregate Intrinsic Value, Granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Life, Exercised", "label": "Weighted Average Remaining Life, Exercised" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisedWeightedAverageRemainingContractualTerms", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants weighted average remaining contractual terms.", "label": "Weighted Average Life of Outstanding Warrants in Months, Granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsGrantedWeightedAverageRemainingContractualTerms", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average life of outstanding warrants in months, ending balance.", "label": "Weighted Average Life of Outstanding Warrants in Months, Ending Balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average life of outstanding warrants in months, beginning balance.", "label": "Weighted Average Life of Outstanding Warrants in Months, Beginning Balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Forfeited.", "label": "Grant Date Fair Value Nonvested, Forfeited", "negatedLabel": "Grant Date Fair Value Nonvested, Forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options nonvested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Aggregated Intrinsic Value, Nonvested Beginning", "periodEndLabel": "Aggregated Intrinsic Value, Nonvested Ending", "periodStartLabel": "Aggregated Intrinsic Value, Nonvested Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested.", "label": "Aggregated Intrinsic Value, Nonvested Beginning [Default Label]", "periodEndLabel": "Grant Date Fair Value Nonvested, Ending", "periodStartLabel": "Grant Date Fair Value Nonvested, Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired", "negatedLabel": "Grant Date Fair Value Nonvested, Expired" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueExpired", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Vested.", "label": "Grant Date Fair Value Nonvested, Vested", "negatedLabel": "Grant Date Fair Value Nonvested, Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sharebased compensation arrangement by sharebased payment award options nonvested grant date fair values", "label": "Grant Date Fair Value Nonvested, Granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValues", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Granted.", "label": "Number of Options Nonvested, Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Options, price per share.", "label": "Weighted Average Grant-Date Fair Value, Nonvested, Expired" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Options, Expired.", "label": "Number of Options Nonvested, Expired" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Contractual Term, Ending.", "label": "Weighted Average Remaining Contractual Term, Outstanding Ending" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Contractual Term,Forfeited.", "label": "Weighted Average Remaining Contractual Term, Forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term, granted.", "label": "Weighted Average Remaining Contractual Term, Granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "CEAD_StockIssuedDuringPeriodSharesCommonSharesIssuedInSettlementOfRestrictedStockUnitsIssuedToDirectors": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common shares issued in settlement of restricted stock units issued to directors", "label": "Common shares issued in settlement of restricted stock units issued to directors, shares" } } }, "localname": "StockIssuedDuringPeriodSharesCommonSharesIssuedInSettlementOfRestrictedStockUnitsIssuedToDirectors", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "CEAD_StockIssuedDuringPeriodSharesFairValueOfRestrictedStockUnitsIssuedToDirectors": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares fair value of restricted stock units issued to directors.", "label": "Fair value of restricted stock units issued to directors, shares" } } }, "localname": "StockIssuedDuringPeriodSharesFairValueOfRestrictedStockUnitsIssuedToDirectors", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "CEAD_StockIssuedDuringPeriodValueCommonSharesIssuedInSettlementOfRestrictedStockUnitsIssuedToDirectors": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common shares issued in settlement of restricted stock units issued to directors.", "label": "Common shares issued in settlement of restricted stock units issued to directors" } } }, "localname": "StockIssuedDuringPeriodValueCommonSharesIssuedInSettlementOfRestrictedStockUnitsIssuedToDirectors", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "CEAD_StockIssuedDuringPeriodValueReverseStockSplits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common shares to round up partial shares following reverse split", "label": "Issuance of common shares to round up partial shares following reverse split" } } }, "localname": "StockIssuedDuringPeriodValueReverseStockSplits", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "CEAD_TemporaryEquityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Temporary Equity" } } }, "localname": "TemporaryEquityPolicyTextBlock", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "CEAD_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017 Equity Plan and 2021 Equity Plan [Member]", "label": "2017 Equity Plan and 2021 Equity Plan [Member]" } } }, "localname": "TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandAndSeventeenEquityPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017 Equity Incentive Plan [Member]", "label": "2017 Equity Incentive Plan [Member]" } } }, "localname": "TwoThousandAndSeventeenEquityPlanMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandAndTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2024 [Member]", "label": "2024 [Member]" } } }, "localname": "TwoThousandAndTwentyFourMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandAndTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2023 [Member]", "label": "2023 [Member]" } } }, "localname": "TwoThousandAndTwentyThreeMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandSeventeenAndTwoThousandTwentyOneEquityPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017 Equity Plan and 2021 Equity Plan [Member]", "label": "2017 Equity Plan and 2021 Equity Plan [Member] [Default Label]", "verboseLabel": "2017 Equity Plan and 2021 Equity Plan [Member]" } } }, "localname": "TwoThousandSeventeenAndTwoThousandTwentyOneEquityPlanMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansTables" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandTwentyOneEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2021 Equity Incentive Plan [Member]", "label": "2021 Equity Incentive Plan [Member]" } } }, "localname": "TwoThousandTwentyOneEquityIncentivePlanMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandTwentyOneEquityPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2021 Equity Plan [Member]", "label": "2021 Equity Plan [Member]" } } }, "localname": "TwoThousandTwentyOneEquityPlanMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_UnderwritersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriters [Member]", "label": "Underwriters [Member]" } } }, "localname": "UnderwritersMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_WarrantsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Disclosure [Text Block]", "label": "Outstanding Warrants", "verboseLabel": "Warrants" } } }, "localname": "WarrantsDisclosureTextBlock", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/Warrants" ], "xbrltype": "textBlockItemType" }, "CEAD_WarrantsRangeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Range [Member]", "label": "Warrants Range [Member]" } } }, "localname": "WarrantsRangeMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "CEAD_WarrantsRangeOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Range One [Member]", "label": "Warrants Range One [Member]" } } }, "localname": "WarrantsRangeOneMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "CEAD_WarrantsRangeThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Range Three [Member]", "label": "Warrants Range Three [Member]" } } }, "localname": "WarrantsRangeThreeMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "CEAD_WarrantsRangeTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Range Two [Member]", "label": "Warrants Range Two [Member]" } } }, "localname": "WarrantsRangeTwoMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "CEAD_WarrantsToPurchaseCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants to purchase common stock" } } }, "localname": "WarrantsToPurchaseCommonStockMember", "nsuri": "http://ceaindustries.com/20230331", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r526", "r528", "r529" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r527" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r530" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r534" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r532" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r522" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r523" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r519" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_BoardOfDirectorsChairmanMember": { "auth_ref": [ "r561" ], "lang": { "en-us": { "role": { "label": "Board of Directors Chairman [Member]" } } }, "localname": "BoardOfDirectorsChairmanMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r561" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_DirectorMember": { "auth_ref": [ "r561", "r619" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [ "r200", "r201", "r202" ], "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r197", "r500", "r574", "r616", "r617" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r197", "r500", "r574", "r616", "r617" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r195", "r353", "r382", "r383", "r384", "r385", "r386", "r387", "r490", "r499", "r504", "r540", "r566", "r567", "r574", "r616" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r195", "r353", "r382", "r383", "r384", "r385", "r386", "r387", "r490", "r499", "r504", "r540", "r566", "r567", "r574", "r616" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r200", "r201", "r202" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r561", "r610" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued liabilities", "totalLabel": "Total" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accounts Payable and Accrued Liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r17", "r503" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r487" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r198", "r199" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalesCommissionCurrent": { "auth_ref": [ "r21", "r493" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Sales commissions payable" } } }, "localname": "AccruedSalesCommissionCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r42", "r131", "r376" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [ "r140", "r141", "r328", "r329", "r330", "r331", "r332", "r333" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r140", "r141", "r328", "r329", "r330", "r331", "r332", "r333" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r72", "r503", "r620" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r291", "r292", "r293", "r404", "r557", "r558", "r559", "r604", "r622" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r287", "r298" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Total share-based compensation expense included in consolidated statement of operations" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AreaOfLand": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of land held.", "label": "Area of land" } } }, "localname": "AreaOfLand", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "xbrltype": "areaItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r106", "r132", "r152", "r182", "r189", "r193", "r203", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r313", "r315", "r327", "r369", "r440", "r503", "r514", "r571", "r572", "r612" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r127", "r137", "r152", "r203", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r313", "r315", "r327", "r503", "r571", "r572", "r612" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r152", "r203", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r313", "r315", "r327", "r571", "r572", "r612" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total Noncurrent Assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncurrent Assets" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [ "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r258", "r259", "r260", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r282", "r283", "r284", "r285", "r286" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Financial Statement Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r112", "r371", "r415", "r435", "r503", "r514", "r541" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash balance, amount" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r28", "r129", "r491" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r29", "r105" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash, Cash Equivalents, and Restricted Cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r28", "r89", "r150" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash and cash equivalents, end of period", "periodStartLabel": "Cash and cash equivalents, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r1", "r89" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r541", "r615" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash equivalent balance, amount" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Federal insured amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-cash investing and financing activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r124", "r133", "r134", "r135", "r152", "r169", "r170", "r175", "r177", "r180", "r181", "r203", "r213", "r215", "r216", "r217", "r220", "r221", "r224", "r225", "r227", "r230", "r236", "r327", "r395", "r396", "r397", "r398", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r416", "r427", "r449", "r469", "r481", "r482", "r483", "r484", "r485", "r535", "r555", "r560" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/Cover", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r237" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "periodEndLabel": "Weighted Average Exercise Price, Ending Balance", "periodStartLabel": "Weighted Average Exercise Price, Beginning Balance", "verboseLabel": "Exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Prefunded conversion warrants" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r23", "r63", "r370", "r426" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies (Note 6)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r98", "r211", "r212", "r488", "r565" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Shares available for future equity awards" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r505", "r506", "r507", "r509", "r510", "r511", "r512", "r557", "r558", "r604", "r618", "r622" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r71" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par or stated value per share", "verboseLabel": "Common stock par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r71", "r427" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r71" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r8", "r71", "r427", "r446", "r622", "r623" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r71", "r373", "r503" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.00001 par value; 200,000,000 authorized; 8,076,372 and 7,953,974 shares issued and outstanding, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r33", "r35", "r60", "r61", "r197", "r487" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r33", "r35", "r60", "r61", "r197", "r393", "r487" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r33", "r35", "r60", "r61", "r197", "r487", "r538" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r64", "r115" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentrations" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r33", "r35", "r60", "r61", "r197" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r33", "r35", "r60", "r61", "r197", "r487" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r55", "r495" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r239", "r240", "r251" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred revenue", "verboseLabel": "Contract with customer liability current" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r252" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Revenue recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSoldOverhead": { "auth_ref": [ "r550" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Indirect cost incurred related to good produced and service rendered.", "label": "Overhead expenses" } } }, "localname": "CostOfGoodsAndServicesSoldOverhead", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/InventoryDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r83", "r152", "r203", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r327", "r571" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r34", "r197" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredCompensationLiabilityCurrent": { "auth_ref": [ "r46", "r102" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.", "label": "Accrued equity compensation" } } }, "localname": "DeferredCompensationLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsAssetsNoncurrent": { "auth_ref": [ "r542" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.", "label": "Deposits" } } }, "localname": "DepositsAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r5", "r41" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation expenses" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r5", "r185" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation and intangible asset amortization expense" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [ "r417", "r418", "r432", "r433", "r434", "r436", "r437", "r438", "r439", "r441", "r442", "r443", "r444", "r457", "r458", "r459", "r460", "r463", "r464", "r465", "r466", "r477", "r478", "r479", "r480", "r505", "r507" ], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r56", "r57", "r58", "r59", "r417", "r418", "r432", "r433", "r434", "r436", "r437", "r438", "r439", "r441", "r442", "r443", "r444", "r457", "r458", "r459", "r460", "r463", "r464", "r465", "r466", "r477", "r478", "r479", "r480", "r494", "r505", "r507" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r574" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Schedule of Revenue by Source" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r254", "r257", "r288", "r289", "r290", "r501" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Equity Incentive Plans" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r143", "r159", "r160", "r161", "r162", "r163", "r167", "r169", "r175", "r176", "r177", "r178", "r325", "r326", "r366", "r380", "r496" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Loss per common share \u2013 basic and diluted" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r31", "r32" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Income (Loss) Per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r21" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued payroll liabilities" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r602" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Unrecognized compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r8", "r125", "r140", "r141", "r142", "r154", "r155", "r156", "r158", "r164", "r166", "r179", "r204", "r205", "r238", "r291", "r292", "r293", "r305", "r306", "r317", "r318", "r319", "r320", "r321", "r322", "r324", "r328", "r329", "r330", "r331", "r332", "r333", "r343", "r388", "r389", "r390", "r404", "r469" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Percentage of ownership change" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets": { "auth_ref": [ "r554", "r563", "r564" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property", "negatedLabel": "Loss on disposal of assets" } } }, "localname": "GainLossOnDispositionOfAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetImpairment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.", "label": "Goodwill and intangible asset impairment" } } }, "localname": "GoodwillAndIntangibleAssetImpairment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r7", "r40" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r82", "r152", "r182", "r188", "r192", "r194", "r203", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r327", "r498", "r571" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r0", "r80", "r108", "r182", "r188", "r192", "r194", "r367", "r378", "r498" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Loss before provision for income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r209", "r210", "r454" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r210", "r454" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement." } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r153", "r300", "r302", "r303", "r304", "r307", "r309", "r310", "r311", "r400" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r111", "r122", "r165", "r166", "r186", "r301", "r308", "r381" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r30" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income taxes paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r4" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r4" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r352", "r553" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "verboseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r4" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r539", "r553" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Operating lease liability, net" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": { "auth_ref": [ "r4" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.", "label": "Increase (Decrease) in Prepaid Expenses, Other", "negatedLabel": "Prepaid expenses and other" } } }, "localname": "IncreaseDecreaseInPrepaidExpensesOther", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": { "auth_ref": [ "r171", "r172", "r177" ], "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.", "label": "Potentially dilutive equity instruments that are convertible into common stock" } } }, "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_IntangibleAssetsNetIncludingGoodwill": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.", "label": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetIncludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r110" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest income (expense), net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r146", "r148", "r149" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r207" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/Inventory" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r545" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfInventoryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r136", "r492", "r503" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://ceaindustries.com/role/ScheduleOfInventoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, net", "totalLabel": "Inventory, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r547" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfInventoryDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r39", "r548" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfInventoryDetails": { "order": 4.0, "parentTag": "us-gaap_InventoryNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory Valuation Reserves", "negatedLabel": "Allowance for excess & obsolete inventory" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r546" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfInventoryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Work in progress" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r208" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Provision for excess and obsolete inventory" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r608" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Schedule of Lease Cost" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseDescription": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Description of lessee's operating lease.", "label": "Operating lease term description" } } }, "localname": "LesseeOperatingLeaseDescription", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r609" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Schedule of Future Annual Minimum Lease Payments" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r342" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r342" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r342" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r342" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r609" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "2023 (excluding the three months ended March 31, 2023)" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r342" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "auth_ref": [ "r607" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lease renew term" } } }, "localname": "LesseeOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "verboseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r20", "r152", "r203", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r314", "r315", "r316", "r327", "r425", "r497", "r514", "r571", "r612", "r613" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r76", "r107", "r375", "r503", "r556", "r562", "r606" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r22", "r128", "r152", "r203", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r314", "r315", "r316", "r327", "r503", "r571", "r612", "r613" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r15", "r66", "r67", "r68", "r69", "r152", "r203", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r314", "r315", "r316", "r327", "r571", "r612", "r613" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total Noncurrent Liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncurrent Liabilities" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_ManagementFeeExpense": { "auth_ref": [ "r62", "r451", "r513", "r621" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment.", "label": "Management fee expense" } } }, "localname": "ManagementFeeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketingAndAdvertisingExpense": { "auth_ref": [ "r84" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising.", "label": "Advertising and marketing expenses" } } }, "localname": "MarketingAndAdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r147" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows From Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r147" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows From Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r89", "r90", "r91" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows From Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r81", "r91", "r109", "r126", "r138", "r139", "r142", "r152", "r157", "r159", "r160", "r161", "r162", "r165", "r166", "r173", "r182", "r188", "r192", "r194", "r203", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r326", "r327", "r379", "r448", "r467", "r468", "r498", "r513", "r571" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://ceaindustries.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit", "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r145", "r159", "r160", "r161", "r162", "r167", "r168", "r174", "r177", "r182", "r188", "r192", "r194", "r498" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net loss available to common shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recently Issued Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r85" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r182", "r188", "r192", "r194", "r498" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r336" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Present value of minimum lease payments", "verboseLabel": "Operating lease liability" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r336" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Current portion of operating lease liability", "verboseLabel": "Operating lease liability, current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r336" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease liability, net of current portion", "verboseLabel": "Operating lease liability, long-term" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r337", "r339" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating cash outflow from operating lease" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r335" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating lease right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r554" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.", "label": "Amortization of operating lease ROU asset" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r341", "r502" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r340", "r502" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r54" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating loss carryforward" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r92", "r93", "r94", "r104" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "Nature of Operations and Significant Accounting Policies" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r21" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other accrued expenses" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r86" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other income (expense), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForCommissions": { "auth_ref": [ "r3" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid for commissions during the current period.", "label": "Payments for commissions" } } }, "localname": "PaymentsForCommissions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForDeposits": { "auth_ref": [ "r551", "r552" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid for deposits on goods and services during the period; excludes time deposits and deposits with other institutions, which pertain to financial service entities.", "label": "Cash payments" } } }, "localname": "PaymentsForDeposits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r3" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Lease rental expense" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": { "auth_ref": [ "r27" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Preferred Stock and Preference Stock", "negatedLabel": "Payment of dividends on series B preferred stock" } } }, "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r88" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r70", "r224" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par or stated value per share", "verboseLabel": "Preferred stock par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r70", "r427" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r70", "r224" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r70", "r427", "r446", "r622", "r623" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r70", "r372", "r503" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, $0.00001 par value; 25,000,000 shares authorized; 0 shares issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r549" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r2" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Net proceeds from sale of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r87" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from the sale of property and equipment" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "auth_ref": [ "r21", "r569", "r570" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued warranty reserve amount", "verboseLabel": "Product warranty accrual" } } }, "localname": "ProductWarrantyAccrualClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r96", "r116", "r120", "r121" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r97", "r130", "r377" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment [Member]" } } }, "localname": "PropertyPlantAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r6", "r368", "r377", "r503" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 }, "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Schedule of Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r97" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r144", "r206" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Provision for doubtful accounts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r253", "r347", "r348", "r420", "r421", "r422", "r423", "r424", "r445", "r447", "r476" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r253", "r347", "r348", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r420", "r421", "r422", "r423", "r424", "r445", "r447", "r476", "r611" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party, Type [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r344", "r345", "r346", "r348", "r349", "r401", "r402", "r403", "r452", "r453", "r454", "r473", "r475" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r65", "r299", "r614" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Product development costs" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r31" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r73", "r100", "r374", "r391", "r392", "r399", "r428", "r503" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r125", "r154", "r155", "r156", "r158", "r164", "r166", "r204", "r205", "r291", "r292", "r293", "r305", "r306", "r317", "r319", "r320", "r322", "r324", "r388", "r390", "r404", "r622" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r183", "r184", "r187", "r190", "r191", "r195", "r196", "r197", "r249", "r250", "r353" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue, net", "terseLabel": "Miscellaneous revenue", "verboseLabel": "Total revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails", "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r183", "r184", "r187", "r190", "r191", "r195", "r196", "r197", "r249", "r250", "r353" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r123", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r489" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r119" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Total remaining performance obligations", "verboseLabel": "Revenue remaining performance obligation" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": { "auth_ref": [ "r536" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation.", "label": "Schedule of Remaining Performance Obligations Expected to be Recognized" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Number of shares sold" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r197", "r537" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Schedule of Accounts Payable and Accrued Liabilities" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r16", "r77", "r78", "r79" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/InventoryTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.", "label": "Summary of Non-vested Non-qualified Stock Option Activity" } } }, "localname": "ScheduleOfNonvestedShareActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": { "auth_ref": [ "r13", "r14", "r51" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.", "label": "Schedule of Share-based Compensation Costs" } } }, "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r255", "r256", "r258", "r259", "r260", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r282", "r283", "r284", "r285", "r286" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Schedule of Restricted Stock Units Activity" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r13", "r14", "r50" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of Stock Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Warrants Outstanding" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/WarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecurityDeposit": { "auth_ref": [ "r542" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.", "label": "Security deposit" } } }, "localname": "SecurityDeposit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r84" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r543", "r544", "r573" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r4" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based compensation", "verboseLabel": "Share based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Vesting rights description" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Number of Units, Forfeited/canceled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Weighted Average Grant-Date Fair Value, Forfeited/Canceled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Number of Units, Granted", "verboseLabel": "Number of shares granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Weighted Average Grant-Date Fair Value, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r270", "r271" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Number of Units Outstanding, ending", "periodStartLabel": "Number of Units Outstanding, beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r270", "r271" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted Average Grant-Date Fair Value Outstanding,ending", "periodStartLabel": "Weighted Average Grant-Date Fair Value Outstanding, Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": { "auth_ref": [ "r103" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average Life of Outstanding Warrants in Months" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Number of shares vested in period", "negatedLabel": "Number of Units, Vested and settled with share issuance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Weighted Average Grant-Date Fair Value, Vested and settled with share issuance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Stock price volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r285" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [ "r255", "r256", "r258", "r259", "r260", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r282", "r283", "r284", "r285", "r286" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.", "label": "Warrants, Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Warrants, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r9", "r10" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Warrants Outstanding", "periodEndLabel": "Warrants Outstanding, Ending Balance", "periodStartLabel": "Warrants Outstanding, Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.", "label": "Number of shares authorized" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Number of shares grant in period", "verboseLabel": "Number of stock options issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "periodEndLabel": "Number of Options, Exercisable Ending" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price, Exercisable Ending" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Number of Options, Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Number of Options, Forfeited/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r266" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Number of Options, Granted", "terseLabel": "Number of share awards granted", "verboseLabel": "Number of Options Nonvested, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Weighted Average Grant-Date Fair Value, Nonvested, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r48" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "periodEndLabel": "Aggregate Intrinsic Value, Outstanding Ending", "periodStartLabel": "Aggregate Intrinsic Value, Outstanding Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r262", "r263" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Number of option remain outstanding", "periodEndLabel": "Number of Options, Outstanding Ending", "periodStartLabel": "Number of Options, Outstanding Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r262", "r263" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price, Outstanding Ending", "periodStartLabel": "Weighted Average Exercise Price, Outstanding Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued under share-based payment arrangement.", "label": "Number of stock options issued", "verboseLabel": "Number of shares issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": { "auth_ref": [ "r603" ], "lang": { "en-us": { "role": { "documentation": "Number of shares purchased for issuance under share-based payment arrangement.", "label": "Number of options to purchase shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r258", "r259", "r260", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r282", "r283", "r284", "r285", "r286" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted Average Exercise Price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Weighted Average Exercise Price, Expired" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Weighted Average Exercise Price, Forfeited/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r266" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Exercise price", "terseLabel": "Exercise price per share", "verboseLabel": "Weighted Average Exercise Price, Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r254", "r261", "r280", "r281", "r282", "r283", "r286", "r294", "r295", "r296", "r297" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Accounting for Share-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r53" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding", "periodEndLabel": "Aggregate Intrinsic Value Outstanding, ending", "periodStartLabel": "Aggregate Intrinsic Value Outstanding, Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options.", "label": "Aggregate Intrinsic Value Outstanding, Vested and settled with share issuance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Expected Term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r48" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "periodEndLabel": "Aggregate Intrinsic Value, Exercisable Ending" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average Remaining Contractual Term, Exercisable Ending" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares", "periodEndLabel": "Number of Options Nonvested, Ending", "periodStartLabel": "Number of Options Nonvested, Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options forfeited.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares", "negatedLabel": "Number of Options Nonvested, Forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options forfeited.", "label": "Weighted Average Grant-Date Fair Value, Nonvested, Forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Grant-Date Fair Value, Nonvested, Beginning", "periodStartLabel": "Weighted Average Grant-Date Fair Value, Nonvested, Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r103" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average Remaining Contractual Term, Beginning", "verboseLabel": "Weighted Average Remaining Contractual Term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Shares, vested", "verboseLabel": "Number of options to purchase shares" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of options vested.", "label": "Weighted Average Grant-Date Fair Value, Nonvested, Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_ShippingAndHandlingMember": { "auth_ref": [ "r575" ], "lang": { "en-us": { "role": { "documentation": "Packing and transport of product.", "label": "Shipping and Handling [Member]" } } }, "localname": "ShippingAndHandlingMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StandardProductWarrantyDescription": { "auth_ref": [ "r43", "r44" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of the product warranty, including the approximate term of the product warranty, how the product warranty arose, and the events or circumstances that would require the warrantor to perform under the product warranty.", "label": "Product warranty description" } } }, "localname": "StandardProductWarrantyDescription", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StandardProductWarrantyPolicy": { "auth_ref": [ "r568" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.", "label": "Product Warranty" } } }, "localname": "StandardProductWarrantyPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r124", "r133", "r134", "r135", "r152", "r169", "r170", "r175", "r177", "r180", "r181", "r203", "r213", "r215", "r216", "r217", "r220", "r221", "r224", "r225", "r227", "r230", "r236", "r327", "r395", "r396", "r397", "r398", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r416", "r427", "r449", "r469", "r481", "r482", "r483", "r484", "r485", "r535", "r555", "r560" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/Cover", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r8", "r26", "r125", "r140", "r141", "r142", "r154", "r155", "r156", "r158", "r164", "r166", "r179", "r204", "r205", "r238", "r291", "r292", "r293", "r305", "r306", "r317", "r318", "r319", "r320", "r321", "r322", "r324", "r328", "r329", "r330", "r331", "r332", "r333", "r343", "r388", "r389", "r390", "r404", "r469" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r154", "r155", "r156", "r179", "r353", "r394", "r416", "r419", "r420", "r421", "r422", "r423", "r424", "r427", "r430", "r431", "r432", "r433", "r434", "r436", "r437", "r438", "r439", "r441", "r442", "r443", "r444", "r445", "r447", "r450", "r451", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r469", "r508" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/Cover", "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r154", "r155", "r156", "r179", "r353", "r394", "r416", "r419", "r420", "r421", "r422", "r423", "r424", "r427", "r430", "r431", "r432", "r433", "r434", "r436", "r437", "r438", "r439", "r441", "r442", "r443", "r444", "r445", "r447", "r450", "r451", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r469", "r508" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/Cover", "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r8", "r25", "r45", "r100", "r222" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Common shares issued and warrants on conversion of series B preferred stock, shares" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock issued during period, shares, issued for services" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r8", "r70", "r71", "r100", "r395", "r469", "r482" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Number of shares issued", "verboseLabel": "Shares issued during the period" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split.", "label": "Issuance of common shares to round up partial shares following reverse split, shares" } } }, "localname": "StockIssuedDuringPeriodSharesReverseStockSplits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r8", "r70", "r71", "r100", "r267" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Number of Options, Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockSplits": { "auth_ref": [ "r8", "r70", "r71", "r100" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of a stock split.", "label": "Stock Issued During Period, Shares, Stock Splits", "verboseLabel": "Reverse stock split" } } }, "localname": "StockIssuedDuringPeriodSharesStockSplits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r8", "r26", "r100" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Common shares issued and warrants on conversion of series B preferred stock" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r71", "r74", "r75", "r95", "r429", "r446", "r470", "r471", "r503", "r514", "r556", "r562", "r606", "r622" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r99", "r151", "r223", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r238", "r323", "r472", "r474", "r486" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "Stockholders\u2019 Equity (Deficit)" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficit" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityReverseStockSplit": { "auth_ref": [ "r101" ], "lang": { "en-us": { "role": { "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.", "label": "Reverse stock split" } } }, "localname": "StockholdersEquityReverseStockSplit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r350", "r351" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r36", "r37", "r38", "r113", "r114", "r117", "r118" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment used primarily for road transportation.", "label": "Vehicles [Member]" } } }, "localname": "VehiclesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [ "r505", "r506", "r509", "r510", "r511", "r512" ], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingMaturityDate": { "auth_ref": [ "r605" ], "lang": { "en-us": { "role": { "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.", "label": "Warrants maturity date" } } }, "localname": "WarrantsAndRightsOutstandingMaturityDate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r605" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrant term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r167", "r177" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average number of common shares outstanding, basic and diluted" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org//1943274/2147483070/710-10-25-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org//810/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(4)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org//606/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.B)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org//330/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org//718/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.C.Q3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org//740/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "808", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//842-20/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org//850/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column A))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column B))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column C))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column D))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column E))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column F))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(4)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(15))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org//1943274/2147483043/710-10-30-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r515": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r516": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r517": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r518": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r519": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r521": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r522": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r523": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r524": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r525": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r526": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r527": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r528": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r529": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r531": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r532": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r533": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r534": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(2))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r565": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(5)", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "https://asc.fasb.org//250/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org//360/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 65 0001493152-23-017264-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-017264-xbrl.zip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�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end